<?xml version="1.0" encoding="utf-8"?>
<XML>
<JOURNAL>
<YEAR>1392</YEAR>
<VOL>23</VOL>
<NO>109</NO>
<MOSALSAL>0</MOSALSAL>
<PAGE_NO>295</PAGE_NO>


<ARTICLES>

	<ARTICLE> 
		<TitleF>ارتباط سطح سرمی N-Terminal pro BNP و کسر جهش بطن چپ در بیماران با نارسایی سیستول قلبی</TitleF>
		<TitleE>Association of serum N-Terminal pro BNP in the Prediction Association of Serum N-Terminal pro BNP in Prediction of Left Ventricular Ejection Fraction in Patients with Systolic Ventricular Dysfunction</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: نارسایی قلبی در آمریکا سالانه حدود 3 میلیون ویزیت سرپایی اورژانس را شامل می‌شود. در نارسایی قلبی NT-pro BNP و در پاسخ به افزایش کشش میوکارد، از بافت میوکارد بطنی ترشح می‌شود.
مواد و روش‌ها: این مطالعه روی 80 فرد در بیمارستان حضرت فاطمه زهرا (س) ساری طی سال‌های 89 تا 90 انجام شد بیماران با 60GFR≤، سن 75≥ سال، با فیبریلاسیون دهلیزی و فشار خون بالا (100/160&#62; BP) از مطالعه خارج شدند. سپس بیماران به دقت مورد معاینه قرار گرفتند و 60 بیمار مبتلا به نارسایی جبران نشده قلبی در سه گروه 20 نفره با تعداد زن و مرد برابر تقسیم شدند؛ گروه اول: %30 LVEF≤، گروه دوم %39 ≤LVEF≤ %30 و گروه سوم %49 ≤LVEF≤ %40 تعداد 20 نفر سالم با %50 LVEF≥ نیز جهت تعیین Cut Point نرمال وارد مطالعه شدند.
یافته‌ها: : در بررسی NT-pro BNP بیش‌ترین میزان مربوط به گروه اول با 90/1781± 10/5370 و کم‌ترین میزان مربوط به گروه چهارم با 32/24± 75/36 بود. در مقایسه چهار گروه، اختلاف آماری معنی‌داری در میزان NT-Pro BNP بین گروه‌های مختلف مشاهده شد (001/0&#60; p). بین مقادیر LVEF با سطح سرمی NT-pro BNP همبستگی ناقص و معکوس مشاهده شد (699/0-= r).
استنتاج: با کاهش LVEF میزان NT-pro BNP به صورت معنی‌داری افزایش می‌یابد که بین آن‌ها یک رابطه همبستگی ناقص و معکوس وجود دارد. این امر امکان تخمین تقریبی EF را با توجه به سطح سرمی NT-pro BNP در بالین میسر می‌کند.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Annually heart failure includes about three million emergency outpatient visits in the United States. In heart failure NT-proBNP will be released in response to increased myocardial stretch
Materials and methods: This study was conducted in 80 individuals attending Fatemeh Zahra Hospital, in Sari, 2010-2011. Patients with GFR≤60, age≥75, atrial fibrillation (AF) and hypertension (BP≥160.100) were excluded. The patients were carefully examined and 60 patients with DHF were divided into three groups Group1 LVEF≤30%, group 2 LVEF≤31-39%, group 3 LVEF≤40-49%. Twenty healthy people with normal LVEF≥50% were also studied to determine the cut point.
Results: The highest level of NT-pro BNP was observed in group 1 (5370.10 ± 1781.90) and the lowest level was seen in group 4 (36.75 ± 24.32). Significant differences were found between the groups in NT-pro BNP level (P&#60;0.001). Also, incomplete and reverse correlation was observed between LVEF values and serum level NT-pro BNP (R= -0.699).
Conclusion: When LVEF reduced NT-pro BNP levels increased significantly which indicates an incomplete and reverse correlation between them. This finding allows using NT-pro BNP level for approximate estimation of ejection fraction in clinical practices.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>2</FPAGE>
			<TPAGE>7</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/16
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/27
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/16
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/27
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>صمد</Name>
				<MidName></MidName>
				<Family>گلشنی</Family>
				<NameE>Samad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Golshani</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>بابک</Name>
				<MidName></MidName>
				<Family>باقری</Family>
				<NameE>Babak</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Bagheri</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>dr.babakbagheri@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>علی</Name>
				<MidName></MidName>
				<Family>قائمیان</Family>
				<NameE>Ali</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghaemian</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>وحید</Name>
				<MidName></MidName>
				<Family>مخبری</Family>
				<NameE>Vahid</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mokhberi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>سهیل</Name>
				<MidName></MidName>
				<Family>عزیزی</Family>
				<NameE>Soheil</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Azizi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>علیرضا</Name>
				<MidName></MidName>
				<Family>خلیلیان</Family>
				<NameE>Alireza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khaninian</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>مهدی</Name>
				<MidName></MidName>
				<Family>نعمتی</Family>
				<NameE>Mehdi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Nemati</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>:  DHF</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>NT-pro BNP</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>LVEF</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>نارسایی قلبی جبران نشده</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>NT-pro BNP</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>کسر جهشی بطن چپ</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Writing Group Members##Thomas Thom; Nancy Haase; Wayne Rosamond, PhD; Virginia J. Howard, MSPH, FAHA; John Rumsfeld, MD, PhD, FAHA; Teri Manolio, MD, PhD, FAHA; Zhi-Jie Zheng, MD, PhD*; Katherine Flegal, PhD*; Christopher O’Donnell, MD, MPH, FAHA; Steven Kittner, MD; Donald Lloyd-Jones, MD; David C. Goff, Jr, MD, PhD, FAHA; Yuling Hong, MD, MSC, PhD, FAHA. Heart Disease and Stroke Statistics—2006 Update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:e85-e151.##2.	William B, Kannel MD, MPH. Incidence and epidemiology of heart failure. Heart Failure Reviews 5, 167-173, 2000##3.	Palazzuoli A, Gallotta M, Quatrini I, Nuti R. Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure. Vascular Health and Risk Management 2010:6 411–418.##4.	Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-328.##5.	Cheung BMY, Kumana CR. Natriuretic peptides-relevance in cardiac disease. JAMA. 1998; 280: 1983-1984.##6.	A Hirayama, H Kusuoka, H Yamamoto, Y Sakata, M Asakura, Y Higuchi, H Mizuno, K Kashiwase, Y Ueda, Y Okuyama, M Hori, K Kodama. Serial changes in plasma brain natriuretic peptide concentration at the infarct and noninfarct sites in patients with left ventricular remodelling after myocardial infarction. Heart 2005;91:1573–1577. doi: 10.1136/hrt.2004.##7.	Mark Richards, MD, PhD;  M. Gary Nicholls, MD;  Tim G. Yandle, PhD;  Chris Frampton, PhD;  Eric A. Espiner, MD; ##John G. Turner, MD;  Rona C. Buttimore, RN;  John G. Lainchbury, MB, ChB;  John M. Elliott, MB, ChB, PhD; Hamid Ikram, MD, PhD; Ian G. Crozier, MD; David W. Smyth, MD.  plasma N-terminal pro-brain natriuretic peptide and adrenomedullin; new neurohormonal predictore of left ventricular function and prognosis after myocardial infarction. Circulation 1998; 97: 1921-1929.##8.	S Talwar, I B Squire, P F Downie, J E Davies, L L Ng. Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. (Heart 2000;84:421–424)##9.	Bonow RO, Mann DL, Zipes DP, Libby P. Braunwald\'s Heart Disease: A Textbook of Cardiovascular Medicine. NINTH EDITION 2011. ##10.	Mugdim Bajrić1, Fahir Baraković1, Zumreta Kušljugić1, Nermin Salkić1, Elmir Jahić1, Mensura Aščerić3*, Farid Ljuca3, Denis Mršić1, Elnur Smajić1, Jasmin Čaluk2, Ramiz Hajrić2. Amino Terminal pro-brain natriuretic peptide in prediction of left ventricular ejection fraction. Bosn J Basic Med Sci. 2008 Aug;8(3):282-6##11.	Saif Anwaruddin, MD,* Donald M. Lloyd-Jones, MD, SCM, FACC,† Aaron Baggish, MD,* Annabel Chen, MD,* Daniel Krauser, MD,* Roderick Tung, MD,* Claudia Chae, MD, MPH, FACC,*. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the pro BNP Investigation of Dysonea in the Emergency Department (PRIDE) Study. Performing your original search, renal function, congestive heart failure, and amino-terminal pro-brain natriuretic, in PubMed will retrieve 25 records. Journal of the American College of Cardiology Vol. 47, No. 1, 2006;47:91–7##12.	I Raymond, B A Groenning, P R Hildebrandt, J C Nilsson, M Baumann, J Trawinski, F Pedersen. The influence of age, sex and other variables on the plasma level of NT-pro brain natriuretic peptid in a large sample of the general population. Heart 2003;89:745–751.##13.	Mehmet Birhan Yılmaz, M.D.,#§ Alain Cohen-Solal, M.D.,# Alexandre Mebazaa, M.D.†. Very early management of acute heart failure syndromes. Türk Kardiyol Dern Arş-Arch Turk Soc Cardiol 2011;39(5):427-243.##14.	Karel Kotaskaa, Jana Popelovab, Marie Tiserovad, Peter Telekesc, Marie Vrzanovad, Jiri Bronskya, Milada Halacovaa, Jiri Kukackaa, Richard Prusaa. NT-pro BNP and BNP values in cardiac patients with different degree of left ventricular systolic dysfunction. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006, 150(1):125–130.##15.	John G.F. Cleland*, Jacqueline Taylor, Nick Freemantle, Kevin M. Goode, Alan S. Rigby, and Michal Tendera. Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study. European Journal of Heart Failure (2012) 14 April, 487–494## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>نقش رسپتور ملاتونینی در بیماران مبتلا به آدنوکارسینوم معده در استان مازندران</TitleF>
		<TitleE>Role of Melatonin Receptor in Patients with Gastric Adenomacarcinoma in Mazandaran Province</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: ملاتونین یک آنتی‌اکسیدان بالقوه است که دارای ویژگی‌های حفاظت سلولی و ضدسرطانی است. غشاء معدی- روده‌ای منبع عمده‌ای از ملاتونین در بدن می‌باشد. با در نظر گرفتن این منبع مهم بسیاری از دانشمندان نقش حفاظتی برای ملاتونین در دستگاه گوارش در نظر گرفته‌اند. با توجه به تعداد بالای بیماران مبتلا به آدنوکارسینومای معده در استان مازندران این مطالعه برای اولین بار با هدف تعیین بیان رسپتور ملاتونینی MT2 در نمونه‌های بافتی آدنوکارسینومای معده و مقایسه آن با افراد سالم انجام شد.
مواد و روش‌ها: 30 بیمار مبتلا به آدنوکارسینومای معده و30 فرد سالم انتخاب شدند. بعد از استخراج RNA از بافت‌ها و تهیه cDNA بیان ژن‌های MT2 وHGPRT با استفاده از روش Real-time PCR مورد ارزیابی قرار گرفتند. پس از اتمام واکنش Real-Time PCR مقادیر Ct به‌دست آمده از نمونه‌های مبتلا و سالم برای هریک از ژن‌های مرجع و MT2 را وارد نرم‌افزار  Excelشد و بعد از به دست آوردن CT∆∆-2 تغییرات بیان این ژن‌ها در نمونه‌ها با تست Tukey و در برنامه SAS مورد ارزیابی قرار گرفت.
یافته‌ها: نتایج به دست آمده از مطالعه ما نشان داد که بیان گیرنده MT2 در بافت‌های سرطانی و بافت‌های مجاورآن‌ها در مقایسه با بافت‌های افراد سالم تا حد زیادی بالاتر است و بیان آن در بافت‌های مجاور بافت سرطانی بسیار بیش‌تر از خود بافت‌های سرطانی و بافت‌های طبیعی است.
استنتاج: نتایج حاصل ازاین مطالعه، برای اولین بار بیان گیرنده MT2 در بافت‌های آدنوکارسینومای معده را نشان داد که هم راستا با مطالعات صورت گرفته در مورد سرطان کولون وسرطان سینه است و بیان بالا در بافت‌های مجاور نشان‌دهنده مکانیزم مقاومتی می‌باشد که بیان کننده نقش دفاعی ملاتونین در سیستم گوارش است.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: According to recent studies melatonin has been known as a potent anti-oxidant with anti-oncostatic and cytoprotective properties. The gastrointestinal tract is the major source of melatonin in periphery. Therefore, many scientists suppose a protective role for melatonin in gastrointestinal tract. Also, there is a high rate of gastric adenocarcinoma in Mazandaran province of Iran, so this study investigated the expression of melatonin receptor in gastrointestinal patients with focusing on MT2 as an important melatonin receptor which its role in many cancers has been shown peviously.
Materials and methods: Gastric adenocarcinoma patients from Mazandaran  province of Iran were selected for this study and normal individuals  as control. After extracting RNA from 30 gastric cancer tissues and 30 normal tissues and preparing cDNA, the expression of melatonin receptor (type 2) has been assayed with Real-time PCR. 
Results: Our experiment has been shown for the first time in Mazandarn province, high expression of melatonin receptor type 2 in gastric cancer tissues compared to control.Also it was revealed that this expression in marginal of cancer patients  was more than cancer tissues and negative control.
Conclusion: In this study for the first time we found the expression of melatonin receptor in gastric adenocarcinoma tissues which was in consistent with other studies as breast and colon cancer and a high expression in marginal tissues indicates a refractory mechanism and defending role of melatonin in GI system .Also high experession of this receptor in gastric cancer people of Mazandarn province may help to know better the etiology of high incidence of this kind of cancer in this area.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>9</FPAGE>
			<TPAGE>15</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/1
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/12/10
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/1
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/12/10
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>محمد</Name>
				<MidName></MidName>
				<Family>شکرزاده</Family>
				<NameE>Mohammad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Shokrzadeh</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>نفیسه</Name>
				<MidName></MidName>
				<Family>نصری نصرآبادی</Family>
				<NameE>Nafiseh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Nasri Nasr Abadi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>سعید</Name>
				<MidName></MidName>
				<Family>عابدیان</Family>
				<NameE>Saeed</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Abedian</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>رامین</Name>
				<MidName></MidName>
				<Family>عطایی</Family>
				<NameE>Ramin</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ataee</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>E-mail:ramin_ataee@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>وحید</Name>
				<MidName></MidName>
				<Family>حسینی</Family>
				<NameE>Seyyad Vahid</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hosseini</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>زربخت</Name>
				<MidName></MidName>
				<Family>انصاری</Family>
				<NameE>Zarbakht</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ansari</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>حامد</Name>
				<MidName></MidName>
				<Family>حقی</Family>
				<NameE>Hamed</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Haghi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Melatonin</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>gastric adenocarcinoma</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>MT2 receptor</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>gene expression</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Mazandaran</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>ملاتونین</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>آدنوکارسینومای معده</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>گیرنده MT2</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>بیان ژن</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Lanoix D, Ouelette R, Vaillancourt C. Expression of melatoninergic receptors in human placental choriocarcinoma cell line. Human Reproduction 2006; 21(8): 1981-1989.##2.	Pandi-perumal S, Sirinivasan V, Maestroni G. Melatonin, natures most versatile biological signal? FEBS Journal 2006; 273(13): 2813-2838.##3.	Rodrigues C, Mayo J, Sainiz R. Regulation of antioxidant enzyme: a significant role of melatonin. J Pineal Res 2004; 36(1): 1-9.##4.	Lanoix D, Beghdadi H, Lafond J, Vaillancourt C. Human Placental trophoblasts synthesize melatonin and express its receptors. J Pineal Res 2008; 45(1): 50-60.##5.	Allegra M, Reiter R. DXTan, The chemistry of melatonin’s interaction with reactive species. J Pineal Res 2003; 34(1): 1-10.##6.	Yasmir Q, Atilio F, Freddy RA. Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction. J Physio Renal 2008; 294(2): 336-344.##7.	Lerner A, Case JD, Takahashi Y, Lee TH, Mori W. Isolation of melatonin the pineal gland factor that lightens melanocytes. J Am Che Soc 1958. 80(2): 2587.##8.	Karasek M, Carrillo-Vico A, Guerrero JM, Winczyk K, Pawlikowski M. Expression of melatonin MT (1) and MT (2) receptors, and ROR alpha (1) receptor in transplantable murine Colon 38 cancer. Neuro Endocrinol Letter 2006; 23(1): 55.##9.	Poon A, Ma A. HTLuk, Melatonin and 2[125I] iodomelatonin binding sites in the human colon. Endocr Res 1996; 22: 77-94.##10.	Turek F, Gillette M. Melatonin, sleep, and circadian rhythms rationale for development of specific melatonin agonists. Sleep Medicine 2004; 5(6): 523-532.##11.	Lissoni P, Rovelli F, Malugani F, Bucovec R, Conti A, Maestroni GJ. Anti-angiogenic activity of melatonin in advanced cancer patients. Neuro Endocrinol Letter 2001; 22(1): 45-47.##12.	Oprea-Ilies G, Haus E, Sackett-Lundeen L, Liu Y, McLendon L, Busch R, et al. Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival. Cancer Res Treat 2013; 137(3): 677-687.##13.	Karasek M, Kowalski AJ, Suzin J, Zylinska K, Swietoslawski J. Serum melatonin circadian profiles in women suffering from cervical cancer. J Pineal Res 2005; 39(1): 73-76.##14.	Barni S, Lissoni P, Crispino S. Neouroimmunomodulation in cancer patients: correlation between melatonin and beta-endorphin blood levels and T-helper/supressor ratio. Int J Biol Markers 1998; 3: 82-86.##15.	Yuan L, Collins AR, Dai J, Dubocovich ML, Hill SM. Hill SM MT(1) melatonin  receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells. Mol Cell Endocrinol 2012; 192(1-2): 147-156.##16.	Livak KJ, Schmittgen TD. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2-∆∆CT Method. Schmittgen Methods 2001; 25(4): 402-408.##17.	Cos S, Fernández R, Güézmes A, Sánchez-Barceló EJ. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res Treat 1998; 58(19): 4383-4390.##18.	Sjoblom M, Safsten B, Flemstrom G. Melatonin-induced calcium signaling in clusters of human and rat duodenal enterocytes. Physiol Gastrointest Liver Physiol 2003; 284(6): G1034-G1044.##19.	Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, Ostrom RS, Slominski AT. Melatonin membrane receptors in peripheral tissues: Distribution and functions. Molecular and Cellular Endocrinology 2012; 351(2): 152-166.##20.	Rodriguez C, Mayo JC, Sainz RM, Antolín I, Herrera F, Martín V, Reiter RJ. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36(1): 1-9.##21.	Quastel M, Rahamimoff RB. Effect of melatonin on spontaneous contractions and response to 5-hydroxytryptamine of rat isolated duodenum. J Pharmacol Chemother 1995; 24: 455-461.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>بررسی پراکندگی موتاسیون های آلفا تالاسمی در مزدوجین مشکوک نهایی شهرستان بابلسر 1385 -91</TitleF>
		<TitleE>Prevalence of Mutations of Alpha Globin Gene in Suspected Alpha Carrier Couples, Babolsar, 2006-2011</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: آلفاتالاسمی یکی از هموگلوبینوپاتی های شایع می باشد. با توجه به ناهمگونی جهش ها و پیچیدگی
فنوتیپ درآلفاتالاسمی، تعیین دقیق نوع جهش زوجین، تنها روش برای تعیین وضعیت جنین در رابطه با ابتلا به هیدروپس
است. شناخت وضعیت فعلی گستره جهش های آلفاتالاسمی در مناطق کشور ، راه سریع تری ر ا HgbH disease فتالیس و
و HgbH برای تعیین جهش در آزمایشات ژنتیک پیش از تولد، ارائه می دهد که باعث پیشگیری از تولد نوزادان با بیماری
یا جلوگیری از تداوم بارداری هیدروپس فتالیس و عوارض مادری آن می گردد.
مواد و روش ها : روش مطالعه این پژوهش ، توصیفی مقطعی است که بر روی 242 نفر ( 111 زن - 131 مرد ) از
و CBC در (MCH&#60; و 27 (MCV&#60; مزدوجین شهرستان بابلسر در فاصله 1385 تا 1391 ، آنمی هیپوکروم و میکروسیتر ( 80
طبیعی و مقاوم به دوره های آهن درمانی و Serum Iron ،TIBC ، و فریتین ( HgbA2&#60; الکتروفورز طبیعی (شامل 3.5
یا بتاگامادلتا تالاسمی یا آلفا بتا Silent مشکوک به آلفاتالاسمی انجام شد و جهت تعیین انواع آلفاتالاسمی و بتا تالاسمی
تالاسمی به مراکز ژنتیک ارجاع شدند، سپس نوع موتاسیون و شاخص های شیوع مشخص گردید.
یافته ها: از بین 242 نفر از مزدوجین با آنمی هیپوکروم و میکروسیتر مشکوک به آلفاتالاسمی که مورد بررسی قرار
85 درصد ) قابل / گرفتند، دو نفر دارای موتاسیون های آلفا- بتاتالاسمی بودند. هم چنین موتاسیون های آلفا در 205 نفر ( 3
77 درصد آلفاتالاسمی خاموش، 19 درصد صفت آلفاتالاسمی ، / 14 درصد) قابل شناسایی نبود. 5 / شناسایی و در 35 نفر ( 7
بودند که فقط یک نفر وابسته به انتقال خون بوده است. HgbH 3/5 درصد
استنتاج: مطالعه فوق در زمینه بررسی انواع موتاسیون های آلفا تالاسمی، میزان جهش حذفی و نقطه ای بود که در این
منطقه در مقایسه با سایر مناطق تا حدودی مشابه می باشد . در این بررسی شایع ترین جهش زنجیره آلفاگلوبین ، مشابه
و نوع وابسته HgbH 3 کیلو باز می باشد با این تفاوت که میزان / بررسی های مناطق مرکزی و جنوبی کشور، موتاسیون 7
انتقال به خون از شیوع کم تری برخوردار است. هم چنین این بررسی نشان دادکه این منطقه دارای تنوع جه شهای حذفی و
می باشد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Alpha thalassemia is one of the most common hemoglobin
disorders. Some combination of alpha globin gene mutations may cause HbH disease with severe anemia
or intermediate thalassemia. In this study we aimed to determine the spectrum of alpha globin gene
mutations especially rare mutation at alpha carrier couples in Babolsar, north of Iran. Discovering this
spectrum is of great importance in perinatal diagnosis of alpha thalassemia and prevention of HbH disease
in newborn and pregnancies affected by hydrops fetalis.
Materials and methods: This descriptive study was carried out in 2006-2011. The research
population included 242 suspected carriers of alpha thalassemia (110 female and 130 male) with
hypocrom and microcytic anemia (MCV &#60;80, and MCH &#60;27) and hgb-electrophoresis (including HgbA2
&#60;3.5), normal ferritin, TIBC, iron serum level, and resistant to iron therapy who were referred to genetics
center for determination of alpha thalassemia, silent beta thalassemia, delta-beta thalassemia, or alphabeta
thalassemia. The type of mutation and frequency indices were also determined.
Results: Among the subjects there were two individuals with alpha-beta thalassemia. Alpha
mutations was detectable in 205 (85.3%) and not detectable in 35 cases (14.7%). We found 77.5% with
silent thalassemia, 19% with thalassemia trait, and 3.5% with HgbH and just one individual who was
transfusion dependent.
Conclusion: We found -α3.7 as the most common alpha globin chain mutation. Also,
comparison of these results with the similar finding from other provinces showed that the distributions of
mutations in the northern area are different with south or southeast of the country. In our study there were
less frequencies of HbH disease dependent to transfusion. However, rare point mutations for example cd
was observed more in this study.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>17</FPAGE>
			<TPAGE>25</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/11
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/12/20
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/11
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/12/20
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>فرزانه</Name>
				<MidName></MidName>
				<Family>ولی‌زاده</Family>
				<NameE>Farzaneh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Valizadeh</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>f.valizadeh48@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>آزاده</Name>
				<MidName></MidName>
				<Family>دیلمی</Family>
				<NameE>Azadeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Deylami</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Alpha Thalassemia</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>mutation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Babolsar</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>آلفاتالاسمی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>موتاسیون</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>بابلسر</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Mahdavi M, Kowsarian M, Karami H, Mohseni A, Vahid-shahi K, Roshan P, et al. Prevalence of hemoglobin alpha-chain gene deletion in neonates in North of Iran. Eur Rev Med Pharmacol Sci 2010; 14(10): 871-875.##2.	Forget BG, Franklin BH. Classification of the Disorders of Hemoglobin. Cold Spring Harbor Laboratory Prespective in medicine 2013; (11684): 12-16.##3.	Valizadeh F, Deylami A. Prevalence of hemoglobinE in premarriage individuals referred to Babolsar, Iran. J Mazand Univ Med Sci 2013; 101(23): 9-18 (Persian).##4.	Zeinali C, Zarbakhsh B. Prevalence of mutations alpha globin gene in suspected alpha carrier couples in Tehran. Blood Journal 2013; 9(4): 414-421.##5.	Akhavan H, Pourtaghi M. Frequency point mutation in the globin gene is frequently referred to Children\'s Hospital in Babol (84-1388. J Gorgan Univ Med Sci 2013; 1(14): 75-82 (Persian).##6.	Valizadeh F, Hashemi-Soteh MB. Prevalence of hemoglobinopathies in premarriage individuals referred to Babolsar, Iran. J Gorgan Uni Med Sci 2012; 14(1): 106-112 (Persian).##7.	Harteveld CL, Higgs DR. Alphathalasemia. Harteveld and Higgs Orphanet Journal of Rare Diseases 2010: 13(5): 10-18.##8.	Borgna-Pignatti C, Galanello R. Thalassemias and relateddisorders: Quantitative disorders of hemoglobin synthesis. In: Wintrobe\'s Clinical Hematology. Greer JP, (eds). Vol 1. 12th ed. Philadelphia: Lippincott Williams and Wilkins; 2009. p. 1083-1031.##9.	Ministry of health and Medical Education of Islamic Republic of IRAN. Appearance of (management thalassemia incidence in IRAN. Health Deputy; Centre for Disease Control; Genetic Office, 2008.##10.	Weatheral DJ, Clegg JB. The thlasemian syndromes. 7Th ed. Oxford: Blackwell Seeince; 2007.##11.	Hosseini Gohari L. Hemoglobin in health and disease-Tehran Minstery of health &#38;Medical Education, HealthDeputy ,Center for Disease Control Tehran:Nasher sedaa 2008:-60-96##12.	Leung Y, Lee CP, Tang MHY, Lau ET. Cost-effectiveness of prenatal screening for 12) thalassaemia in Hong Kong. Article first published online: 23OCT20078652(200011) 65:3&#60;183::AID-AJH1&#62;3.0.CO;2-R.##13.	Farshadi E, Ariani Kashani A, Karimipoor M, Azarkeivan A, Habibi Pourfatideh R, Fallah MS, et al. Molecular analysis of alpha-thalassemia deletion mutations, and of lossless carriers Iranian suspected. Blood 2010; 7(2 (27): s70-77.##14.	Golafshan H. Answers &#38; questions about Hemoglobinopathies and thalasemia. Shiraz: Navid Shiraz, 2008. p. 54-56 (Persian).##15.	Khatami Sh. Synthesis of beta-globin chains for the differential diagnosis of alpha-thalassemia carriers &#38;Globin chain synthesis and analysis of DNA, complementary test in the diagnosis of thalassemia. Blood 2007; ##4(4): 239-246.##16.	Zandi Kh, Pedram M. Distribution of alpha-thalassemia mutations in Khuzestan province: Genetics of the third millennium. 2007; 7(15): 33-42.##17.	Alibakhshi MA, Akramipour R. Molecular analysis of alpha globin gene deletions among patients with microcytic hypochromic anemia in Kermanshah-Iran-journals. J Kermanshah Univ Med Sci 2011; 14(5): 10-20 (Persian).##18.	Drkhshndh paykar P, Shahgholi E. Blood parameters associated Alphathalasemia carrier with kind. Journal of School Health &#38; Anstitue 2009; 7(2): 33-15. ##19.	Neishabury ML, Abbasi-Moheb L, Najmabadi H. Alpha-thalassemia deletion analysis in Iran. Arch Iran Med 2001; 4(4): 160-421. ##20.	El-Kalla S, Baysal E. Alpha-thalassemia in the United Arab Emirates. Acta Haematol 1998; 100(1): 49-53.##21.	El-Kalla S, Baysal E. Alpha-thalassemia in the United Arab Emirates. Acta Haematol 1998; 100(1): 49-53.##22.	Borges E, Wenning MR, Kimura EM, Gervásio SA, Sonati MF,Costa FF. High prevalence of alpha-thalassemia among individuals with microcytosis and hypochromia without anemia. Braz J Med Biol Res 2001; 34(6): 759-762.##23.	Adekile AD, Gu LH, Baysal E, Haider ##MZ, al-Fuzae L, Aboobacker KC, et al. Molecular characterization of alpha-thalassemia determinants, beta-thalassemia alleles and beta S haplotypes among Kuwaiti Arabs. Acta Haematol 1994; 92(4): 176-181.##24.	Ne-Win K, Harano K, Harano T, Myint T, Rai-Mra B, Myint A, et al. Common alpha-thalassemia deletions in transfusion-dependent thalassemia patients in the Southeast Asia region of Myanmar. Lab Hematol 2006; 12(3): 139-142.##25.	White JM, Byrne M, Richards R, Buchanan TKatsoulis E, Weerasingh K. Red cell geneticabnormalities in Peninsular Arabsalpha- thalassemia. Med Genet 1986; 23(3): 245-251.##26.	Fowkes FJ, Allen SJ, Allen A, Alpers MP, Weatherall DJ, Day KP. Increased microerythrocyte count inhomozygous alpha(+)- thalassaemia contributes toprotection against severe malarial anaemia. PLoS Med 2008; 5(3): 56.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>بررسی وضعیت نظام ارجاع بیماران در برنامه پزشک خانواده و بیمه روستایی در استان های شمالی ایران: 1391</TitleF>
		<TitleE>Evaluation of the Referral System Situation in Family Physician Program in Northern Provinces of Iran: 2012-2013</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: سطح‌بندی نظام مراقبت سلامت به منظور کاهش هزینه، ایجاد عدالت و امکان دسترسی آحاد مردم به خدمات مورد نیاز انجام می‌گیرد. نظام ارجاع به عنوان پل ارتباطی، ارائه‌دهندگان و دریافت کنندگان خدمات را از پایین‌ترین سطح به سطوح بالاتر و بالعکس هدایت می‌نماید. این مطالعه به منظور بررسی عملکرد نظام ارجاع در برنامه پزشک خانواده و بیمه روستایی در استان‌های شمالی کشور انجام گرفت.
مواد و روش‌ها: مطالعه از نوع مقطعی بوده که در شش ماهه دوم 1391 انجام گرفت. 25 درصد مراکز مجری برنامه پزشک خانواده و بیمه روستایی در استان‌های گلستان، مازندران و گیلان، مجموعاً 139 مرکز از 552 مرکز مجری به‌صورت تصادفی منظم انتخاب و در هر مرکز منتخب 7 تا 8 بیماری که با ارجاع پزشک خانواده به سطح 2 مراجعه و خدمات سطح2 را دریافت نموده و در زمان پرسشگری در منزل خود حضور داشتند، با مصاحبه ساختارمند مورد مطالعه قرار گرفتند. ابزار جمع‌آوری داده‌ها پرسشنامه محقق ساخته شامل 2 بخش متغیرهای فردی و رعایت قواعد نظام ارجاع از قبیل مراجعه به پزشک خانواده با ارجاع خانه بهداشت، خواست ارجاع به سطح 2، انتخاب پزشک سطح 2، نوع خدمات سطح، ارائه پس‌خوراند، مراجعه مجدد به سطح 1، ثبت اطلاعات در پرونده سلامت و موارد دیگر بوده که روایی و پایایی آن مورد تأیید قرار گرفت.
یافته‌ها: از 963 بیمار ارجاع شده به سطح 2 که موفق به دریافت خدمات شدند، 687 نفر (71 درصد) زن بودند. 320 نفر (33 درصد) از بیماران ارجاع شده، فرم ارجاع از خانه‌های بهداشت را به همراه داشتند. ضرورت ارجاع 299 نفر (31 درصد) بنا به تشخیص پزشکان خانواده بوده و پزشکان خانواده در 161 مورد ارجاع (17 درصد) در انتخاب پزشک متخصص سطح 2، نقش داشته‌اند. پزشکان متخصص سطح 2 برای 155 بیمار (1/16 درصد) ارجاعی پذیرفته شده، نتایج ویزیت را به پزشک خانواده‌شان پس‌خوراند دادند. از بین بیماران مراجعه کننده به سطح 2، تنها 149 نفر (5/15 درصد)، به نزد پزشک ارجاع دهنده خود بازگشتند. 697 بیماری (3/85 درصد) که به سطح اول باز نگشتند، علت اصلی را عدم آگاهی ذکر نمودند. میزان رعایت قواعد نظام ارجاع در خیلی از موارد در استان‌های شمالی کشور تفاوت معنی‌دار وجود داشت (05/0&#60; P).
استنتاج: نتایج این مطالعه نشان داد که وضعیت نظام ارجاع در برنامه پزشک خانواده مطلوب نبوده و نیاز به مداخله و بهبودی دارد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Health care system is organized at three levels in order to increase efficacy and effectiveness and create justice and also people availability. Considering the three levels of primary health care, access of people to specialized services through referral system is possible. With regard to the importance of referral system in family physician program, this study was performed to evaluate the function of referral system and network system in Northern provinces of Iran.
Material and methods: This analytic study was performed in autumn and winter of 2012. Twenty five percent of health centers (139 centers from 552) which implement the family physician program and rural insurance coverage by medical universities of Golestan, Mazandaran, Babol and Guilan were randomly selected. In each center, 7-8 patients who were referred to level 2 by their family physician and received necessary services were evaluated. They were at their homes at inquiry time.
Results: From 963 patients who received the level 2 services, 687 cases (71%) were females and 276 (29%) were males. Three hundred and twenty cases (33%) had referral form from health house. Only 299 (31%) persons referred to the centers because of diagnosis of family physician and in 161 (17%) of cases, the family physician had a role to choose a specialist of level 2. For 155 (16.1%) of cases, the specialists wrote the results of their evaluation in feedback form. Only 149 (15.5%) of patients returned to their family physicians. Six hundred ninety-seven (79.6%) of patients did not return to their family physician because of lack of knowledge.
Conclusion: The results of this study showed that many principles for referral system from level 1 to higher levels and vice versa are not considered that require education, reformation and intervention in this field.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>27</FPAGE>
			<TPAGE>35</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/4
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/15
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/4
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/15
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>سید داود</Name>
				<MidName></MidName>
				<Family>نصرالله پور شیروانی</Family>
				<NameE>Seiyed Davoud</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Nasrollahpour Shirvani</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>ابراهیم</Name>
				<MidName></MidName>
				<Family>میکانیکی</Family>
				<NameE>Ebrahim</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mikanik</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>حسن</Name>
				<MidName></MidName>
				<Family>اشرفیان امیری</Family>
				<NameE>Hasan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ashrafian Amiri</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>محمدجواد</Name>
				<MidName></MidName>
				<Family>کبیر</Family>
				<NameE>Mohammad Javad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Kabir</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>ناهید</Name>
				<MidName></MidName>
				<Family>جعفری</Family>
				<NameE>Nahid</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Jafari</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>بهرام</Name>
				<MidName></MidName>
				<Family>طهماسبی</Family>
				<NameE>Bahram</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Tahmasbi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>ارسلان</Name>
				<MidName></MidName>
				<Family>داداشی</Family>
				<NameE>Arsalan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Dadashi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>محمد</Name>
				<MidName></MidName>
				<Family>نعیمی طبیعی</Family>
				<NameE>Mohammad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Nahimi Tabihi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Referral system</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Family physician</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Health care center</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Health levels</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>نظام ارجاع</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>پزشک خانواده</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>بیمه روستایی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>مرکز بهداشتی درمانی</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Motlagh ME, Nasrollahpour Shirvani SD, Ashrafian Amiri H, Kabiri MJ, Shabestani Monfared A, Mohoudi S, et al. Understanding rural insurance insured loans, terms and conditions of the benefit plan insurance ID Rural family physician in the northern provinces of Iran. Journal of North Khorasan University of Medical Sciences 2010; 2(2,3): 33-38 (Persian).##2.	Davoudi S. Introduction to health Sector Reform. 1st ed. Tehran: Asare Mouaser; 2006. p. 233-237 (Persian).##3.	Ferdosi M, Vatankhah S, Khalesi N, Ebadi Fard Azar F, Ayoobian A. Designing a referral system management model for direct treatment in social security organization. Iranian Journal of Military Medicine 2012; 14(2): 129-135 (Persian).##4.	Shahdpour K, Pileroudi S. Health for all and primary health cares in 20th and 21st centuries, Ministry of Health and Medical Education, Nashreh Tandis 1999; p. 192-113 (Persian).##5.	Starfield B. Primary care, concept, evaluation and policy. UK: Oxford University Press; 1992. p. 70-85.##6.	Morrell DC. Symptom interpretation in general practice. J R Coli Gen Pract 1972; 22(118): 297-309.##7.	Coleman P, Irons R, Nicholl J. Will alternative ##immediate care services reduce demands for non-urgent treatment at accident and emergency. Emerg Med J 2001; 18(6): 482-487.##8.	Tawfik KA, Al Shehri AM, Abdul-Aziz F, Khwaja MS. Patterns of referral from health centers to hospital in Riyadh region. EMHJ 1997; 3(2): 236-253.##9.	World Health Organization. Hospital and health for all (Report of a WHO Expert Commttiee on the Role of Hospitals at the First Referral Level. 1st ed. Geneva; 1987. p. 20-25.##10.	Palmer PE. Feeling unwell? Must you go straight to hospital? World Health Forum 1991; 12(1): 38-42.##11.	Pileroudi S. Township network health and treatment. Iran, Unicef Office 1999; p. 12-13 (Persian).##12.	Rouhani S. Evaluation the Referral System Situation in the patients referred to the hospitals of Mazandaran University of Medical Sciences. J Mazand Univ Med Sci 1998; 10(26): 27-32 (Persian).##13.	Family physician Instruction, Ministry of Health and Medical Education, Version 12, 2011; p. 4-102 (Persian).##14.	Nasrollahpour Shirvani D, Ashrafian Amiri H, Motlagh ME, Kabir MJ, Maleki MR, Shabestani Monfared A, et al. Evaluation of the Function of Referral System in Family Physician Program in Northern Provinces of Iran: 2008. J Babol Univ Med Sci 2010; 11(6): 46-52 (Persian).##15.	Nasrollahpour Shirvani SD, Raeisee P, Motlagh ME, Kabir MJ, Ashrafian Amiri H. Evaluation of the Performance of Referral System in Family PhysicianProgram in Iran University of Medical Sciences: 2009. Hakim Research Journal 2010; 13(1): 19-25 (Persian).##16.	Chaman R, Amiri M, Raei Dehaghi M. The national family physician and the quality of referral system. Payesh (Journal of The Iranian Institute For Health Sciences Research) 2012; 11(6): 785-790 (Persian).##17.	Park JE, Park AK. Park\'s textbook of preventive and social medicine Vol 2. (Trans. Shodjai-Tehrani H). 2nd ed. Tehran: Samat; 2004 (Persian).##18.	Pileroudi S. Township network health and treatment, Unisef, 1999. p. 32-33 (Persian).##19.	Shams A, Mofid M, Rejlian F. Survey of Referal System Influenced Factors from ##the Perspective of Referrings of Isfahan Educatinal Hospitals. Health Information Management 2011; 7(Supple): 669-678 (Persian).##20.	Ohara K, Melendez V, Uehara N, Ohi G. Study of a patient referral system in the Republic of Honduras. Health Policy Plan 1998; 13(4): 359-370.##21.	Masoudzahe A, Khalilian AR, Sefidchian AR. Evaluation the referal pathway of psychiatric patients in first admission in the psychiatric department of Shahid Zare Hospital of Mazandaran. J Mazand Univ Med Sci 2001; 11(33): 1-10 (Persian).##22.	Vanulden CJT, Winkens R, Weeseling G, Cerbolder H, Vanscayck CP. Use of out of hours services: a comparsion between two organisations. Emerg Med J 2003; 20(2): 184-187.##23.	Stephen WJ. Primary medical care and the future of the medical profession. World Health Forum 1981; 2(3): 316.##24.	Huoseyni Faraji H, Performance evaluation of family physician program in Imam Khomeini\'s Relief Committee Yazd prouince, 2005: 24 (Persian) ##25.	Clancy CM, Franks P. Utilization of specialy and primary care: The Impact of H.M.O insurance and patient related factors. JOF Practice 1997; 45(6): 500-508.##26.	Panahi B. Operational process of the social security system. J Soc Secur 2009; 1(1): 91-99 (Persian).##27.	Leibowitz R, Day S, Dunt D. A systematic review of the effect of different models of after hours primary medical care services on clinical outcomes, medical workload and patient and GP satisfaction. Family practice 2003; 20: 311-317.##28.	Kersnik J. An evaluation of patient satisfaction with family practice care in Slovenia. Int J Qual Health Care 2000; 12(2): 143-147.##29.	Family physician and referral system Instruction in urban. Ministry of Health and Medical Education, Version 02, 2012; 22 (Persian).##30.	Hosseini SR, Dadashpour M, Mesbah N. Assessment of referral system in health care delivery center of Paeengatab, Babol, 2003. ##J Babol Univ Med Sci 2005; 7(27): 85-90 (Persian).#### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>استاندارد سازی و تعیین میزان سوربات پتاسیم در دوغ به روش کروماتوگرافی مایع با کارایی بالا</TitleF>
		<TitleE>Validation Method and Determination of Potassium Sorbat in Dough with HPLC</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: با توجه عوارض تأیید شده نگهدارنده‌های شیمیایی از جمله سوربات‌ها در سلامت عمومی و ایمنی غذایی، دقت و نظارت بر کاربرد نگهدارنده‌ها در مواد غذایی کاملاً ضروری می‌باشد. افزودن سوربات پتاسیم در دوغ بر اساس استاندارد ملی ایران ممنوع است. هدف این پژوهش معتبرسازی روش اندازه‌گیری سوربات پتاسیم در دوغ و هم‌چنین بررسی وجود آن در دوغ تولیدی استان مازندران می‌باشد.
مواد و روش‌ها: در این مطالعه 100 نمونه دوغ‌های تولیدی در کارخانه‌های استان مازندران جمع‌آوری شدند. آزمون به روش کروماتوگرافی مایع با کارآیی بالا (HPLC) و با دتکتور UV انجام شد. معتبرسازی روش آزمون بر اساس راهنمای ICH و USP انجام گردید.
یافته‌ها: ضریب همبستگی معادله منحنی کالیبراسیون برابر با 9/99 درصد به دست آمد. دامنه خطی بودن از 19 تا 100 میکروگرم در میلی‌لیتر بود و حد تشخیص (LOD) و حد تعیین مقدار (LOQ) به ترتیب 37/6 و 11/19 محاسبه شد. دقت روش از نظر تکرارپذیری و دقت میانی در محدوده قابل پذیرش قرار داشت.
استنتاج: نشان می‌دهد که در 32 درصد نمونه‌ها سوربات پتاسیم وجود داشت. 22 درصد نمونه‌ها دارای سوربات پتاسیم بالاتر از 100 میلی‌گرم بر کیلوگرم و 10 درصد از نمونه‌ها حاوی سوربات پتاسیم کم‌تر از 100 میلی‌گرم بر کیلوگرم بودند. با توجه به وجود سوربات پتاسیم در دوغ که مغایر با استاندراد ملی ایران می‌باشد، نظارت مناسب بر مصرف نگهدارنده‌های مختلف از جمله سوربات پتاسیم در دوغ تولیدی مازندران و ایران ضروری به نظر می‌رسد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: According to the confirmed dangerous side effects of chemical preservatives such potassium sorbate in public health and food safety, accurate monitoring of the presence of preservatives in food is necessary.  Since, according to Iran national standard, using potassium sorbate in dough as preservative is prohibited, so, this study aimed to investigate the presence of potassium sorbate in dough and validation method of potassium sorbate detection.
Material and methods: In this study, 100 dough samples were collected from Mazandaran province factories. The samples were analyzed by high performance liquid chromatography (HPLC), UV detectors. Validation was performed according to USP and ICH guidelines.
Results: The correlation coefficient of curve equation was 99.9%.  The linearity rang was from 19 to 100 µg/ml and the limit of detection LOD and limit of quantification (LOQ) were 6.37 and 19.11 µg/ml, respectively. The accuracy of repeatability and intermediate precision of the range were acceptable. Potassium sorbate was detected in 32% samples. Content of Potassium sorbate in 22% of samples was greater than 100 mg/kg and in 10% of samples were lower than 100 mg/kg.
Conclusion: With regard to the presence of potassium sorbate in dough samples despite of Iran national standard ban on the use of it in dough, continues monitoring of several preservatives such as potassium sorbate seems to be necessary.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>37</FPAGE>
			<TPAGE>44</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/4
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/15
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/4
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/15
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>محمد</Name>
				<MidName></MidName>
				<Family>قلی پور</Family>
				<NameE>Mohammad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Gholipour</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Gholipour49@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>زین العابدبن</Name>
				<MidName></MidName>
				<Family>بابایی</Family>
				<NameE>Zinelabidine</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Babai</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>زهرا</Name>
				<MidName></MidName>
				<Family>محمدی</Family>
				<NameE>Zahra</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mohammadi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>لاله</Name>
				<MidName></MidName>
				<Family>کریم زاده</Family>
				<NameE>Laleh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Karimzadeh</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>محمد حسین</Name>
				<MidName></MidName>
				<Family>اصفهانی زاده</Family>
				<NameE>Mohammad Hossein</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Esfahani zadeh</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>صابر</Name>
				<MidName></MidName>
				<Family>عابدی</Family>
				<NameE>Saber</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Abedi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Validation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Potassium sorbate</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>dough</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>determination</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>استانداردسازی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سوربات پتاسیم</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>دوغ</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>اندازه‌گیری</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Cieslik E, Sadowska-Rociek A, Ruiz ##JMM, Surma-Zadora M. Evaluation of QuEChERS method for the determination of organochlorine pesticide residues in selected groups of fruits. J Food Chem 2011; 125(2): 773-778.##2.	Institute of Standards and Industrial Research of Iran. Pesticides-Maximum residue limit of pesticides-Pome, stone &#38; small fruits &#38; nuts. NO:13117. 1th ed. Tehran: ISIRI; 2009 (Persian).##3.	Jokanovic M. Structure-activity relationship and efficacy of pyridinium oximes in the treatment of poisoning with organophosphorus compounds: A review of recent data. Curr Top Med Chem. 2012; 12(16): 1775-1789. ##4.	Fenik J, Tankiewicz M, Biziuk M. Properties and determination of pesticides in fruits and vegetables. Trac-Trend Anal Chem 2011; ##30(6): 814-826.##5.	Meschi M. List of authorized pesticides.##1th ed. Karaj: Ministry of Agriculture, Plant Protection Organization; 2007 (Persian).##6.	Castillo M, Gonzalez C, Miralles A. An evaluation method for determination of non-polar pesticide residues in animal fat samples by using dispersive solid-phase extraction clean-up and GC/MS. Anal Bioanal Chem 2011; 5(400): 1315-1328.##7.	Fatemy LS, Tabatabaei SJ, Fallahi E. The effect of silicon on the growth and yield of strawberrygrown under saline conditions. Journal of Horticultural Sciences 2009; 23(1): 88-95.##8.	Marjanlo A, mostofi Y, Shoeibi Sh, Maghami M. Effect of essence oil of basil on Control of gray rot and post-harvest quality of strawberries (Selva). J Medicinal Plants 2008; 8(1(:131-139.##9.	Looser N, Kostelac DT, Scherbaum E, anastassiades M, Zipper H. Pesticide Residues in Strawberries sampled from the Market of the Federal State of Baden Württemberg in the Period between 2002 and 2005. J Verbr Lebensm 2006; (1): 135-141.##10.	Khosh akhlagh F, Soltani M. Zoning of Strawberry cultivation agricultural region using geographical information systems. Journal of Humanities Research and Cultural Studies (sepehr) 2006; 20(78): 31-38 (Persian).##11.	Nguyen TD, Yu JE, Lee DE, Lee GH. A multiresidue method for the determination of 107 pesticides in cabbage and radish using QuEChERS sample preparation method and gas chromatography mass spectrometry.J Food Chemistry 2008; 110: 207-213.##12.	Angelo M, Des A, Lehotay SJ. Fast and Easy Multiresidue Method Employing Acetonitrile Extraction/Partitioning and “Dispersive Solid- Phase Extraction” for the Determination of Pesticide Residues in Produce. Journal of AOAC International 2003; 86(2): 412-431.##13.	Motamedzadegan A, Mortazavi A, Maghsoodloo Y, Amiri B, Esmailzadeh Kenari R. Evaluation of pesticide residues in melons sprayed three time with diazinon in Khorasan-Razavi province. Agricultural Science and Technology Journal 2006; 5(1): 13-19.##14.	Nougadère A, Sirot V, Kadar A, Fastier A, Truchot E, Vergnet C, et al. Total diet study on pesticide residues in France: Levels in food as consumed andchronic dietary risk to consumers. Environment International 2012; 45: 135-150.##15.	Ferrer C, Martinez-Bueno MJ, Lozano L, Fernandez-Alba AR, Pesticide residue analysis of fruit juices by LC–MS/MS direct injection. One year pilot survey. Talanta 2011; 83: 1552-1561.##16.	Yadegaran L, Moattar F, Morowati M, Riazi Z. Determination of organophosphate residues in apple product Urmia region cooling. Journal of Environmental Sciences and Technology 2002; 1(15): 25-42 (Persian).##17.	Kort WJ, Arsenault TL, Pylypiw HM, Mattina MJI. Reduction of pesticide residues on product by rinsing. Journal of Agricultural and Food Chemistry 2000; 48: 4666-4670.##18.	Jahaed Khaniki GH, Fadaei AM, Sadeghi M, Mardanie G. Study of Oxydimeton methyl residues in cucumber &#38; tomato grown in some of greenhouses of Chaharmahal va Bachtiari province (Iran) by HPLC method. J Shahrekord Univ Med Sci 2011; 13(4): 9-17 (Persian).##19.	Ghabbour SI, Zidan ZH, Sobhy HM, Mikhail WZA, Selim MT. Monitoring of Pesticide Residues in Strawberry and Soil from Different Farming Systems in Egypt. American-Eurasian J Agric &#38; Environ Sic 2012; 12(2): 177-187.##20.	Shokrzadeh M, Saeedi S. The investigation and measurement of residues of benomyl and mancozeb pesticides in shrub and nonshrub cucumbers sampled from different regions of Mazandaran province (Iran). J Environmental, Agricultural and Chemitry 2009; 8(3): 174-178.##21.	Zand E, Baghestani MA, Bitarafan M, Shimi P. A Guidline for Herbicides in Iran. Mashhad: Jahad Publication; 2007 (Persian).## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>بررسی ارتباط پلی مورفیسم پروموترژن CCR5 در موقعیت -59353T/C با عفونت HCV</TitleF>
		<TitleE>Survey on the Association of CCR5 Promoter -59353T/C Polymorphism with HCV Infection</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: هپاتیت C یک بیماری حاد یا مزمن کبدی در سراسر جهان است. کموکایندها و رسپتورهای کموکاینی با به‌کارگیری و فعال‌سازی سلول‌های التهابی به سمت کبد آلوده در ایجاد یک پاسخ ایمنی مؤثر علیه ویروس هپاتیت C (HCV) شرکت دارند. رسپتور کموکاینی CCR5 روی سلول‌های مختلفی از سیستم ایمنی بیان شده و گزارش شده است که پلی‌مورفیسم CCR5-59353T/C ممکن است با عفونت HCV مرتبط باشد. از این رو، این مطالعه به منظور تعیین ارتباط بین این پلی‌مورفیسم با استعداد ابتلا به عفونت HCV در بیماران ایرانی انجام شد.
مواد و روش‌ها: در این مطالعه 100 بیمار مبتلا به HCV و 100 فرد سالم به طور تصادفی انتخاب شدند. با روش نمک اشباع DNA ژنومی از بافیکوت استخراج شد. ژنوتیپ‌های CCR5-59353(T/C) توسط روش PCR اختصاصی آلل تعیین شدند. محصولات PCR رویژل آگارز 5/1 درصد الکتروفورز شدند و برای تجزیه و تحلیل آماری از آزمون Chi-square استفاده شد.
یافته‌ها: فراوانی آلل واریانت C در گروه بیماران مبتلا به HCV 42 درصد و در افراد سالم 37 درصد بود که از نظر آماری تفاوت معنی‌داری نداشت (3/0p=). همچنین فراوانی ژنوتیپ هموزیگوت CCR5-59353CC در بیماران مبتلا به HCV، 16 درصد و افراد سالم 12 درصد بود و هیچ تفاوت معنی‌داری بین دو گروه مشاهده نشد (4/0p=).
استنتاج: بر اساس یافته‌های ما پلی مورفیسم CCR5-59353T/C در جمعیت مورد مطالعه به عنوان یک فاکتور ژنتیکی میزبان جهت تعیین استعداد ابتلا به عفونت HCV تأثیرگذار نمی باشد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Hepatitis C is an acute or chronic liver disease worldwide. Chemokines and chemokine receptors are involved in the effective immune response to hepatitis C virus (HCV) infection through the efficient recruitment and activation of inflammatory cells to infected liver. The CC-chemokine receptor (CCR) 5 is expressed on the several cells of the immune system and has been reported that the CCR5-59353T/C polymorphism may be associated with HCV infection. Hence, this study was aimed to determine the association of this polymorphism with susceptibility to HCV infection in Iranian patients.
Material and methods: In this study, 100 HCV infected patients and 100 healthy individuals were randomly selected. Genomic DNA was extracted from blood buffy coat using the salting out method. The CCR5-59353(T/C) genotypes were determined using Allele Specific PCR method. The PCR products were electrophoresed on 1.5% agarose gel. The data were analyzed using Chi-square test.
Results: The frequency of C variant allele was 42% in HCV infected patients and 37% in healthy individuals which was not statistically significant (P= 0.3). Also, the frequency of CCR5-59353C/C genotype was 16% in patients infected with HCV and 12% in healthy individuals and no significant difference was observed between the two groups (P= 0.4).
Conclusion: Based on our findings, CCR5-593535T/C polymorphism is not effective in the study population as a host genetic factor in determining susceptibility to HCV infection.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>46</FPAGE>
			<TPAGE>53</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/8
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/12/17
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/8
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/12/17
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>آسیه</Name>
				<MidName></MidName>
				<Family>حسینی</Family>
				<NameE>Asieh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hosseini</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>زهره</Name>
				<MidName></MidName>
				<Family>شریفی</Family>
				<NameE>Zohreh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sharifi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>فهیمه</Name>
				<MidName></MidName>
				<Family>اغبانی آرانی</Family>
				<NameE>Fahimeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Baghbani-arani</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Chemokine receptor</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Polymorphism</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>CCR5-59353</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>HCV</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>رسپتور کموکاینی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>پلی مورفیسم</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>CCR5-59353</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>HCV</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Sharma SD. Hepatitis C virus: molecular biology &#38; current therapeutic options. Indian J Med Res 2010; 131(    ): 17-34 .##2.	MohdHanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57(4): 1333-1342. ##3.	Alavian SM, Adibi P, Zali MR. Hepatitis C virus in Iran: epidemiology of an emerging infection. Arch Iranian Med 2005; 8(2): 84-90.##4.	Hellier S, Frodsham AJ, Hennig BJ, Klenerman P, Knapp S, Ramaley P, et al. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology 2003; 38(6): 1468-1476. ##5.	Ahlenstiel G, Woitas RP, Rockstroh J, Spengler U. CC-chemokine receptor 5 (CCR5) in hepatitis C—at the crossroads of the antiviral immune response? J Antimicrob Chemother 2004; 53(6): 895-898. ##6.	Coenen M, Nattermann J. The role of CCR5 in HCV infection. Eur J Med Res 2010; 15(3): 97-101. ##7.	Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, et al. HIV-1 entry into CD4cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381(6584): 667-673. ##8.	McDermott DH, Zimmerman PA, Guignard F, Kleeberger CA, Leitman SF, Murphy PM. CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet 1998; 352(9131): 866-870. ##9.	Mummidi S, Ahuja SS, Gonzalez E, Anderson SA, Santiago EN, Stephan KT, et al. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med 1998; 4(7): 786-793. ##10.	Konishi I, Horiike N, Hiasa Y, Michitaka K, Onji M. CCR5 promoter polymorphism influences the interferon response of patients with chronic hepatitis C in Japan. Intervirology 2004; 47(2): 114-120. ##11.	Al-Sharif FM, JiffriOAl, Azhar EI. CCR5Δ32 andCCR5-59029 allele frequency among hepatitis C virus infected and in non-HCV infected Saudi Population. World Appl Sci J (cytokine) 2011; 56(1): 611-614.##12.	Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16(3): 1215. ##13.	Khajavi R, Rafiei A, Haghshenas MR, Hosseini-khah Z, Farazmandfar T, Sharbafi R. Association between Interleukin-28B genetic variants and hepatitis C. J Mazand Univ Med Sci 2012; 22(95): 19-27 (Persian).##14.	Ferna´ndez-Mestre MT, Montagnani S, Layrisse Z. Is the CCR5-59029-G/G genotype a protective factor for cardiomyopathy in Chagas disease? Hum Immunol 2004; 65(7): 725-728. ##15.	Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997; 185(9): 1681-1691.##16.	Paxton WA, Liu R, Kang S, Wu L, Gingeras TR, Landau NR, et al. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines. Virology 1998; 244(1): 66-73. ##17.	Larrubia JR, Benito-Martínez S, Calvino M, Sanz-de-Villalobos E, Parra-Cid T. Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J Gastroenterol 2008; 14(47): 7149-7159. ##18.	Promrat K, McDermott DH, Gonzlez CM, Kleiner DE, Koziol DE, Lessie M, et al. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology 2003; 124(2): 352-360. ##19.	KsiaaCheikhRouhou L, Gorgi YL, Skhiri HA, Aouadi H, Ayed SJ, Sfar I, et al. Chemokine and chemokine receptor gene polymorphism in Tunisian hemodialysis patients with HCV infection. Arab J Nephrol Transplant 2011; 4(3): 117-124. ##20.	Ahn SH, Kim DY, Chang HY, Hong SP, Shin JS, Kim YS, et al. Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea. J Med Virol 2006; 78(12): 1564-1571.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF> تاثیر افزودن نیتروگلیسیرین به لیدوکایین بر درد و تغییرات همودینامیک در روش بی حسی منطقه ایی داخل وریدی در جراحی اندام فوقانی</TitleF>
		<TitleE>The effect of adding nitroglycerine as an AS adjuvant to lidocaine on pain and Hemodynamic Variables of intravenous regional anesthesia upper extremity surgery</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: بی‌حسی منطقه‌ای داخل وریدی روشی و قابل اعتماد برای ترمیم جراحات اندام فوقانی می‌باشد. جهت بهبود کیفیت بلوک حسی، کاهش درد تورنیکه و بی دردی بعد از عمل ترکیبات متفاوتی به داروهای بی‌حس‌کننده موضعی در بی حسی منطقه‌ای داخل وریدی اضافه می‌شوند. این مطالعه به منظور بررسی اثر نیتروگلیسیرین با لیدوکایین در بهبود کیفیت بی‌حسی منطقه‌ایی داخل وریدی در جراحی اندام فوقانی انجام شد.
مواد و روش‌ها: در این مطالعه کارآزمایی بالینی 40 بیمار با ASA (American Society of Anesthesiologists) کلاس I یا II، که کاندید عمل جراحی اندام فوقانی بودند، به طور تصادفی در دو گروه مساوی قرار گرفتند. در گروه شاهد برای انجام بی‌حسی منطقه‌ای داخل وریدی mg/kg3 لیدوکایین 5/0 درصد و در گروه مداخله علاوه بر آن 200 میکروگرم نیتروگلیسیرین مورد استفاده قرار گرفت. علایم همودینامیک 5، 10، 15 و 20 دقیقه بعد از تزریق داروهای بیهوشی اندازه‌گیری شد. زمان شروع و بازگشت بلوک حسی و حرکتی، شروع و شدت درد تورنیکه بر اساس نمره‌دهی VAS (Visual analogue scale) در حین عمل و علایم همودینامیک و میزان شدت درد بر اساس نمره‌دهی VAS در 5/0، 2، 4، 6 و 12 ساعت بعد ازعمل اندازه‌گیری و ثبت شد. هم‌چنین مقدار دریافت پتیدین و فنتانیل در حین و بعد از عمل در بیماران ثبت شد.
یافته‌ها: نتایج نشان داد که شروع بلوک حسی در گروه دریافت کننده نیتروگلیسیرین سریع‌تر (51042± 45/2 دقیقه در مقابل 26803/1± 35/4 دقیقه)، زمان بازگشت بلوک حسی (1734/2± 25/8 دقیقه در مقابل 99041± 825/3 دقیقه) و حرکتی (80255± 025/3 دقیقه در مقابل 15166/1± 2000/4 دقیقه) در گروه مداخله کندتر و زمان شروع درد تورنیکه درگروه مداخله دیرتر 12039/3± 5/22 نسبت به گروه شاهد 77963/2± 4/19 بود. میانگین ضربان قلبی در 5/0، 2 و 4 ساعت بعد از باز کردن تورنیکه دارای کاهش معنی‌داری در گروه مداخله نسبت به شاهد بود (05/0p&#60;) هم‌چنین میزان شدت درد در 5/0 ساعت اول بعد از عمل در گروه مداخله کم‌تر از گروه شاهد بود (22± 05/1 دقیقه در مقابل 30± 1/1 دقیقه) و درکل در این موارد بین گروه مداخله و شاهد تفاوت آماری معنی‌داری وجود داشت (05/0p&#60;).
استنتاج: استفاده از نیتروگلیسیرین سبب افزایش اثر داروی بی‌حسی می‌شود بدون آن که افزایش چندانی در میزان عوارض به ویژه عوارض همودینامیک در بیمار ایجاد نماید.

شماره ثبت کارآزمایی بالینی : 1 N2013012012205IRCT</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Intravenous regional anesthesia (IVRA) is a simple and reliable method for upper extremity injuries. Different additives have been combined with local anesthetics to improve block quality, decrease tourniquet pain and postoperative analgesia in IVRA. This study was performed to evaluate the effect of (NTG) in quality improvement when added to lidocaine in IVRA.
Material and methods: In a clinical trial, 40 patients ASA (American Society of Anesthesiologists) I-II, the candidates with upper extremity injury were scheduled for IVRA randomly allocated into two groups. Under identical condition, the control group received 3mg/kg mg lidocaine %0.5 and the study group received 3mg/kg mg lidocaine %0.5 plus 200µg nitroglycerine. Hemodynamic variables were measured and recorded at 5, 10, 15, 20, and 30 min after anesthetic solution administration. The onset and recovery times of sensory and motor block were measured and recorded and tourniquet pain based on visual analog scale (VAS) score in all patients. After the tourniquet deflation, at 30 min and 2, 4, 6 and 12 h, hemodynamic variables, VAS score, total analgesic consumption in the first 24 h after operation, and the side effects were noted.
Results: Sensory block onset time was less in NW in comparison with the control group (2.45±0.51042 vs 4.35±1.26803) Sensory and motor recovery times were prolonged in NW group compared to the control group (8.25±2.1734 vs 3.825±0.99041 min) for sensory, (4.2000±1.15166 vs 3.025±0.80255 min) for motor recovery with statistical significance (P&#60;0.05). The onset time tourniquet pain was prolonged in NW in comparison with the control group (22.5±3.12039 vs 19.4±2.77963 min). Pulse rate at 0.5, 2 and 4 hr postoperatively was lower in the study group (P&#60;0.05). Postoperative analgesia after 0.5h of tourniquet deflation was prolonged with statistically significant difference in VAS scores (1.1±0.30 vs 1.05±0.22).
Conclusion: Totally, according to the obtained results, it may be concluded that the use of nitroglycerine added to lidocaine would result in an increase in the effect of anesthetic without additional adverse effects.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>55</FPAGE>
			<TPAGE>61</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/8
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/19
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/8
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/19
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>ندا</Name>
				<MidName></MidName>
				<Family>برازنده</Family>
				<NameE>Neda</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Barazandeh</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>مهدی</Name>
				<MidName></MidName>
				<Family>ابتهاج</Family>
				<NameE>Mehdi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ebtehaj</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>فیروزه</Name>
				<MidName></MidName>
				<Family>نادری</Family>
				<NameE>Firoozeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Naderi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Intravenous regional anesthesia</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Nitroglycerin</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Lidocaine</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>بی‌حسی منطقه‌ای داخل وریدی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>نیتروگلیسیرین</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>لیدوکایین</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Charles B, Gray R. local Anasthetics: Millers Anesthesia. 7rd ed. USA. Philadelpia: Elsevier; 2010.##2.	Strichartz GR, Berde CB. Local Anesthetics. In: Miller RD. Miller`s Anesthesia, 6th ed. USA. Philadelphia: Elsevier, 2005. p. 573-604.##3.	Lauretti GR, and et al.Transdermal nitroglycerine enhances spinal sufentanil  postoperative analgesia following orthopedic surgery. J Anesth 1999; 90: 734-739.##4.	Elmetwaly KF, Hegazy N. does the use of ketamin or nitroglycerin as an adjuvant to lidocaine improve the quality of intravenous regional anastheaia? Saudi J Aanesth 2010     ; 4(2): 55-62.##5.	Glantz L and et al. Efficacy of transdermal nitroglycerin combined with etodolac for the treatment of chronic post-thoracotomy pain: an open-label prospective clinical trial. J Pain Symptom Manage 2004; 27( 3): 277-281.##6.	Talebi H, Hossein Zadeh H, Eidi M, Anbari Z. Comparing the effects of adding pancoronium and fentanyl to lidocaine during intravenous regional anesthesia. Rahavard Danesh, Sci J of Arak Univ Med Sci 2003; 24: 36-39 (Persian).##7.	Aleboyeh MR, Azarian M. Comparison of the effect of the combination of lidocaine+ fentanyl+pavlon and lidocaine in IVRA. Sci J of Hamadan Univ Med Sci 2003; 27( 13): 16-12 (Persian).##8.	Choyce A, Peng P. A systematic review of adjuncts for intravenous regional anesthesia for surgical procedure. Can J Anaesth 2002; 49: 32-45.##9.	Turan A, Karamanloglu B, Memis D, Kaya G, Pamukçu Z. Intravenous regional anesthesia using prilocaine and  neostigmine. Anesth Analg 2002; 95: 1419-1422.##10.	Estèbe JP, Gentili ME, Langlois G, Mouilleron P, Bernard F, Ecoffey C. Lidocaine priming reduces tourniquet pain during intravenous regional anesthesia: a preliminary study. Reg Anesth Pain Med 2003; 28( 2 ): 120-123.##11.	Memis D, Turan A, Karamanlioglu B, Pamukcu Z,Kurt I. Adding dexmedetomidine to lidocaine forintravenous  regional anesthesia. Anesth Analg 2004; 97(3): 835-540.##12.	Sen S, Ugur B, Aydın ON, Ogurlu M, Gursoy F, Savk O. The analgesic effect of nitroglycerin added to lidocaine on intravenous regional anesthesia. Anesth Analg 2006; 102(3): 916-20.##13.	Elmetwaly KF, Hegazy NA, Aboelseoud AA, Alshaer AA. Does the use of ketamine or nitroglycerin as an adjuvant to lidocaine improve the quality of intravenous regional anesthesia? Saudi J Anaesth 2010; 4(2): 55-62.##14.	Banihashem M. Comparison of lidocain-Nitroglycerin with lidocaine for Intravenous Regional Anesthesia. J Babol Univ Med Sci 2012; 14(1): 7-12 (Persian).##15.	Prado WA, Schiavon VF, Cunha FQ. Dual effect of local application of nitric oxide donors in a   model of incision pain in rats. Eur J Pharmacol 2002; 441: 57-65.##16.	Abbasivash R, Hassani E, Aghdashi MM, Shirvani M. The effect of nitroglycerin as an adjuvant to lidocaine in intravenous regional anesthesia. Middle East J Anesthesiol 2009; 20(2): 265-269. ##17.	Raj PP, Garcia CE, Burleson JW, Jenkins MT. The site of action of intravenous regional anesthesia. Anesth Analg 1972; 51: 776–86##18.	Brill S, Middleton W, Brill G, Fisher A. Bier’sblock: 100 years old and still going strong! Acta Anaesthesiol Scand 2004; ##48(1): 117-122.##19.	Rosenberg PH. Intravenous regional anesthesia: nerve block by multiple mechanisms. Reg Anesth 1993; 18: 1-5.##20.	Hashimoto S, Kobayashi A. Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites. Clin Pharmacokinet 2003; 42(8): 205-2021.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>بررسی کیندلینگ الکتریکی به وسیله تحریکات الکتریکی مکرر کف پای موش صحرایی</TitleF>
		<TitleE>Repeated Foot Pad Electrical Stimulation Facilitate Electrical Kindling in Rats</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف : کیندلینگ یکی از مدل های صرع است که توسط تحریکات مکرر مغز ا یجاد می گردد . آمیگدال به
دلیل نقشی که هم در انسان و هم در موش در ایجاد کیندلینگ و در شرطی شدن ناشی از ترس دارد مورد توجه قرار
گرفته است . به این ترتیب هدف از مطالعه حاضر ارزیابی تحریکات الکتریکی مکرر کف پای مو ش های صحرایی به هنگام
ترس و اثر آن بر روی تسهیل ایجاد کیندلینگ الکتریکی آمیگدال است.
برای ایجاد شرطی شدن احترازی فعال Wistar مواد و روش ها: در این مطالعه تجربی، 32 موش صحرایی نر از نژاد
دو طرفه تحت آزمایش شاتل باکس قرار گرفته و بر اساس پاسخ های ارائه شده توسط حیوان به دو گروه دیر یاد گیر و زود
یادگیر تق سیم شدند . بر اساس تحقیقات قبلی آزمایش ها برروی گروه دیر یادگیر انجام گرفت. موش های دیر یادگ یر به دو
گروه تقسیم شدند . گروه آزمون برای 10 روز متوالی تحت ت أثیر تحریکات هم زمان صوتی و الکتریکی کف پا قرار
با گروه کنترل همانند گروه آزمون رفتار شد با این تفاوت که فقط تحریکات صوتی را دریافت کردند .(n= گرفتند ( 10
پس از 10 روز برای ایجاد کیندلینگ الکتریکی تحت ت أثیر تحریکات الکتریکی آمیگدال قرار گرفته و کیندل .(n= 8)
شده و پارامترهای تشنجی مورد ارزیابی قرار گرفت . در پایان داده ها با استفاده از آزمون آنالیز واریانس یک طرفه و آزمون
توکی تجزیه و تحلیل شد.
یافته ها: نتایج حاصل از این تحقیق نشان داد که قرار گرفتن موش های صحرایی نر دیر یادگیر در معرض تحریکات
مکرر الکتریکی سبب تسهیل ایجاد کیندلینگ در آن ها می گردد.
استنتاج: بر اساس یافته های حاضر، به نظر می رسد قرارگیری موش هایی که با شرطی شدن در شاتل باکس مشکل
دارند، در معرض تحریکات الکتریکی مکرر در شرایط ترس می تواند استعداد ابتلاء آن ها به کیندلینگ را افزایش دهد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Kindling is an animal model of epilepsy induced by repeated
stimulation of the brain. The amygdala has been the focus of interest due to large part to its role in
epilepsy induction and in fear conditioning in both human and rats. The purpose of the present study was
to evaluate whether low electrical stimulation of foot pad of rats during fear can facilitate amygdala
electrical kindling susceptibility.
Material and methods: 32 Wistar male rats trained for the two way active avoidance learning
in the shuttle box on the basis of escape response were divided into fast and slow learning animals and
then each group was randomly assigned to two groups. Test groups (n= 10) received conditional and
unconditional stimulus and control groups (n= 8) received conditional stimulus for ten days. The rats
were kindled by electrical stimulation of basolateral amygdala and the seizure parameters were noted. The
data were analyzed using one way ANOVA and Tukey’s test.
Results: The results of the present study demonstrate that repeated electrical stimulation of slow
learning animals during fear condition facilitates kindling induction.
Conclusion: It seems that repeated electrical stimulation after fearing in rats that have
impairments in performance of shuttle box conditioning increase the susceptibility to electrical kindling.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>63</FPAGE>
			<TPAGE>69</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/18
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/29
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/18
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/29
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>محمد رضا</Name>
				<MidName></MidName>
				<Family>پالیزوان</Family>
				<NameE>Mohammad Reza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Palizvan</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>dr.palizvan@arakmu.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>شادی</Name>
				<MidName></MidName>
				<Family>خادمی</Family>
				<NameE>Shadi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khademi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>fear conditioning</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>kindling</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>electrical stimulation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>electrical kindling</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>شرطی شدن ترس</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>کیندلینگ الکتریکی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تحریک الکتریکی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>آمیگدال</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Westbrook GL. Seizures and Epilepsy. In: Kandle ER, Schwart JH, Jessell TM. Principles of neural science. 4th ed. New York: McGrow-Hill; 2000. p. 910-916.##2.	Rall TW, Shleifer LS. Drugs effective in the therapy of the epilepsies. In: Goodman Gillman A, Rall TW, Nies AS, Taylor P, (eds). The pharmacological basis of therapeatics. New York: Pergamon Press; 1991. p. 436-462.##3.	Striano S, Coppola A, del Gaudio L, Striano P. Reflex seizures and reflex epilepsies: old models for understanding mechanisms of epileptogenesis. Epilepsy Res 2012; 100(1-2): 1-11.##4.	Kasteleijn-Nolst Trenité DG. Provoked and reflex seizures: surprising or common? Epilepsia 2012; 53(Suppl 4): 105-113.##5.	Mirnajafi-zadeh J, Pourgholami MH, Palizvan MR, Rostampour M, Fallahi M. Anticonvulsant action of 2- chloroadenosine injected focally into the perirhinal cortex in amygdaloid kindled rats. Epilepsy Res 1999; 37: 37-43.##6.	Dehuna A, Leone AP, Longendorf F. Chronic habihual cocaine abuse and kindling- induced epilepsy, a case report. Epilepsia 1991; 32: 890-894.##7.	Collins DR, Pare D. Differential fear conditioning induces reciprocal changes in the sensory responses of lateral amygdala neurons to the CS(+) and CS(-). Learn Mem 2000; 7(2): 97-103.##8.	Barat SA, Abdel-Rahman MS. Cocaine and lidocaine in combination are synergistic convulsants. Brain Res 1996; 742: 157-162.##9.	Ebert U, Rundfeldt C, Losher W. Development and pharmacological suppression of secondry afterdischarges in the hippocampus of amygdala-kindled rats. Eur J Neurosci 1995; 17: 732-741.##10.	Alasvand Zarasvand M, Mirnajafi-Zadeh J, Fathollahi Y, Palizvan MR. Anticonvulsant effect of bilateral injection of N6-cyclohexyladenosine into the CA1 region of the hippocampus in amygdala-kindled rats. Epilepsy Res 2001; 47(1-2): 141-149.##11.	Mirnajafi-Zadeh J, Mortazavi M, Fathollahi Y, Alasvand Zarasvand M, Palizvan MR. Effect of transient hippocampal inhibition on amygdaloid kindled seizures and amygdaloid kindling rate. Brain Res 2002; 954(2): 220-226.##12.	Palizvan MR, Fathollahi Y, Semnanian S, Hajezadeh S, Mirnajafizadh J. Differential effects of pentylenetetrazol-kindling on long-term potentiation of population excitatory postsynaptic potentials and population spikes in the CA1 region of rat hippocampus. Brain ##Res 2001; 898(1): 82-90.##13.	Cui LJ, Xie ZF, Piao HR, Li G, Chai KY, Quan ZS. Synthesis and anticonvulsant activity of 1-substituted-7-benzyloxy-4, 5-dihydro-[1,2,4] triazolo[4,3-a] quinoline. Biol Pharm Bull 2005; 28(7): 1216-1220.##14.	Palizvan MR, Khademi Sh, Ghaznavi E Effect of repeated electrical stimulation in Pentylenetetrazol induced kindling in male rats. Arak Medical University Journal 2005; 8(30): 21-14.##15.	Paxinos G, Watson C. The rat brain in stereotaxis coordinates. California: Academic Press; 1986.##16.	Ngoupaye GT, Ngo Bum E, Ngah E, Talla E, Moto FC, Taiwe GS, et al. The anticonvulsant and sedative effects of Gladiolus dalenii extracts in mice. Epilepsy Behav 2013; 28(3): 450-456.##17.	Moscarello JM, LeDoux JE. Active avoidance learning requires prefrontal suppression of amygdala-mediated defensive reactions. J Neurosci 2013; 33(9): 3815-3823.##18.	Aldavert-Vera L, Huguet G, Costa-Miserachs D, Ortiz SP, Kádár E, Morgado-Bernal I, et al. Intracranial self-stimulation facilitates active-avoidance retention and induces expression of c-Fos and Nurr1 in rat brain memory systems. Behav Brain Res 2013; 250: 46-57.##19.	Wilensky AE, Schafe GE, Kristensen MP, LeDoux JE. Rethinking the fear circuit: the central nucleus of the amygdala is required for the acquisition, consolidation, and expression of Pavlovian fear conditioning. J Neurosci 2006; 26(48): 12387-12396.##20.	LeDoux JE, Farb C, Ruggiero DA. Topographic organization of neurons in the acoustic thalamus that project to the amygdala. J Neurosci 1990; 10: 1043-1054.##21.	Collins DR, Pare D. Differential fear conditioning induces reciprocal changes in the sensory responses of lateral amygdala neurons to the CS+ and CS-. Learn Mem 2000; 7: 97-103.##22.	D.R. Collins, and D. Pare, Differential fear conditioning induces reciprocal changes in the sensory responses of lateral amygdala neurons to the CS+ and CS-. Learn Mem 2000; 7(2): 97-103.##23.	Iwata J, LeDoux JE, Meeley MP, Arneric S, Reis DJ. Interinsic neurons in the amygdaloid field projected to by medial geniculate body mediate emotional responses conditioned acoustic stimuli. Brain Res 1986; 383(1-2): 195-214.##24.	Martin JH. The collective electrical behavior of cortical neurons: In: Principles of neural science. Kandel ER, Schwartz JH, (eds). Jessell TM. USA: McGrohill; 1991. p. 1227-1246.##25.	Fisher RS. Animal models of epilepsies. Brain Res Rev 1989; 14: 245-278.##26.	Nieminen SA. Amygdala kindling increased fear-response, but did not impair spatial memory in rats. Physiol Behav 1992; 51: 845-849.##27.	Kellett J, Kokkinidis L. Extinction deficit and fear reinstatement after electrical stimulation of the amygdala: implications ##for kindling-associated fear and anxiety. Neuroscience 2004; 127(2): 277-287## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>بررسی روایی و پایایی ابزار سنجش متغیرهای تداوم رفتارهای پیشگیری کننده از عفونت ناشی از ویروس هپاتیت ب در کارکنان خدمات بهداشتی درمانی</TitleF>
		<TitleE>Psychometric measure continuous variables preventive behaviors of hepatitis B virus infection in health care workers</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: لزوم اندازه‌گیری تداوم رفتارهای پیشگیری کننده، مورد تأکید پژوهشگران عرصه سلامت قرار دارد. حصول چنین هدفی مستلزم به کارگیری ابزاری برخوردار از روایی و پایایی مناسب در متون علمی است.
مواد و روش‌ها: این مطالعه توصیفی- مقطعی درسال 1392 با روش نمونه‌گیری تصادفی دو مرحله ای برروی 135 نفر از کارکنان مرکز بهداشت شرق تهران انجام شد. از طریق بررسی روایی صوری کیفی و کمی، محاسبۀ نسبت و شاخص روایی محتوای ابزار، با قضاوت کیفی یک پانل 14 نفره از خبرگان و روایی سازه با فاکتور آنالیز اکتشافی تأییدی و پایایی با تعیین توافق درونی (ضریب آلفای کرونباخ ) و روش‌های بازآزمایی، تخمین و مورد تأیید قرار گرفت.
یافته‌ها: از کل 50 گویۀ اولیه، 3 گویه اصلاح و 5 گویه حذف و پس از محاسبۀ شاخص امتیاز تأثیر آیتم (با مقادیر بالاتر از 5/1) با CVI بیش‌تر از 70/0 و CVR بالاتر از80/0، نهایتاً به تعداد 45 مورد کاهش یافتند. تحلیل عامل اکتشافی با چرخش واریماکس، 3 عامل را با مقدار ایگن بیش‌تراز یک ایجاد کرد که قادر به پیش بینی 52/74 درصد از تغییرات کل ابزار بود. تحلیل عاملی تأییدی برازش قابل قبولی را برای مدل 3 عاملی با 3 دامنه نشان داد. زیرشاخه‌ها همگنی خوبی را نشان دادند به طوری که میانگین همبستگی بین سؤالی بیش‌تر از 35/0 بود (001/0p&#60;). پایایی کل ابزار با محاسبۀ آلفای کرونباخ برابر 83/0 تأیید شد و نتایج آزمون بازآزمون نشان دهنده ثبات پرسش‌نامه و گویه‌های آن بود.
استنتاج: نتایج این مطالعه، شواهد مناسبی در خصوص استحکام ساختار عاملی و پایایی ابزار را فراهم نمود و می‌تواند در توسعه ابزار برای مقاصد تحقیقاتی، آموزشی و عملی در کارکنان سلامت، مورد توجه پژوهشگران قرار گیرد. کیفیت روان‌سنجی، ابزار نیز راضی‌کننده بود. البته محدودیت‌های روش شناسی باید در توسعه بیش‌تر پرسش نامه مدنظر قرارگیرد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: The need for continuous measures of preventive behaviors, health researchers is highlighted. Means of achieving that goal requires the use of adequate reliability and validity in the scientific literature.
Material and methods: This cross-sectional study was done in 2013 on a two-stage random sampling method, 135 persons were Tehran Health Center East. Through the qualitative and quantitative study of face validity, content validity index calculation and judging the quality via a 14-member panel of experts and validity by performing exploratory factor analysis-with the agreement reliability (coefficient alpha) and test-retest method of estimating was approved.
Results: A total of 50 males, first three items need to be corrected with the number 45 on the calculation of the index scores of items (with quantity greater than 1.5) with CVI greater than 0.07 and CVR higher than 0.08 down found. As demonstrated, good homogeneity of subdirectories than the average correlation between questions 0.35 (P&#60;0.001). By calculating Cranach's alpha reliability of the tool, 0.83 was verified and the results show test-retest stability of the questionnaire and its subdivisions.
Conclusion: The evidence of the strength of the factor structure and the reliability of an instrument can be developed to provide a tool for research, teaching and practice of health workers are of interest. The psychometric quality of the instrument was satisfactory. The course restrictions of the methodology should be considered in the development of more questionnaires.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>71</FPAGE>
			<TPAGE>82</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/28
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/8
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/28
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/8
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>محمد حسین</Name>
				<MidName></MidName>
				<Family>دلشاد</Family>
				<NameE>Mohammad Hossein</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Delshad</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>علیرضا</Name>
				<MidName></MidName>
				<Family>حیدرنیا</Family>
				<NameE>Alireza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hidarnia</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>hidarnia@modares.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>شمس الدین</Name>
				<MidName></MidName>
				<Family>نیکنامی</Family>
				<NameE>Shamsodin</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Niknam</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Psychometrics</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Preventive behaviors</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>health care workers</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>روان سنجی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>رفتارهای پیشگیری کننده</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>کارکنان خدمات بهداشتی درمانی</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Alaedini M, Paghe A, Fakhar M, Nasiri E. Implementing Infection Control Principles in Medical Teaching Hospitals of Mazandaran University of Medical Sciences. J Mazand Univ Med Sci 2013; 23(98): 274-280 (Persian).##2.	Habibiyan R, Evaluate the safety of hepatitis B vaccine in medical staff, J Shahrekord Univ Med Sci 2002; 5(1): 41-46. (Persian)##3.	Sparkes AC. Validity in qualitative inquiry and the problem of criteria implications for sports psychology. Sport Psych 1998; 12(4): 363-386.##4.	Keith G, Alan B, Islay S. Validity in clinical research: a review of basic concepts and denitions Physical Therapy. Sport 2000; 1: 19-27.##5.	Waltz CF, Strickland OL, Lenz ER. Measurement in nursing and health research. 3rd ed. Philadelphia:PA:F.A.Davis Publishers   ; 2005.##6.	Polit DF, Beck CT. Nursingresearch: Principls and methods, 7th ed. Philadelphia: Lippincott; 2004.##7.	Patricia A, Higgins RN, Andrew J, Straub ANP. GNP Understanding the error of our ways: Mapping the concepts of validity and reliability. Nurs Outlook 2006; 54(1): 23-29.##8.	Safari M, Ghofranipour F, Shojaei Zadeh D, Heidarnia A, Pakpur Haji Agha A. Theories, models and methods of health education and health promotion. Volume I. 2nd ed. Tehran: Sobhan; 2012.##9.	Karimi M, Niknami Sh, Hidarnia A. Effect of health education on AIDS prevention For Practices under 25 years of prison inmates Qezelhesar Tehran. J Tehran Univ Med Sci 2002; 2(4): 36-38 (Persian).##10.	Dixon JK. Factor Analysis. In: Munro BH. Statistical Methods for Health Care Research. 4rd ed. New York: Lippincott; 2001.##11.	Polit DF, Beck CT, Owen SV. Is the CVI an Acceptable Indicator of Content Validity? Research in Nursing &#38; Health 2007; 30(1): 459-467.##12.	Bartlett MS. A note on the multiplying factors for various chi square approximations. 4rd ed. New York: Lippincott; 1954.##13.	Byrne BM. Structural equation modeling with LISREL, PRELIS, and SIMPLIS: Basic concepts, applications, and programming. ##1 rd ed. Mahwah, NJ: Lawrence Erlbaum Associates; 2006.##14.	Yaghmaie F, Ahmadi M. Content validity and its estimation. J Med Edu Spring 2003; 3)1): 25-27 (Persian).##15.	Khorasani H, Ameriuon A, Zarychy A, Tavakoli R, Zabul R, shokuh M. The knowledge and practice of infection control nurses and hospital administrators in hospitals or other medical sciences. (AS), J Military Med 2009; 2(11): 97-101 (Persian).##16.	Gholami Fesharaki M, Jamali M J, Rahmati Najarkolaei F, Mohamadian M, Habibi M,Aghamiri Z. Validity and Reliability of the Najmiyeh Outpatients Satisfaction Questionnaire. Health Education &#38; Health Promotion (HEHP) 2013, 1 (1): 13- 20 (Persian).##17.	Aeen F, Delaram M, Frozande N, Daris F. Parental attitudes of senior female high school students in Shahrekord about how to deal with children and their effect on attitude change. J Shahrekord Univ Med Sci 2001; 3(1): 75-83 (Persian).##18.	Bakhshian A, Moqaddasian S, Zamanzadeh W, Prone C, Bakhshian A. Knowledge, attitudes and practices of intensive care nurses in teaching hospitals of Tabriz on hospital infection control. Journal of Nursing and Midwifery, J Iran Univ Med Sci 2010; 64(23): 17-28 (Persian).##19.	Bnayyan Sh, Kazemian A, kheiri S. Knowledge, attitudes and practices of women attending health centers Borujen screening methods for breast cancer and its risk factors. J Shahrekord Univ Med Sci 2005; 7(4): 28-34 (Persian).##20.	Karimy M, Abedi Ah R, Amin-Shokravi F, Tavafian SS. Preventing HIV Transmission among the Opiate- Dependent Population in Zarandieh: Evaluation of the HBM-Based Educational Programs. Health Education &#38; Health Promotion (HEHP) 2013, 1 (1): 21- 31 )Persian(.##21.	Adibi P, Nik KB, Alizadeh M, Zali MR, Esmaeili A. Multistage Group Education for Hepatitis B patients. Iranian J Med Edu 2002; 4(8): 34-50 (Persian).##22.	Delshad MH, Hidarnia A, Niknami S. Investigating the application of the principles of standard precautions to prevent. HBV infection. Zahedan J Res Med Sci (ZJRMS) 2014; 16(4): 50 (Persian).##23.	Bashirian S, Hidarnia A, Allahverdipour H, Hajizadeh E. The Theory-Based Substance Abuse Prevention Program for Adolescents. Health Education &#38; Health Promotion (HEHP) 2013, 1 (1): 3- 12(Persian).##24.	Khalaj M, Mohammadi ZE. Evaluating the impact of health education in primary schools in Aknowlege and feeding behaviors, Qazvin J Univ Med Sci 2006; 8(1): 41-49 (Persian).##25.	Rezaei N, Tahbaz F, Kimyagar M, Majd H. Effect of nutrition education on knowledge, attitude and practice of patients and type 1 diabetes in the city J of Shahrekord UniV Med Sci 2006; 8(2): 52-59 (Persian).##26.	Asadpour M, Ghofranipour F, Niknami Sh, Ardebili EH. Promotion and Maintebance of Preventive Behaviors from HIV and HCV Infections in Health Care Workers with Using Constructions of Health Belief Mode In Precede-proceed Model , Undergraduate thesis PHD Health public, 1 red ed. Tarbiat Modares University of Tehran, 2010 (Persian).##27.	HamidZadeh Y, Niknami Sh, Babaei GL. Effect of health education program on knowledge, attitudes and preventive behaviors Wiki barbers in the prevention of hepatitis B. PhD Thesis, J Tehran Univ Med Sci 1996; 2(2): 50-58 (Persian).##28.	Kline P. An Easy Guide to Factor Analysis. ##3 rd ed. London: Routledge. 1994.##29.	Koopman C, Rotheram Borous MJ, Henderson R, Bradley JS, Hunter I. Beliefs about preventing AIDSBAPA scale. 1990. Available from: URL: http://www.CHIPTS.org/CHIPT S/ARCHIVE/6756ed.htm. Accessed September 16, 1990.##30.	Rosmawati M, Chirk J, Wen T, Suraya Zainol A, Li, Pand Wah Y. attitudes and practices among people with chronic hepatitis B attending a hepatology clinic in Malaysia: A crosssectional study. BMC Public Health 2012;12(601):1471-2458##31.	Yitayal S, Tamrat A, Adane M. Hepatitis B virus infection among medical waste handlers in Addis Ababa, Ethiopia. BMC Research Notes 2011, 4(479):1756-0500.#### ###### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>مقاومت آنتی بیوتیکی انتروکوک به لاینزولید بدون سابقه مصرف</TitleF>
		<TitleE>Enterococcus Resistance to Linezolid without History of Use</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: مقاومت به آنتی‌بیوتیک های انتخابی، بحثی جدی و نگران کننده است. هدف این مطالعه، بررسی مقاومت آنتی‌بیوتیکی انتروکوک به لاینزولید بوده که هنوز در کشور ایران استفاده نشده است.
مواد و روش‌ها: این مطالعه توصیفی روی 100 نمونه مدفوعی از بیماران بستری در بخش‌های بیمارستان شهید بهشتی کاشان در سال 1391 انجام شد. نمونه ها در محیط ترانسپورت به آزمایشگاه میکروبیولوژی منتقل شد و پس از انجام تست‌های تشخیصی بیوشیمیایی، انتروکوک بودن آن‌ها اثبات شد. سپس تست آنتی‌بیوگرام با Disk Diffusion انجام شد. با کمک E-test، حداقل غلظت مهاری وانکومایسین سنجیده شد. نتایج در نرم افزار SPSS با کای اسکوئر و نیز t زوجی تحلیل شد.
یافته‌ها: میانگین سنی بیماران29/18 26/52  سال بود. 48 نفر زن (48 درصد) و بقیه مرد بودند. 34 نفر (34 درصد) با انتروکوک مقاوم با وانکومایسین و 33 نفر (33 درصد) با انتروکوک مقاوم با لاینزولید کلونیزه بودند. با E-test، 73 سویه به وانکومایسین حساس (MIC≤4 g/ml) و 27 سویه مقاوم (g/ml 32&#60;MIC) بودند و هیچ موردی از حد واسط مشاهده نشد. مصرف آنتی‌بیوتیک، مهم‌ترین فاکتور خطر کلونیزاسیون انتروکوک مقاوم به وانکومایسین بود (05/0p&#60;). برای لاینزولید نیز مدت مصرف آنتی‌بیوتیک، در گذشته، تنها عامل مؤثر در مقاومت بود (05/0p&#60;).
استنتاج: وجود 33 درصد مقاومت در بیمارانی که تا به حال سابقه مصرف آنتی‌بیوتیک لاینزولید را نداشته‌اند، می‌تواند نشان‌دهنده مقاومت متقاطع انتروکوک به دو آنتی‌بیوتیک لاینزولید و وانکومایسین باشد، که حتماً در مطالعات آینده باید بررسی‌های ژنومی گسترده‌تری روی آن‌ها انجام شود.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Resistance to choice antibiotics is serious and focus of concern. Therefore, the current study was done to identify the enterococcus resistance pattern to Linezolid- choice antibiotic, which has not yet been used in the country.
Material and methods: This descriptive study was a laboratory research done on 100 stool samples gathered from hospitalized patients of Shahid Beheshti Hospital, Kashan, 2012. The samples were transferred to the university microbiology laboratory in transport media and the entrococcus identity was established through biochemical tests. Then Linezolid and Vancomycin antibiogram was recorded by means of Disk Diffusion method. On the other hand, Minimum Inhibition Concentration (MIC) for Vancomycine was measured by E-test method. Finally, the results were analyzed by means of SPSS software- Chi square test, and paired T-test.
Results: The mean age was 52.26±18.29 years old. Forty eight subjects were females (48%) and the rest were males. Thirty four subjects were colonized with Vancomycine Resistant entrococci and 33 others with Linezolid Resistant entrococci. Using the E-test method, 73 strains were sensitive to vancomycine (MIC≤4g/ml), 27 resistant (MIC&#62;33g/ml), and none was intermediate. Using antibiotic was one of the most important risk factors for vancomycine resistance in enterococci (P&#60;0.05). The duration of antibiotic use with Linezoid in the past was the only effective factor in resistance (P&#60;0.05).
Conclusion: The resistance rate of enterococci was 33%, without any history of linezolid use in the past, this can conclude that sort of cross resistance to both vancomycine and linezolid, synchronically that suggests the necessity of future studies about genome basics of the issue.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>84</FPAGE>
			<TPAGE>91</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/4
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/15
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/4
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/15
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>ایمان</Name>
				<MidName></MidName>
				<Family>غفارپسند</Family>
				<NameE>Iman</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghaffarpasand</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>ghaffarpasand@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>رضوان</Name>
				<MidName></MidName>
				<Family>منیری</Family>
				<NameE>Rezvan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Moniri</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Enterococcus</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Antibiotic Resistance</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Vancomycine</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Linezolid</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>انتروکوک</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>مقاومت آنتی‌بیوتیکی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>وانکومایسین</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>لاینزولید</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Chavers LS, Moser SA, Benjamin WH, et al. Vancomycin resistant enterococci: 15 years ##and counting. J Hosp Inf 2003; 53: 159-171.##2.	Wang JT, Chang SC, Wang HY, Chen PC, ##Shiau YR, Lauderdale TL. TSAR Hospitals. High rates of multidrug resistance in Enterococcus faecalis and E. faecium isolated from inpatients and outpatients in Taiwan. Diagn Microbiol Infect Dis 2013; 75(4): 406-411.##3.	Furtado GH, Mendes RE, Pignatari AC, ##Wey SB, Medeiros EA. Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies. Am J Infect Control 2006; 34(7): 447-451.##4.	Kolar M, Pantucek R, Vagnerova I, Sauer P, Kesselova M, Cekanova L, et al. Prevalence of vancomycin-resistant enterococci in hospitalized patients and those living in the community in the Czech Republic. New Microbiol 2006; 29(2): 121-125.##5.	Cattoir V, Leclercq R. Twenty-five years ##of shared life with vancomycin-resistant enterococci: is it time to divorce? J Antimicrob Chemother 2013; 68(4): 731-742.##6.	Briggs S, Upton A, Bilkey M, Taylor S, Roberts S, Holland D. Vancomycin-resistant Enterococcal colonization of hospitalized patients in Auckland. N Z Med J 2006; 115(1160): U145.##7.	Lee SC, Wu MS, Shih HJ, Huang SH, ##Chiou MJ, See LC, et al. Identification of vancomycin-resistant enterococci clones and inter-hospital spread during an outbreak in Taiwan. BMC Infect Dis 2013; 13: 163-169.##8.	Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, et al. Effect of antibiotic therapy on the density of vancomycin-resistant Enterococci in the stool of colonized patients. N Engl J Med 2000; 343(26): 1925-1932.##9.	Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in E. faecium. New England J Medicine 1988; 319: 157-161.##10.	Hayakawa K, Marchaim D, Pogue JM, Ho K, Parveen S, Nanjireddy P, Sunkara B, et al. Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: a case-case-control study. Am J Infect Control 2012; 40(10): e261-263.##11.	Seedat J, Zick G, Klare I, Konstabel C, Weiler N, Sahly H. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection. Antimicrob Agents Chemother 2006; 50(12): 4217-4219.##12.	National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility tests, 4th ed. Approved standards. NCCLS document M7-A2. National Committee for Clinical Laboratory Standards, Villanova, Pa, 1990.##13.	Nihonyanagi S, Adachi Y, Onuki T, Nakazaki N, Hirata Y, Fujiki K, et al. Emergence of linezolid-resistant Enterococcus faecalis strains from two inpatients in a pediatric ward. Kansenshogaku Zasshi 2012; 86(5): 555-562.##14.	Bonora MG, Ligozzi M, Luzzani A, Solbiati M, Stepan E, Fontana R. Emergence of linezolid resistance in Enterococcus faecium not dependent on linezolid treatment. Eur J Clin Microbiol Infect Dis 2006; 25(3): 197-198.##15.	Zeana C, Kubin CJ, Della-Latta P, Hammer SM. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature. Clin Infect Dis 2001; 33(4): 477-482.##16.	Scheetz MH, Knechtel SA,  Malczynski M, Postelnick MJ, Qi C. Increasing Incidence ##of Linezolid-Intermediate or- Resistant, Vancomycin-Resistant Enterococcus faecium Strains Parallels Increasing Linezolid Consumption. Antimicrob Agents Chemother 2008; 52(6): 2256-2259.##17.	Raad II, Hanna HA, Hachem RY, Dvorak T, Arbuckle RB, Chaiban G, et al. Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin. Antimicrob Agents Chemother 2004; 48(9): 3583-3585.##18.	Bassetti M, Farrel PA, Callan DA, Topal JE, Dembry LM. Emergence of linezolid-resistant Enterococcus faecium during treatment of enterococcal infections. Int J Antimicrob Agents 2003; 21(6): 593-594.##19.	Johnson AP, Tysall L, Stockdale MV, Woodford N, Kaufmann ME, Warner M, et al. Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit. Eur J Clin Microbiol Infect Dis 2002; 21(10): 751-754.##20.	Burleson BS, Ritchie DJ, Micek ST, Dunne WM. Enterococcus faecalis resistant to linezolid: case series and review of the literature. Pharmacotherapy 2004; 24(9): 1225-1231.##21.	Ramírez E, Gómez-Gil R, Borobia AM, Moreno F, Zegarra C, Muñoz R, et al. Improving linezolid use decreases the incidence of resistance among Gram-positive microorganisms. Int J Antimicrob Agents 2013; 41(2): 174-178.##22.	Swoboda S, Fritz S, Martignoni ME, Feldhues RA, Hoppe-Tichy T, Buchler MW, et al. Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report. J Antimicrob Chemother 2005; 56(4): 787-789.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>بررسی میزان باقی مانده انواع سموم ارگانوفسفره در توت فرنگی تولیدی استان مازندران</TitleF>
		<TitleE>Assessment of Organophosphorus Residues together in Strawberry Produced in Mazandaran, Iran</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: برای کنترل آفات در محصولات مختلف کشاورزی از جمله توت فرنگی، از آفت‌کش‌ها استفاده می‌شود. با توجه به این‌که توت‌فرنگی پوسته سطحی یک‌نواختی مشابه سایر میوه‌ها ندارد، لذا سموم دفع آفاتی که در پرورش این میوه به کار برده می‌‌شوند، در آن نفوذ کرده و به راحتی نیز از آن حذف نمی‌‌شود. از این‌رو این تحقیق با هدف بررسی میزان هم زمان باقی‌مانده آفت‌کش‌های ارگانوفسفره در توت‌فرنگی تولیدی استان مازندران انجام شده است.
مواد و روش‌ها: در این مطالعه 211 نمونه توت فرنگی از شهرهای استان مازندران در بهار سال 1391 از سطح مزارع تولیدی جمع‌آوری شد و به‌طور هم‌زمان باقی‌مانده سموم مالاتیون، دیازینون، دورسبان (کلرپیروفوس) و اتیون در آن‌ها مورد بررسی قرار گرفت. آماده‌سازی نمونه‌ها با روش QUECHERS صورت گرفت و به‌وسیله دستگاه GC-mass اندازه‌گیری کمی سموم مورد نظر انجام شد. مقایسه میانگین هرکدام از سموم با حدود استاندارد به روش آنالیز واریانس یک‌طرفه (ANOVA) مورد بررسی آماری قرار گرفت.
یافته‌ها: نتایج پژوهش نشان داد که میانگین و انحراف معیار کل غلظت سموم مالاتیون، دیازینون، دورسبان و اتیون بر حسب ppb به ترتیب 8/2±52/4، 8/6±2/37، 78/1± 07/6 و74/1±67/2 بود. از سوی دیگر اگر چه میانگین دیازینون و دورسبان در نمونه‌های مورد بررسی پایین‌تر از حد مجاز استاندارد ملی ایران به ترتیب100 و300 ppb می‌باشد در حالی که براساس این استاندارد مصرف مالاتیون و اتیون درتوت فرنگی مجاز نمی‌باشد.
استنتاج: یافته‌های به دست آمده مبنی بر وجود باقی مانده سموم در نمونه‌ها، کنترل دوره ای سلامت این محصول ضروری به نظر می‌رسد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Pesticides are used to control pests in agricultural crops. According to the integrity and permeability status of surface skin of strawberry, pesticides can penetrate and precipitate in the fruit. Thus, the study was performed to assess the level of Organophosphorus pesticide residues together in strawberry produced in Mazandaran province.
Material and methods: In this study, 211 strawberry samples were collected in the different cities of Mazandaran province during spring 2012, and the residual levels of malation, diazinon, dursban and etion were analyzed using QUECHERS and GC-MS. The data were analyzed by One-way ANOVA statistical analysis. P&#60; 0.05 was comprehended as significant.
Results: The results showed that the mean residual contents of malation, diazinon, dursban and etion were 4.58±2.8 ppb, 37.2±6.8 ppb, 6.07±1.78 ppb and 2.67±1.74 ppb, respectively. Despite the malation and etion, the mean concentrations of diazinon and dursban in strawberry samples were lower than that of Iran standard level.
Conclusion: As a result, regarding to the use of large amount of unaccepted pesticides, permanent control of pesticide residues in agricultural products such as strawberry, seems to be necessary.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>93</FPAGE>
			<TPAGE>102</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/5
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/16
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/5
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/16
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>محمد</Name>
				<MidName></MidName>
				<Family>قلی پور</Family>
				<NameE>Mohammad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Golepoor</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>محمد</Name>
				<MidName></MidName>
				<Family>شکرزاده</Family>
				<NameE>Mohammad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Shokrzadeh</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>mslamuk @yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>محمدحسین</Name>
				<MidName></MidName>
				<Family>اصفهانی زاده</Family>
				<NameE>Mohammad Hossein</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Esfahenezadeh</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>لاله</Name>
				<MidName></MidName>
				<Family>کریم زاده</Family>
				<NameE>Laleh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Karemzadeh</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>بهار</Name>
				<MidName></MidName>
				<Family>ابراهیم مقام</Family>
				<NameE>Bahar</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ebrahemmagam</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>ابراهیم</Name>
				<MidName></MidName>
				<Family>صالحی فر</Family>
				<NameE>Ebrahim</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Salehifar</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>احمدعلی</Name>
				<MidName></MidName>
				<Family>عنایتی</Family>
				<NameE>Ahmad Ali</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Enayati</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Organophosphorus pesticide residues (malation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>diazinon</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>dursban and etion)</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>strawberry</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>باقی مانده سموم ارگانوفسفره (مالاتیون</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>دیازینون</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>دورسبان و اتیون)</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>توت فرنگی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>گازکروماتوگرافی جرمی</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Cieslik E, Sadowska-Rociek A, Ruiz JMM, Surma-Zadora M. Evaluation of QuEChERS method for the determination of organochlorine pesticide residues in selected groups of fruits. J Food Chem 2011; 125(2  ): 773-778.##2.	Institute of Standards and Industrial Research of Iran. Pesticides-Maximum residue limit of pesticides-Pome, stone &#38; small fruits &#38; nuts. NO: 13117. 1th ed. Tehran: ISIRI; 2009.##3.	Jokanovic M. Structure-activity relationship and efficacy of pyridinium oximes in the treatment of poisoning with organophosphorus compounds: A review of recent data. Curr Top Med Chem. 2012; 12(  16   ): 1775-1789. [Epub ahead of print]##4.	Fenik J, Tankiewicz M, Biziuk M. Properties and determination of pesticides in fruits and vegetables. Trac-Trend Anal Chem 2011; ##30( 6   ): 814-826.##5.	Meschi M. List of authorized pesticides.##1th ed. Karaj: Ministry of Agriculture, Plant Protection Organization; 2007.##6.	Castillo M, Gonzalez C, Miralles A. An evaluation method for determination of non-polar pesticide residues in animal fat samples by using dispersive solid-phase extraction clean-up and GC/MS. Anal Bioanal Chem 2011;  5    (400): 1315-1328.##7.	Fatemy LS, Tabatabaei SJ, Fallahi E. The effect of silicon on the growth and yield of strawberrygrown under saline conditions. Journal of Horticultural Sciences 2009; 23(1): 88-95.##8.	Marjanlo A, mostofi Y, Shoeibi Sh, Maghami M. Effect of essence oil of basil on Control of gray rot and post-harvest quality of strawberries (Selva). J Medicinal Plants 2008; 8(1(: 131-139.##9.	Looser N, Kostelac DT, Scherbaum E, anastassiades M, Zipper H. Pesticide Residues in Strawberries sampled from the Market of the Federal State of Baden Württemberg in the Period between 2002 and 2005. J Verbr Lebensm 2006; (1): 135-141.##10.	Khosh akhlagh F, Soltani M. Zoning of Strawberry cultivation agricultural region using geographical information systems. Journal of Humanities Research and Cultural Studies(sepehr)2006;20(78): 32-38.[Persian] http://www.magiran.com/sepehr/p914029##11.	Nguyen TD, Yu JE, Lee DE, Lee GH. A multiresidue method for the determination of 107 pesticides in cabbage and radish using QuEChERS sample preparation method and gas chromatography mass spectrometry.J Food Chemistry 2008; 110: 207-213.##12.	Angelo M, Des A, Lehotay SJ. Fast and Easy Multiresidue Method Employing Acetonitrile Extraction/Partitioning and “Dispersive Solid- Phase Extraction” for the Determination of Pesticide Residues in Produce. Journal of AOAC International 2003; 86(2): 412   - 431    .##13.	Motamedzadegan A, Mortazavi A, Maghsoodloo Y, Amiri B, Esmailzadeh Kenari R. Evaluation of pesticide residues in melons sprayed three time with diazinon in Khorasan-Razavi province. Agricultural Science and Technology Journal 2006 5( 1   ): 13-19.##14.	Nougadère A, Sirot V, Kadar A, Fastier et al. Total diet study on pesticide residues in France: Levels in food as consumed andchronic dietary risk to consumers. Environment International 2012; 45: 135-150.##15.	Ferrer C, Martinez-Bueno MJ, Lozano L, Fernandez-Alba AR, Pesticide residue analysis of fruit juices by LC–MS/MS direct injection. One year pilot survey. Talanta 2011; 83: 1552-1561.##16.	Yadegaran L, Moattar F, Morowati M, Riazi Z. Determination of organophosphate residues in apple product Urmia region cooling. Journal of Environmental Sciences and Technology 2002; (15): 25-42. [Persian]##17.	Kort WJ, Arsenault TL, Pylypiw HM, Mattina MJI. Reduction of pesticide residues on product by rinsing. Journal of Agricultural and Food Chemistry 2000; 48: 4666-4670.##18.	Jahaed Khaniki GH, Fadaei AM, Sadeghi M, Mardanie G. Study of Oxydimeton methyl residues in cucumber &#38; tomato grown in some of greenhouses of Chaharmahal va Bachtiari province (Iran) by HPLC method. J Shahrekord Univ Med Sci 2011; 13(4): 9-17.##19.	Ghabbour SI, Zidan ZH, Sobhy HM, Mikhail WZA, Selim MT. Monitoring of Pesticide Residues in Strawberry and Soil from Different Farming Systems in Egypt. American-Eurasian J Agric &#38; Environ Sic 2012; 12(2): 177-187.##20.	Shokrzadeh M, Saeedi S. The investigation and measurement of residues of benomyl and mancozeb pesticides in shrub and nonshrub cucumbers sampled from different regions of Mazandaran province (Iran). J Environmental, Agricultural and Chemitry 2009; 8(3): 174-178.##21.	Zand E, Baghestani MA, Bitarafan M, Shimi P. A Guidline for Herbicides in Iran. Mashhad: Jahad Publication; 2007.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>ارزیابی الگوی شایستگی های مدیران بخش سلامت: رویکرد مدل سازی معادلات ساختاری</TitleF>
		<TitleE>Measurig Competency Model for Managers in the Health Sector (Structural Equation Modeling Approach)</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: نقش مدیران نظام سلامت در اداره هر چه بهتر سیستم ارائه خدمات بهداشتی درمانی همواره مورد تأکید بوده و انتخاب بهترین افراد برای این امر مورد توجه قرار دارد. هدف کلی پژوهش حاضر، طراحی و ارزیابی الگوی شایستگی مدیران بخش سلامت و ارزیابی آن از نگاه مدیران میانی نظام سلامت است.
مواد و روش‌ها: مطالعه حاضر، توصیفی- تحلیلی به صورت مقطعی بوده که در آن جامعه آماری کلیه مدیران در بخش سلامت کشور بودند. ابزار گردآوری اطلاعات در این پژوهش پرسشنامه محقق ساخته بوده که بین 385 نفر توزیع شد و برای ارزیابی مدل پیشنهادی که با استفاده از مطالعات کتابخانه‌ای و میدانی (مصاحبه با 30 نفر از مدیران نظام سلامت کشور) ساخته شده بود مورد استفاده قرار گرفت. این پرسشنامه دارای 8 طبقه اصلی در معیارهای شایستگی مدیران و حاوی 63 سؤال بود. روایی این پرسشنامه با استفاده از روایی سازه و برای اطمینان از پایایی آن ضریب آلفای کرونباخ محاسبه شد (بالاتر از 79/0 برای هر یک از طبقات). برای تجزیه و تحلیل داده‌های پرسشنامه از آمار استنباطی (تحلیل عاملی تأییدی و مدل معادلات ساختاری با تعیین شاخص T-Value) و نرم افزار LISREL استفاده شده است.
یافته‌ها: پرسشنامه کامل شده تعداد 280 نفر (1/75 درصد) از شرکت‌کنندگان در این مطالعه مورد تجزیه و تحلیل قرار گرفت. براساس نتایج به‌دست آمده مقادیر T-Value برای طبقات دانش و معلومات حرفه‌ای، مهارت‌های رفتاری و فکری، نگرش و بینش، اعتبار، ویژگی‌های شخصیتی، خدمت‌گزاری، مسؤلیت‌پذیری و توجه به ارزش‌های اعتقادی و اخلاقی به ترتیب 17/2 ،43/3 ،55/6 ،39/8 ،31/9 ،68/10 ،06/11، 90/11 به‌دست آمد.
استنتاج: توجه و به کارگیری ملاک‌های ارائه شده در مدل پیشنهادی الگوی شایستگی مدیران نظام سلامت که توسط مدیران سطح میانی نیز رتبه بندی شده است، می‌تواند یکی از راه های بهبود کیفی مدیریت در نظام سلامت کشور باشد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: The role of health system managers has always been emphasized in the efficient running of system of hygienic and remedial services and much attention is paid to the selection of the best persons to do that. The main purpose of this study was to design the managers' competency model of health sector and evaluate them from the standpoint of middle managers of health system.
Material and methods: The study population included all the health system managers in Iran. The questionnaires were distributed among 385 people. The data were collected through the researcher's questionnaire which was used to assess the model proposed by applying library and field studies (interviewing with 30 person of health system managers of Iran). The questionnaire contains 8 main categories in competency criteria of managers and includes 63 questions. It was validated in terms of construct validity and Cronbach' alpha was used to ensure its internal consistency reliability. (more than 0.79 for each category). Inferential statistics (confirmatory factor analysis and structural equations model by specifying T-Value) and "LISREL" software was used to analyze the data collected from the questionnaire.
Results: 280 filled out questionnaires of the participants (75.1%) were analyzed in this study. Based on the collected data, T. values for knowledge of and professional awareness competencies, behavioral and intellectual, personal traits, service, responsibility, and considering the ideological and moral (ethical) values equal 11.90, 11.06, 8.39, 10.68, 6.55, 9.31, 3.43, and 2.17
Conclusion: Considering and applying the presented criteria in proposed competency model of health system managers which are ranked by the middle managers can be one of the way of improving the quality of management in the health system of Iran.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>104</FPAGE>
			<TPAGE>113</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/10
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/21
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/10
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/21
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>منصور</Name>
				<MidName></MidName>
				<Family>رنجبر</Family>
				<NameE>Mansour</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ranjbar</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>احمد</Name>
				<MidName></MidName>
				<Family>خائف الهی</Family>
				<NameE>Ahmad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khaef Elahi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>: khaef-aa@modares.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>حسن</Name>
				<MidName></MidName>
				<Family>دانایی فرد</Family>
				<NameE>Hassan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Danaee Fard</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>علی اصغر</Name>
				<MidName></MidName>
				<Family>فانی</Family>
				<NameE>Aliasghar</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Fani</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Competency model</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>management</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>health sector</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>مدل شایستگی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>مدیریت</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>بخش سلامت</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>ایران</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Nwokah N, Gladson A, Augustine I. Managerialcompetencies and marketing effectiveness in corporate organizations in Nigeria. JMD, 2008; 27(8): 858-878.##2.	Rappe C, Zwick T. Developing Leader shipcompetence of Production unit managers. Journal of Management Development 2007; 26(4): 312-330.##3.	Ansariranani Gh, Tabatabei S. The impact ##of meritocracy on productivity, the 1st Conference on Meritocracy in Organizations, Tehran: Shiveh; 2006.##4.	Bourgault J, Charih M, Maltais D, Rouillard L. Hypothesese concerning the prevalence of competencies among government executives. According to three organizational variables. Public personnel management 2006; 35(3): 89-119.##5.	Razaghi M. Finding managers’ competency scale, M.A. dissertation, Management and Planning Research and Training Higher Education Institute; 2007##6.	Klein CJ, Fowles ER. An Investigation of nursing competence and the competency outcomesperformance assessment curricular approach: Senior student’s self-reported perceptions 2009; 25(2): 109-21.##7.	Cochran GR, Ohio State University Extension Competency Study: Developing a Competency Model for a 21st Century Extension Organization. Dissertation for Degree of Doctor of Philosophy in the Graduate School of the Ohio State University; 2009##8.	Adams K. Competency’s American origins and the conflicting approaches in use today. Competency 1996; 3(2): 8-44.##9.	Scotter J.R.V. Relationships of task performance and organizational culture. IJIC, 2000; 4(14): 1-31.##10.	Levenson Alec R, Vander stede W.A, Cohen S.G. Measuring the Realationship Between managerialCompetencies and Performance. Journal of Management 2006; 32(360): 32.##11.	Sarmad Z, Bazargan E, Hejazi A. Methodologies in behavioral sciences, Tehran: AGAH Publications; 1998.##12.	Dehghani Soltani M. A Survey of Effective Factors on Evaluating Consumers, Attitude towards Brand Extension of Iranian Tire Product. Master Dissertaion, Ilam University; 2012.##13.	Natigh T. The impact of social capital on knowledge management, M.S. public administration, Managment and Economy School, Alameh Tabatabei University; 2006.##14.	Ekrami M, Rajabzade S. Factors Improvement of Measure of Managers Competency. JPMD, 2011; 77.##15.	Asadifard R, KhaefElahi A, Rezaeian A. Competency Model of Iranian Public Administers (In Based of Imam\'Sahifeh): Grounded Theory Approach. Master Dissertaion, TarbiatModares University; 2008.##16.	Edwards A. Competency modeling as an antecedent for effective Leadership development and succession planning within the public social services environment, 1346. Dissertation for Degree of Doctor of Philosophy in the Benedictine University; 2009.##17.	Tucker J. The moderators of patient satisfaction. Journal of Management in Medicine 2002; 16(1): 48-56.##18.	Irannejadeparizi M, Sasangohar, P. Organization and Management Theory to Practice, Tehran: Institute of Banking Publication; 1994.##19.	Sherman R. Management competencies and sample indicators for the improvement of adult education program, A Publication of Building Professional Development Partnerships for Adult Educators Project, 2003.#### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>بررسی میزان سرب، کادمیوم و کروم در برنج های هندی وارداتی و برنج طارم تولیدی استان گلستان</TitleF>
		<TitleE>Study of the Amount of Pb, Cd and Cr in Imported Indian Rice to Iran and Tarom rice Produced in the Province of Golestan</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: آلودگی به فلزات سنگین یکی از مشکلات مهم زیست محیطی و یکی از نگرانی‌های مهم بهداشت مواد غذایی به شمار می‌آید. برنج یکی از انواع پر مصرف غلات در جهان است که به طور گسترده در رژیم غذایی مردم وجود دارد. در این تحقیق میزان سرب، کادمیوم و کروم در برنج طارم مزارع استان گلستان و مقایسه آن با برنج وارداتی هندی در همان استان بررسی شده است.
مواد و روش‌ها: ده برند معروف برنج هندی پرفروش از بازار استان خریداری شد که به صورت کدهای 1 تا 10 شماره‌گذاری شد. هر یک از شهرستان‌های استان گلستان بر اساس موقعیت جغرافیایی، 20 نمونه برنج طارم تهیه گردید که شامل شهرستان‌های گرگان، علی آباد، مراوه تپه، مینودشت، گنبد و گالیکش است. غلظت فلزات مورد نظر در نمونه‌ها توسط دستگاه جذب اتمی سنجیده شد.
یافته‌ها: نتایج تحقیق حاضر نشان می‌دهد که به صورت کلی در برنج ایرانی میزان سرب ppm 09/0± 32/0، میزان کادمیوم ppm 05/0± 17/0 و میزان کروم ppm 10/0± 17/0 مشاهده شد و در برنج هندی این مقادیر برای سرب ppm 19/0± 33/0 برای کادمیوم ppm 02/0± 04/0 و برای کروم ppm 11/0± 28/0 به دست آمد. بین مقادیر سرب در برنج ایرانی و هندی از لحاظ آماری تفاوت قابل توجهی وجود ندارد (05/0&#62;  p). لیکن در مورد کادمیوم و کروم این تفاوت قابل توجه است به صورتی که در برنج ایرانی میزان کادمیوم بیش‌تر از برنج هندی مشاهده شد (001/0&#60; p) و در برنج هندی میزان کروم بیش‌تر به دست آمد (001/0&#60; p).
استنتاج: با توجه به یافته‌های فوق الذکر به نظر می‌رسد تفاوت برنج‌های ایرانی و هندی ببیش‌تر مرتبط با میزان کادمیوم و کروم می‌باشد و میزان سرب تفاوت چندانی ندارد و لذاتوصیه می‌شود با توجه به عوارض تماس طولانی مدت با فلزات سنگین، میزان فلزات سنگین و میزان دریافت هفتگی آن‌ها از طریق سایر محصولات کشاورزی همانند سبزیجات به صورت دوره‌ای مورد ارزیابی قرار گیرد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Heavy metal pollution has always been a major cause of environmental contamination and is considered as a major concern for food health. Rice is the most popular food among Iranians and the presence of heavy metals in trace level in rice has received special attention because they are directly related to health .In this study, the amount of Pb, Cd and Cr in Tarom rice farms in the province of Golestan was determined and compared with imported Indian rice in this province.
Material and methods: Ten famous brands of Indian Rice were bought from market of this province as were coded from 1to 10. From the cities of Golestan including Gorgan, Ali Abad, Maraveh-Tapeh, Minoodasht, Gonbad and Galikesh based on the geographical location of each city, 20 rice samples were collected. The concentration of heavy metals in samples was measured using atomic absorption technique.
Results: Our data showed that generally the amount of Pb, Cd and Cr in Iranian rice were 0.32±0.09 ppm, 17±0.5 ppm and 17±0.10 ppm, respectively and 0.33±0.19 ppm, 0.04±0.02 ppm and 0.28±0.11ppmwere observed for concentration of Pb, Cd and Cr in Indian rice, respectively. There was no significant difference (P&#62;0.05) between the amount of lead in Iranian Rice and Indian Rice. However, the amount of cd in Iranian rice was significantly more than the Indian rice. One the other hand, the amount of Cr in Indian rice was significantly (P&#60;0.001) more than the Iranian rice.
Conclusion: Considering the aforesaid findings, it seems that the difference between Indian and Iranian rice is mainly related to the amount of Cr and Cd but there was no difference in the amount of Pb in both samples. So, it is recommended that in accordance to the adverse effects of chronic exposure to heavy metals, the amount of heavy metals and weekly intake of them via other agricultural products such as vegetables should be evaluated periodically.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>115</FPAGE>
			<TPAGE>123</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/28
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/8
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/28
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/8
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>محمد</Name>
				<MidName></MidName>
				<Family>شکرزاده</Family>
				<NameE>Mohammad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Shokrzadeh</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>متین</Name>
				<MidName></MidName>
				<Family>پران دوجی</Family>
				<NameE>Matin</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Paran-Davaji</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>فاطمه</Name>
				<MidName></MidName>
				<Family>شکی</Family>
				<NameE>Fatemeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Shaki</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>fshaki.tox@gmail.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Pb</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Cd</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Cr</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Rice</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Iran</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سرب</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>کادمیوم</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>کروم</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>برنج</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Shuklasr P. Adsorption of Cu, Ni, and Zn on ##modified jute fibers. Bioresource Technology ##2005; 96(13): 1430-1438.##2.	Lie GC, Lin HT, Lai CS. Investigation of the heavy metal content in soil and rice at the fields irrigated by the waste water of cadmium stearate manufactory. Proceeding of the 2nd Workshop of Soil Pollution Prevention; 1990; National Taiwan University, Taipei, Taiwan.##3.	Fu J, Zhou Q, Liu J, Liu W, Wang T, Zhang Q, et al. High levels of heavy metals in rice from atypical e-Waste recycling area in southeast Chinaand its potential risk to human health. Chemosphere. 2008; 71(7): 1269-1275.##4.	Zazouli MA, Bandpei AM, Maleki A, Saberian M, Izanloo H. Determination of cadmium and leadcontents in black tea and tea liquor from Iran .AsiaJournal of Chemistry. 2010; 22(2): 1387-93.##5.	FAO. FAO statistical databases. Food and AgricultureOrganization; 2004 [cited 2002 Jul 9]. Available from:http: // apps. fao. org/.##6.	Khaniki G, Zazooli MA. Cadmium and lead contentin rice in the North Iran.Int J Agriculture &#38; Biology. 2005; 7:1026-29.##7.	Bosque MA, Schuhmacher M, Domino JL, LobetJM. Concentration of Lead and Cadmium in edible invegetable from Tarragona province Spain. Science ofThe total Environment. 1990;95:61-67##8.	Saleh IA, Shinwari N. Report on the levels ofcadmium, andmercury in importedRice grain samples.BIOL TRACE ELEM RES 2001; 83:91-95.##9.	Lin HT, Wong SS, Li GC. Heavy metal content ofrice and shellfish in Taiwan. Food and Drug Analysis.2004;12(2):167-74.##10.	Raikwar K, Kumar M, Singh P, Singh A. Toxic effect ofheavymetals in livestock Health. Vet. World 2001; 1(1): 28-30.##11.	Sadiqe M.Toxic metal chemistry in marine ##environments. New York: Marceldekker, Inc. 1992; 92-96.##12.	Morisshita T, funoto N. Varietal differences in cadmium levels of rice grains of Japonica, Indica, Javanica and hybrid varieties produced in the same plot of a fild. Soil Sci Plantnutr 1987; 33(4): 629-637.##13.	Malakootian M, Yaghmaeian K, Meserghsni M, Mahvi AH, Daneshpajouh, M. Determination of Pb, Cd, Cr and Ni concentration in imported Indian rice to iran. Iran J Health &#38; Environ 2011; 4(1): 77-84.##14.	Rahman S, et al. Determination of lead and cadmium in pulses and cereals by atomic absorbtion. Pakistan J Sci Ind Res 1990; 33(3): 85-88.##15.	Shimbo S, Zhang ZW, Watanabe T, Nakatsuka H, Mutsuda N, Higashikawa K. Cadmium and leadcontents in rice and other cereal products in Japanin 1998-2000. SCI Total Environ 2001; 281(1-3): 165-75.##16.	ASTM. Standard Guide for Preparation ofBiological Samples for Inorganic Chemical Analysis. Pennsylvania: American Society of Testing and Material; 1999. p. 84-89.##17.	Chino M, Moriyama K, Saito H, Morn T. the amount of heavy metal derived from domestic sources in japan. Water Air Soil Poll 1991; 57: 829-837.##18.	Bakhtiarian A, Gholipour M, Ghazi-Khansari M. Lead and cadmium content ofkorbal rice in Northern Iran. Iranian J Publ Health 2001; 30(3-4): 129-132.##19.	Benet JC. Cecil Textbook of Medicine. 20th ed. Philadelphia: WB Saunders Co.; 1996. p. 61-67.##20.	Maleki A, Zazooli MA, Shokrzadeh M. Investigation of Cadmium Content in Iranian Rice (Oryza sativa): Its Weekly Intake. J Appl Sci Environ Manag 2007; 11(1): 101-105.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>بررسی و مقایسه پیامدهای بارداری و پری ناتال در دو روش انتقال جنین تازه و انجماد یافته</TitleF>
		<TitleE>Gestational and Perinatal Outcomes in Fresh and Frozen Embryos Transfer</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف : در سه دهه گذشته با ظهور روش های نوین کمک باروری
به داخل رحم از جمله (fresh) و انتقال جنین تازه (IVF) موارد ناباروری منجر به حاملگی شده است . لقاح خارج رحمی
این روش ها است. مطالعه نویسندگان پیامدهای بارداری و پری ناتال مشابه را در دو روش انتقال جنین تازه و انجماد یافته و
در بعضی موارد پیش آگهی بهتر را در روش انتقال جنین انجماد یافته گزارش کرده اند.
بر روی مادران بارداری که به مراکز نازایی شهرستان ساری مراجعه کرده و case series مواد و روش ها: این مطالعه
بااستفاده از درمان های کمک باروری درعرض سالهای 1383 تا 1390 باردارشده بودند، صورت گرفت . در این مطالعه
پیامدهای بارداری و پری ناتال در دوروش انتقال جنین تازه و انجماد یافته مورد بررسی قرار گرفت.
49 درصد ) فقط مردانه و در 92 مورد ( 23 درصد ) فقط زنانه و در 53 مورد / یافته ها: علت نازایی در 199 مورد ( 8
13/3 درصد ) ناشی از هر دو عامل بوده است . در 56 مورد ( 14 درصد ) نیز نازایی با علت نامشخص بوده است . هیچ کدام )
با هم تفاوت معن ی داری نداشته است . بستری fresh و frozen از عوارض بارداری مادری و جنینی در دو روش انتقال جنین
1/ در 3 بیمار ( 2 Frozen 3 درصد ) و در روش انتقال / در 5 بیمار ( 3 Fresh به علت تهدید به سقط در روش انتقال جنین
و درمان کمک تنفسی NICU از نظر بستری در .(p=0/ درصد) مشاهده شد که از نظر آماری، این تفاوت معنی دار نبود ( 13
نیز در دو روش انتقال، اختلاف معنی داری آماری وجود نداشت.
تفاوت ی نداشته و frozen و fresh در دو روش انتقال جنین IVF استنتاج: پیامدهای پری ناتال در بارداری های با روش
پیامدها در دو روش یکسان بوده است.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: In the past three decades with the advent of modern assisted
reproductive techniques (ART) and transfer of fresh or freeze embryos into the uterus, pregnancy has
resulted in many cases of infertility. The studies of authers were shown comparable gestational and
perinatal outcomes in two methods and sometimes better outcomes in freezeembryo transfer.
Material and methods: This case series study was done on pregnant women who underwent
intracytoplasmic microinjectionand embryo transfer (ICSI-ET) at the infertility clinics in Sari city.
Pregnancy and perinatal outcomes were evaluatedand compared in two transfer way, fresh embryo
transfer (fresh-ET) and freeze embryo transfer (freeze-ET).
Results: Male factors cause infertility in 199 cases (49.8%) and female factors cause in 92 cases
(23%). In 53 cases (13.3%) both male and female factors contributed.The cause of infertility was
unknownin 56 cases (14%). None of maternal and fetal complications of pregnancy had significant
differences in this two embryos transfer methods.In the fresh-ET cycles, 5 patients (3.3%) were
hospitalized due to threatened abortion versus 3 patients (1.2%) in freeze-ET cycles. There was no
statistically significant difference in two methods about NICU admission and the need of respiratory
support.
Conclusion: In this study, we have demonstrated that gestational and perinatal outcomes in both
embryo transfer methods, fresh and freeze ET were similar</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>125</FPAGE>
			<TPAGE>132</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/17
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1393/2/27
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/17
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1393/2/27
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>سپیده</Name>
				<MidName></MidName>
				<Family>پیوندی</Family>
				<NameE>Sepideh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Peivandi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>dr_peyvandi@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>فاطمه</Name>
				<MidName></MidName>
				<Family>فاضل تبار ملکشاه</Family>
				<NameE>Fateme</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Fazeltabar Malekshah</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>مریم</Name>
				<MidName></MidName>
				<Family>شهیدی</Family>
				<NameE>Maryam</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Shahidi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>علی رضا</Name>
				<MidName></MidName>
				<Family>خلیلیان</Family>
				<NameE>Alireza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khalilian</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>ART</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>ICSI</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Fresh ET</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Freeze ET</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تزریق داخل سیتوپلاسمی اسپرم</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>انتقال جنین تازه</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>انتقال جنین منجمد</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>روش کمک باروی نوین(ART )</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Jones GM, Trounson AO, Lolatgis N, Wood C. Factors affecting the success of human blastocyst development and pregnancy following in vitro fertilization and embryo transfer. Fertil Steril 1998; 70: 1022-1029.##2.	Van Steirteghem AC, Liu J, Joris H, Nagy Z, Janssenswillen C, Tournaye H, et al. Higher success rate by intracytoplasmic sperm injection than by subzonal insemination. Report of a second series of 300 consecutive treatment cycles. Hum Reprod 1993; 8(7): 1055-1060.##3.	Van Steirteghem A, Bonduelle M, Liebaers I, Devroey P. Children born after assisted reproductive technology. Am J Perinatol 2002; 19(2): 59-65.##4.	Ludwig M, Diedrich K. Follow-up of children born after assisted reproductive technologies. Reprod Biomed Online 2002; 5(3): 317-22.##5.	Hansen M, Bower C, Milne E, de Klerk ##N, Kurinczuk JJ. Assisted reproductive technologies and the risk of birth defects a systematic review. Hum Reprod 2005; 20(2): 328-338.##6.	Suleena Kansal Kalra MSCE, Ratcliffe SJ. Perinatal morbidity after in vitro fertilization is lower with frozen embryo transfer, Fertility and Sterility 2011; 95(2): 548-553.##7.	Shevell T, Malone FD, Vidaver J, Porter TF, Luthy DA, Comstock CH, et al. Assisted reproductive technology and pregnancy outcome. Obstet Gynecol 2005; 106(5): 1039-1045.##8.	Chung K, Coutifaris C, Chalian R, Lin K, Ratcliffe SJ, Castelbaum AJ, et al. Factors influencing adverse perinatal outcomes in pregnancies achieved through use of assisted reproductive technology. FertilSteril 2006; 86(6): 1634-16341.##9.	Zeilmaker GH, Alberda AT, van Gent I, Rijkmans CM, Drogendijk AC. Two pregnancies following transfer of intact frozen-thawed embryos. Fertil Steril 1984; 42: 293-296.##10.	Nyboe Andersen A, Goossens V, Bhattacharya S, Ferraretti AP, Kupka MS, de Mouzon J, et al. Assisted reproductive technology and intrauterine inseminations in Europe, 2005. Results generated from European registers by ESHRE. Hum Reprod 2009; 24(6): 1267-1287.##11.	Wennerholm UB, Hamberger L, Nilsson L, Wennergren M, Wikland M, Bergh C. Obstetric and perinatal outcome of children conceived from cryopreserved embryos. Hum Reprod 1997; 12: 1819-1825.##12.	Wang YA, Chambers GM, Dieng M, Sullivan EA. Assisted Reproductive Technology in Australia and New Zealand 2007. Assisted Reproduction Technology Series. Sydney, Australia: AIHW National Perinatal Statistics Unit, 2009.##13.	Human Fertilization and Embryology Authority. A Long Term Analysis of the HFEA Register Data (1991–2006). UK, Available from: http:// www.hfea.gov.uk/docs/Latest_long_ term_data_analysis_report_frontcover.pdf. Accessed September 28, 2009.##14.	Pinborg A, Loft A, AarisHenningsen A-K, Rasmussen S, Nyboe Andersen A. Infant outcome of 957 singletons born after frozen embryo replacement: The Danish National Cohort Study 1995–2006. Fertil Steril 2010; 94(4): 1320-1327.##15.	Wennerholm UB, Soderstro¨ m-Anttila V, Bergh C, Aittoma¨ki K, Hazekamp J, Nygren KG, et al. Children born after cryopreservation of embryos or oocytes: a systematic review of outcome data. Hum Reprod 2009; 24(9): 2158-2172.##16.	Wang YA, Sullivan EA, Black D, Dean J, Bryant J, Chapman M. Preterm birth and low birthweight after assisted reproductive technology-related pregnancy in Australia between 1996 and 2000. Fertil Steril 2005; 83(6): 1650-1658.##17.	Shih W, Rushford DD, Bourne H, Garrett C, McBain JC, Healy DL, et al. Factors affecting low birthweight after assisted reproduction technology: difference between transfer of fresh and cryopreserved embryos suggests an adverse effect of oocyte collection. Hum Reprod 2008; 23(7): 1644-1653.##18.	Dulioust E, Toyama K, Busnel MC, Moutier R, Carlier M, Marchaland C, et al. Long-term effects of embryo freezing in mice. Proc Natl Acad Sci USA 1995; 92: 589-593.##19.	Wennerholm UB, Albertsson-Wikland K, Bergh C, Hamberger L, Niklasson A, Nilsson L, et al. Postnatal growth and health in children born after cryopreservation as embryos. Lancet 1998; 351: 1085-1090.##20.	Belva F, Henriet S, Van den Abbeel E, Camus M, Devroey P, Van der Elst J, et al. Neonatal outcome of 937children born after transfer of cryopreserved embryos obtained by ICSI and IVF and comparison with outcome data of fresh ICSI and IVF cycles. Hum Reprod 2008; 23(10): 2227-2238.##21.	Wang YA, Chapman M, Costello M, Sullivan EA. Better perinatal outcomes following transfer of fresh blastocysts and blastocysts cultured from thawed cleavage embryos: a population-basedstudy. Human Reproduction 2010; 25(6): 1536-1542.##22.	Pelkonen S, Koivunen R, Gissler M, Nuojua-Huttunen S, Suikkari AM. Perinatal outcome of children born after frozen and fresh embryo transfer: the Finnish cohort study 1995–2006. Human Reproduction 2010; 25(4): 914-923.##23.	Keirse MJ. International variations in intrauterine growth. Eur J Obstet Gynecol Reprod Biol 2000; 92(1): 21-28.##24.	Wada I, Macnamee MC, Wick K, Bradfield JM, Brinsden PR. Birth characteristics and perinatal outcome of babies conceived from cryopreserved embryos. Hum Reprod 1994; 9(3): 543-546.##25.	Helmerhorst FM, Perquin DA, Donker D, Keirse MJ. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. Br Med J 2004; 328(7434): 261-265.##26.	Pinborg A, Lidegaard O, Freiesleben NC, Andersen AN. Vanishing twins: a predictor of small-for-gestational age in IVF singletons. Hum Reprod 2007; 22(10): 2707-2714.##27.	Romundstad LB, Romundstad PR, Sunde A, ##von Du¨ring V, Skjaerven R, unnell D, et al. Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study. Lancet 2008; 372(9640): 737-743.##28.	Schieve LA, Ferre C, Peterson HB, Macaluso M, Reynolds MA, Wright VC. Perinatal outcome among singleton infants conceived through assisted reproductive technology in the United States. Obstet Gynecol 2004; 103(6): 1144-1153.##29.	Wennerholm UB, Hamberger L, Nilsson L, Wennergren M, Wikland M, Bergh C. Obstetric and perinatal outcome of children conceived from cryopreserved embryos. Hum Reprod 1997; 12(8): 1819-1825.##30.	Poikkeus P, Unkila-Kallio L, Vilska S, Repokari L, Punama¨ki RL, Aitokallio-Tallberg A, et al. Impact of infertility characteristics and treatment modalities on singleton pregnancies after assisted reproduction. Reprod Biomed Online 2006; 13(1): 135-144.##31.	Check JH, Katsoff B, Wilson C, Choe JK, Brasile D. Pregnancy outcome following fresh vs frozen embryo transfer into gestational carriers using a simplified slow freeze protocol. Clin Exp Obstet Gynecol 2012; 39(1): 23-24.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>تأثیر هیوسین- ان- بوتیل بروماید بر آریتمی سینوسی- تنفسی در افراد جوان سالم</TitleF>
		<TitleE>The Effect of Hyoscine-N-Butylbromide on Respiratory Sinus Arrhythmia in Healthy Young Subjects</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: نوسان در ضربان قلب تحت تأثیر عوامل مختلفی ایجاد می‌شود که یکی از این عوامل تنفس است. دامنه نوسان ضربان قلب طی دم و بازدم معیاری کمی در اختیار ما قرار می‌دهد که برآوردی از عملکرد واگ قلبی محسوب می‌شود. هدف ما از انجام این مطالعه بررسی اثرتک دوز هیوسین بر دامنه نوسان ضربان قلب و میزان عملکرد واگ قلبی می‌باشد.
مواد و روش‌ها: مطالعه حاضر مداخله‌ای یک سوکور از نوع متقاطع می‌باشد که در آن 15 آزمودنی مذکر جوان سالم شرکت کردند. هر آزمودنی دو بار با فاصله یک هفته مراجعه می‌کرد. قبل و به مدت یک ساعت بعد از تزریق عضلانی هیوسین یا پلاسبو، آزمون تنفس عادی و عمیق کنترل شده هر 10 دقیقه انجام شد. معیار مربوط به عملکرد واگ یعنی دامنه آریتمی سینوسی تنفسی (RSA) بین قبل و زمان‌های بعد از تزریق دارو یا پلاسبو توسط RM_ANOVA آنالیز شد.
یافته‌ها: تنفس عمیق به طور واضحی سبب افزایش دامنه RSA شد. آنالیز واریانس یک طرفه معیار RSA در آزمون تنفس عمیق نشان داد که هیوسین- ان- بوتیل بروماید باعث کاهش دامنه RSA شد که در دقیقه 50 بعد از تزریق، به حد پایه برگشت. نتایج مشابهی طی آزمون تنفس عادی کنترل شده نیز مشاهده شد، با این تفاوت که دامنه RSA در دقیقه 40 پس از تزریق هیوسین به میزان پایه برگشت.
استنتاج: یافته‌های این مطالعه نشان داد که تزریق عضلانی 20 میلی‌گرم آمپول هیوسین سبب کاهش فعالیت واگ قلبی می‌شود که در دقیقه 40 و 50 بعد از تزریق به سطح پایه می‌گردد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Fluctuations in the heart rate can be affected by many factors such as breathing. The amplitude of heart rate variability during inhalation and exhalation provides a quantitative measure that puts the estimate of cardiac vagal function which is considered. The aim of this study was to investigate the effect of a single dose of hyoscine-N-butylbromide (hyoscine) on the amplitude of heart rate variability, namely cardiac vagal activity.
Material and methods: 15 healthy young male subjects participated in the study. Each subject came to the laboratory twice with one week interval. Before and one hour after intramuscular injection of hyoscine or placebo, normal and deep breathing tests were performed every 10 minutes. The amplitude of respiratory sinus arrhythmia (RSA) associated with cardiac vagal activity between periods before and after administration of the drug/ or placebo were analyzed by RM_ANOVA.
Results: Comparing with normal breathing, deep breathing increases the amplitude of the RSA. The One way ANOVA of RSA showed that hyoscine reduced the RSA amplitude that at 50 min after injection returned to basal level. Similar results were also observed during normal breathing test except that RSA amplitude at 40 min after injection of hyoscine returned to baseline.
Conclusion: Overall, the findings of this study showed that intramuscular injection of 20 mghyoscine reduces cardiac vagal activity that returned to base line 40-50 minutes after the injection.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>134</FPAGE>
			<TPAGE>141</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/4
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/15
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/4
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/15
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>سید علی</Name>
				<MidName></MidName>
				<Family>کاهانی</Family>
				<NameE>Ali</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Kahani</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>سید عباس</Name>
				<MidName></MidName>
				<Family>فروتن</Family>
				<NameE>Abbas</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Forotan</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>اسماعیل</Name>
				<MidName></MidName>
				<Family>اکبری</Family>
				<NameE>Esmaeil</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Akbari</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>E-mail: akbari_esmaeil@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Hyoscine- N-buthyl bromide</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>respiratorysinusarrhythmia</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>هیوسین- ان- بوتیل- بروماید</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>آریتمی سینوسی تنفسی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>آزمون تنفس عمیق</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Hulme EC, Birdsall NJ, Buckley NJ. Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol 1990; 30: 633-673.##2.	Tytgat GN. Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain. Drugs 2007; 67(9): 1343-1357. ##3.	Schäfer E, Ewe K. The treatment of irritable colon. Efficacy and tolerance of buscopan plus, buscopan, paracetamol and placebo in ambulatory patients with irritable colon. Fortschr Med 1990; 108(25): 488-492. ##4.	Spinks A, Wasiak J. Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database Syst Rev 2011; 6: CD002851.doi:10.1002/14651858. ##5.	Eckberg DL. The human respiratory gate. J Physiol 2003; 548(2): 339-352.##6.	Grossman P, Taylor EW. Toward understanding respiratory sinus arrhythmia: relations to cardiac vagal tone, evolution and biobehavioralfunctions. Biol Psychol 2007; 74: 263-285. ##7.	Whitsel EA, Raghunathan TE, Pearce RM, Lin D, autaharju PM, Lemaitre R, et al. RR-interval variation, the QT interval index and risk of primary cardiac arrest among patients without clinically recognised heart disease. Eur Heart J 2001; 22(2): 165-173. ##8.	Dekker JM, Crow RS, Folsom AR, Hannan PJ, Liao D, Swenne CA, et al. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In Communities. Circulation 2000; 102(11): 1239-1244. ##9.	Fakhrzadeh H, Yamini-Sharif A, Sharifi ##F, Tajalizadekhoob Y, Mirarefin M, Mohammadzadeh M, et al. Cardiac autonomic neuropathy measured by heart rate variability and markers of subclinical atherosclerosis in early type 2 diabetes. ISRN Endocrinol 2012; 2012: 168264. ##10.	Ziegler D. Cardiovascular autonomic neuropathy: clinical manifestations and measurement. Diabetes Rev 1999; 7(4): ##342-357.##11.	Pivatelli FC, Dos Santos MA, Fernandes GB, Gatti M, de Abreu LC, Valenti VE, et al. Sensitivity, specificity and predictive values of linear and nonlinear indices of heart rate variability in stable angina patients. Int Arch Med 2012; 5(1): 31.##12.	Bigger JT Jr, Fleiss JL, Steinman RC, Rolnitzky LM, Schneider WJ, Stein PK. RR variability in healthy, middle-aged persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction. Circulation 1995; 91(7): 1936-1943. ##13.	Akbari E, Foroutan A. The effect of dicyclomine hydrochloride, an anticholinergic agent, on heart rate variability in healthy subjects. Journal of Mazandaran University of Medical Sciences 2009; 19(72): 10-17 (Persian).##14.	Kavanagh JJ, Grant GD, Anoopkumar-Dukie S. Low dosage promethazine and loratadine negatively affect neuromotor function. Clin Neurophysiol 2012; 123(4): 780-786. ##15.	Schiffers M, Sauermann P, Schurch B, Mehnert U. The effect of tolterodine 4 and 8 mg on the heart rate variability in healthy subjects.World J Urol 2010; 28(5): 651-656. ##16.	Weise F, Baltrusch K, Heydenreich F. Effect of low-dose atropine on heart rate fluctuations during orthostatic load: a spectral analysis. J Auton Nerv Syst 1989; 26(3): 223-230.##17.	Kottmeier CA, Gravenstein JS. The parasympathomimetic activity of atropine and atropine methylbromide. Anesthesiology 1968; 29(6): 1125-1133. ##18.	Vybiral T, Bryg RJ, Maddens ME, Bhasin SS, Cronin S, Boden WE, et al. Effects ##of transdermal scopolamine on heart rate variability in normal subjects. Am J Cardiol 1990; 65(9): 604-608. ##19.	Al-Ani M, Forkins AS, Townend JN, Coote JH. Respiratory sinus arrhythmia and central respiratory drive in humans.Clin Sci (Lond) 1996; 90(3): 235-241. ##20.	Perlstein I, Stepensky D, Krzyzanski ##W, Hoffman A. A signal transduction pharmacodynamic model of the kinetics of the parasympathomimetic activity of low-dose scopolamine and atropine in rats. J Pharm Sci 2002 Dec; 91(12): 2500-2510.##21.	Wang L, Wang L, Zhang Y, Zhang B, Chen M. Low dose transdermal scopolamine increases cardiac vagal tone in patients after acute myocardial infarction. Chin Med J (Engl) 2002; 115(5): 770-772.##22.	Antelmi I, de Paula RS, Shinzato AR, Peres CA, Mansur AJ, Grupi CJ. Influence of age, gender, body mass index, and functional capacity on heart rate variability in a cohort of subjects without heart disease. Am J Cardiol 2004; 93(3): 381-385.##23.	Bernardi L, Wdowczyk-Szulc J, Valenti C, Castoldi S, Passino C, Spadacini G, et al. Effects of controlled breathing, mental activity and mental stress with or without verbalization on heart rate variability. J Am Coll Cardiol 2000; 35: 1462-1469.##24.	Brown TE, Beightol LA, Koh J, Eckberg DL. Important influence of respiration on human R-R interval power spectra is largely ignored. J Appl Physiol 2003; 75(75): 2310-2317.##25.	Golding JF, Stott JR. Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate. Br J Clin Pharmacol 1997; 43(6): 633-637. ##26.	Bettermann H, Cysarz D, Portsteffen A, Kümmell HC. Bimodal dose-dependent effect on autonomic, cardiac control after oral administration of Atropa belladonna. Auton Neurosci 2001; 90(1-2): 132-137. ##27.	Sundra TM, Harrison JL, Lester GD, Raidal SL, Phillips JK. The influence of spasmolytic agents on heart rate variability and gastrointestinal motility in normal horses. Res Vet Sci 2012; 93(3): 1426-1433. ##28.	Shields RW Jr. Heart rate variability with deep breathing as a clinical test of cardiovagal function. Cleve Clin J Med 2009; 76(Suppl 2): S37-340. ## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>مقایسه تنظیم شناختی هیجان در دانشجویان سیگاری و غیر سیگاری</TitleF>
		<TitleE>The Compression Cognitive Emotion Regulation in Smokers and Non-Smoker Students</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: سیگار رایج‌ترین و ارزان‌ترین ماده اعتیادآور است که بر اساس فرضیه خوددرمانی خانتزیان، افراد بسیاری به خاطر اختلال در تنظیم هیجانی به این اعتیاد روی می‌آورند. با این حال در ارتباط با این سازه درباره سیگار خصوصاً در ایران پژوهشی به چشم نمی‌خورد. هدف پژوهش حاضر مقایسه راهبردهای منفی تنظیم شناختی هیجان در دانشجویان سیگاری و غیرسیگاری بود.
مواد و روش‌ها: مطالعه حاضر از نوع توصیفی تحلیلی می‌باشد. برای انجام پژوهش حاضر 80 نفر از دانشجویان پسر غیر سیگاری دانشگاه تبریز در سال 1392- 1391 به روش نمونه‌گیری تصادفی انتخاب شدند و با 80 دانشجوی سیگاری که به صورت سرند کردن انتخاب شدند، مقایسه شدند. آزمودنی‌ها پس از انتخاب، به پرسشنامه راهبردهای منفی تنظیم شناختی هیجان پاسخ دادند. داده‌ها پس از جمع‌آوری به کمک نرم افزار SPSS19 مورد تجزیه و تحلیل قرار گرفتند. برای تحلیل داده‌ها از آمار توصیفی و تحیل واریانس چند متغیره MANOVA استفاده شد.
یافته‌ها: نتایج نشان داد که بین دانشجویان سیگاری و غیرسیگاری در مؤلفه‌های تنظیم شناختی هیجان تفاوت معنی‌داری وجود دارد. بدین‌گونه که دانشجویان سیگاری بیش‌تر از راهبردهای تنظیم شناختی منفی استفاده می‌کنند (05/0p&#60;).
استنتاج: به جاست که استفاده از راهبردهای مثبت تنظیم شناختی هیجان به دانشجویان آموزش داده شود. مخصوصاً در ایران که اطلاعات ما پیرامون شیوع این موضوع و نقش آن در مسائل مختلف بسیار اندک است.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Cigarette is the most common and cheapest addictive substance associated with physical, financial, familial and social harm. Khantezian self-medication hypothesis proposes that many people smoke because of low distress tolerance and emotional deregulation. However, there is no research concerning this issue in Iran.The aim of this study was to investigate Compression Emotion Regulation Negative Strategies in Smokers and Non-Smoker Students.
Material and methods: According to this, 80 smokers and 80 non-smoking male students of Tabriz University were selected randomly. The participants were examined by Emotion Regulation Negative Strategies questionnaires. The data were analyzed by SPSS software. For data analysis, descriptive statistics and multivariate analysis of variance was used.
Results: The results showed that smokers and nonsmoker students in-cognitive components of setting that there is a significant difference excitement. Thus, students who smoke have more negative cognitive strategies to regulate.
Conclusion: Therefore, the appropriate use of positive cognitive emotion regulation strategies can be taught to students, especially in our country, because our information about this problem is very little.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>143</FPAGE>
			<TPAGE>150</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/28
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/8
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/28
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/8
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>منصور</Name>
				<MidName></MidName>
				<Family>بیرامی</Family>
				<NameE>Mansour</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Bayrami</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>یزدان</Name>
				<MidName></MidName>
				<Family>موحدی</Family>
				<NameE>Yazdan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Movahedi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>yazdan_movahedi@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>عبدالخالق</Name>
				<MidName></MidName>
				<Family>میناشیری</Family>
				<NameE>Abdolkhlegh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Minashiri</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Cognitive Emotion Regulation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Smokers</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Non-Smoker</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>student</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تنظیم شناختی هیجان</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سیگاری</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>غیرسیگاری</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>دانشجویان</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Atav S, Spencer GA. Health risk behaviors among adolescents attending rural, suburban, and urban schools: Acomparative study. J FameCommu Heal 2002; 25(2): 53-64.##2.	Memon A, Moody PM, Sugathan TN, el-Gerges N, al-Bustan M, al-Shatti A, et al. Epidemiology ofsmoking among Kuwaiti adults: prevalence, characteristics, and attitudes. Bull World Heal Organ 2000; 78(11): 1306-15.##3.	Centers for Disease Control and Prevention. Smoking and tobacco use: fact sheet. (November 2006). [On-Line]. Retrieved October 9, Available: http://www.cdc.gov /tobacco/data_statistic/Factsheets/adult_cig_smoking.htm.2007; 27-28.##4.	American Cancer Society. Cancer Facts and Figures. Publication No. 5008.03.2003; 42-43.##5.	Ahmadi J, Khalili H, Jooybar R, Namazi N, MohammadagaeiP. Prevalence of cigarette smoking in Iran. J PsychoRep 2001; 89(2): 339-41.##6.	Rigotti NA, Lee JE, Wechsler H. US college students`use of tobacco products: results of a national survey. JAMA 2000; 284(34): 699-705.##7.	Glantz, M D. Vulnerability to drug abuse: Introduction and overview. Washington, DC: American Psychological Association. 1992.##8.	Mayer JD, Caruso DR, Salovey P. Emotional intelligence meets traditionalstandards for intelligence, Intelligence 1999; 27(9): 267-298.##9.	Jacobs M, Snow J, Geraci M, Meena Vythilingam M, Blair R, Charney DS, et al. Association between level of emotional intelligence andseverity of anxiety in generalized social phobia. J Anx Disor 2008; 87(11): 9-24.##10.	Parker JD, Taylor RN, Eastabrookj M, Schell SL, Wood LM. Problemgambling in adolescence: Relationships with internet misuse, gaming abuse andemotional intelligence. J Pers Individ Dif 2008; 45(7): 174-180.##11.	Trinidad DR, Johnson CA. The Associationbetween Emotional Intelligence and Early AdolescentTobacco and Alcohol Use. J Pers Individ Dif 2002; 32(1): 95-105.##12.	Trinidad DR, Unger Jb, Chou CO, Johnson A. TheProtective Association of Emotional Intelligence withPsychosocial Smoking Risk Factors for Adolescent. J Pers Individ Dif 2004; 36: 945-954.##13.	Mayer JD, Salovey P. What Is Emotional Intelligence? In: Salovey P, Sluyter D(Eds). EmotionalDevelopment and Emotional Intelligence: Implicationfor Educators. New York; Basic Books. 1997; 150-161.##14.	Kuntsche E, Knibbe R, Gmel, Gerhard, Engels R. WhoDrinking and Why? A Reviewof ociodemographic, Personality, andContextual Issues Behind the Drinking Natives in Young People. J Addic Behavi 2006; 31(4): 1844-1857.##15.	Kassel JD, Shiffman S. Attentional Mediation of CigaretteSmoking’s Effect on Anxiety. J Heal Psycho 2000; 16(7): 359-368.##16.	Goldsmith AA. Effects of Mood Induction on the Relationshipsbetween Generalized Anxiety and Alcohol-related Beliefs in YoungAdult Drinkers, Unpublished Doctoral Dissertation. University of Cincinnati. 2008.##17.	Khodaee A. Comparison of Five Personality Factors And Emotional Intelligent In The AddictPersons And Non Addict In Tehran City.Thesis M A Tarbiat Moallem University. Tehran .2005;[ in Persian].##18.	Garnefski N, Kraaij V, Spinhoven P. Negative LifeEvents, Cognitive Emotion Regulation and EmotionalProblems. J PersIndivid Dif 2001; 30: 1311-1327.##19.	Yusefi F. The relationship of cognitive emotion regulation strategies with depression and anxiety in the middle students.J Rese on Exce Child 2007; 4: 871-892. (in Persian).##20.	Zahid A, Kalthoum Q, Abolghsimi A, Narimani M. The relationship between emotion regulation strategies and interpersonal behavior inAdverse drug users. J Addic Rese 2010; 11.99-113. (In Persian).##21.	Parker DA, Taylor GJ, Bagby RM. The relationship between emotion intelligence and alexithymia. J Pers Individ Dif. 2001; 30, 107-115##22.	Doran N, Mccharque D, Cohen L. Impulsivity and the reinforcing value of cigarette smoking. J Addic Behavi 2007; 32: 90-98.##23.	Terry-McElrath Y M, Emery S, Szczypka G, Johnston LD. Potential Exposure to Anti-drug Advertising and Drug-related Attitudes, Beliefs, and Behaviors among United States Youth, J AddicBehavi 2011;36: 116-124.##24.	ZhouX. Attempts to quit smoking and relapse: Factors associated with success or failure from the ATTEMPT cohort study. J Addic Behavi 2009; 34(4), 365-373.##25.	Fox HC, Axelrod SR. Paliwal P, Sleeper J, Sinha R. Difficulties in emotionregulation and impulse control during cocaine abstinence. J Dru and Alcoho Depen 2007; 89(33): 388-394.##26.	Fox HC, Hong KA, Sinha R. Difficulties in emotion regulation and impulsecontrol in recently abstinent alcoholics compared with social drinks. J Addic Behavi 2008; 33: 388-394.##27.	Khantzian EJ. The self-medication hypothesis of substanceuse disorders: A reconsideration and recent applications.Harv Rev Psychi 1997; 4: 231−44.##28.	Suh JJ, Ruffins S, Robins CE. Self-MedicationHypothesis: connecting affective experience and drugchoice. Psychoanal Psychol 2008; 25: 518-32.##29.	MayerJd, David R, Caruso DR, Salovey P.Emotional Intelligence Meets Traditional Standard ForAn Intelligence. J Pers Individ Dif 1999; 27: 267-298.##30.	Dawes M, Clark D, Moss H. Family and PeerCorrelates Of Behavioral Self-Regulation in Boys atRisk for Substance Use. American JDru and Alcoho Abu 1999; 25: 249-237.##31.	Mayer JD, Salovey P. What Is Emotional Intelligence? In: Salovey P, Sluyter D (Eds). EmotionalDevelopment and Emotional Intelligence: Implicationfor Educators. New York; Basic Books. 1997; 150-161.##32.	Trinidad DR, Johnson CA. The Associationbetween Emotional Intelligence and Early AdolescentTobacco and Alcohol Use. J Pers Individ Dif 2002; 32(1): 95-105.##33.	Trinidad DR, Unger Jb, Chou CO, Johnson A. TheProtective Association of Emotional Intelligence withPsychosocial Smoking Risk Factors for Adolescent. J Pers Individ Dif 2004; 36: 945-954.##34.	Zarepour M, Sadeghi R, SadeghiTabatabai A R, Syadi S. Factors influencing smoking behavior in male students by BASNEF Tehran University of Medical Sciences in 2009. Address: School of Nursing and Midwifery 2011; 9(1). 23-29. (in Persian).## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>سبک زندگی ارتقا دهنده سلامت و خودکارآمدی در نوجوانان پسر </TitleF>
		<TitleE>Health promoting lifestyles and self-efficacy in adolescent boys</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: این مطالعه با هدف تعیین وضعیت سبک زندگی ارتقا دهنده سلامت و زیر دامنه‌های آن در نوجوانان پسر و ارتباط آن‌ها با خودکارآمدی و مشخصات فردی- اجتماعی انجام شد.
مواد و روش‌ها: این مطالعه با شرکت 750 نفر از نوجوانان پسر در سال 1391 انجام شد. از روش نمونه‌گیری تصادفی استفاده گردید. معیارهای ورود به مطالعه، تمایل به شرکت در پژوهش، ملیت ایرانی، ساکن بودن در شهر سنندج و سن 18-14 سال بودند. پرسش‌نامه‌های سبک زندگی ارتقا دهنده سلامت نوجوانان (تغذیه، فعالیت فیزیکی، مسؤولیت پذیری سلامت، مدیریت استرس، حمایت اجتماعی و درک زندگی) و خودکارآمدی عمومی Sherer مورد استفاده قرار گرفت. برای تعیین اعتبار پرسش‌نامه‌ها از سنجش اعتبار محتوایی و صوری استفاده شد. همچنین با انجام پیش آزمون و پس آزمون بر روی 30 نفر، پایایی از دو بعد تکرار پذیری و انسجام درونی (Cronbach's alpha) تعیین شد. برای تحلیل داده‌ها از رگرسیون خطی چند متغیره استفاده گردید.
یافته‌ها: میانگین ± انحراف معیار سن نوجوانان پسر 0/1 ± 6/15 بود. اغلب آن‌ها (88 درصد) در مدارس دولتی و نیمه دولتی در حال تحصیل بودند. میانگین نمره‌ی کلی رفتارهای ارتقا دهنده سلامت 49/3 بود. متغیرهای خودکارآمدی، مقطع تحصیلی، شغل پدر و میزان درآمد با نمره‌ی کلی سبک زندگی ارتقا دهنده سلامت ارتباط معنی‌داری داشتند.
استنتاج: نتایج مطالعه نشان داد که علاوه بر خودکارآمدی، برخی مشخصات فردی- اجتماعی نیز از پیش‌گویی کننده‌های رفتارهای ارتقا دهنده سلامت بودند. با توجه به اهمیت سبک زندگی ارتقا دهنده سلامت در زندگی افراد، لازم است تا راهکارهایی برای افزایش خودکارآمدی و ارتقای هر چه بیشتر سبک زندگی نوجوانان ارایه گردد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: This study aimed to determine the health promoting lifestyle status and its dimensions in adolescent boys and its relationship with self-efficacy and socio-demographic characteristics.
Materials and methods: 750 adolescent boys selected by random sampling were enrolled this study in 2013. Inclusion criteria were being interested in participation in the research, having the Iranian nationality, being 14-18 years old and being resident of the city of Sanandaj, Iran. Data was collected by Adolescent Healthy Lifestyle questionnaire (nutrition, physical activity, stress management, health responsibility, social support, and spiritual growth dimensions) and Sherer General Self-Efficacy scale. Content and face validity were measured to determine the validity of the questionnaires. In addition, pre- and post-test were implemented on 30 adolescents to determine the reliability (ICC or Intra Class Correlation) and internal consistency (Cronbach's alpha coefficient). Multivariate linear regression analysis was used to analyse the data.
Results: The mean of age was 15.6 ± 1.0 years. Majority of the boy students were studying in governmental and semi-governmental schools. There was a significant correlation between variables of self-efficacy, course of education, father's occupation, and income with health promoting lifestyle.
Conclusion: The findings show that in addition to self-efficacy as the main predictor, some of the socio-demographic characteristics also are among the predictors of health behaviors. With consideration of the importance of health promoting lifestyle, it is necessary to provide strategies to promote lifestyle in adolescents.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>152</FPAGE>
			<TPAGE>162</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/8
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/12/17
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/8
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/12/17
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>سکینه</Name>
				<MidName></MidName>
				<Family>محمد علیزاده چرندابی</Family>
				<NameE>Sakineh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mohammad-Alizadeh-Charandabi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>مژگان</Name>
				<MidName></MidName>
				<Family>میرغفوروند</Family>
				<NameE>Mojgan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mirghafourvand</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>نیکتا</Name>
				<MidName></MidName>
				<Family>توانانژاد</Family>
				<NameE>Nikta</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Tavananezhad</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>soshyant777@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>مهسا</Name>
				<MidName></MidName>
				<Family>کارخانه</Family>
				<NameE>Mahsa</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Karkhaneh</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Health-promoting lifestyle</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>self-efficacy</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>adolescent boys</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سبک زندگی ارتقا دهنده سلامت</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>خودکارآمدی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>نوجوانان پسر</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Park JE, Park K. Park\'s textbook of preventive and social medicine. 17th ed: Jabalpur: M/S Banarsidas Bhanot publishers; 2002.##2.	Baheiraei A, Mirghafourvand M. Health promotion: from concepts to practice. Tehran: Noor-e-Danesh; 2011.##3.	Mo PKH, Winnie WSM. The inﬂuence of health promoting practices on the quality of life of community adults in Hong Kong. Soc Indic Res 2010; 95(3): 503-517.##4.	Myers RE. Promoting healthy behaviors: How do we get the message across? Int J Nurs Stud 2010; 47(4): 500-512.##5.	Barnes DM, Almasy N. Refugees’ perceptions of healthy behaviors. J Immigr Health 2005; 7(3): 185-193.##6.	Ghanaei Chamanabad A, Mirdoraghib F, Pakmehr H. The relationship of M.A. students\' metacognitive and self-efficacy beliefs with their mental health. Procedia Soc Behav Sci 2011; 15: 3050-3055.##7.	Lee Y, Salman A, Fitzpatrick JJ. HIV/AIDS preventive self-efficacy, depressive symptoms, and risky sexual behavior in adolescents: A cross-sectional questionnaire survey. Int J Nurs Stud 2009; 46: 653-660.##8.	World Health Organization. 10 Facts on adolescent health. [cited 2012 1 Aug]. Available from: http://www.who.int/features/ factfiles/adolescent_health/en/index.html. Accessed August 1, 2012.##9.	Statistical Center of Iran. Information technology 2011 [cited 2011 15 Sep ]. Available from: http://www.amar.org.ir/Defa ult.aspx?tabid=1160. Accessed September 15, 2011.##10.	Salonna F, van Dijk JP, Geckova AM, Sleskova M, Groothoff JW, Reijneveld SA. Social inequalities in changes in health-related behaviour among Slovak adolescents aged between 15 and 19: a longitudinal study. BMC Public Health 2008; 8(1): 1-13.##11.	Brownell KD, Schwarts MB, Puhl MB, Henderson KE, Harris JL. The need for bold action to prevent adolescent obesity. J Adolesc Health 2009; 45: S8-S17.##12.	Walker Z, Townsend J, Oakley L, Donovan C, Smith H, Hurst Z, et al. Health promotion for adolescents in primary care: randomised controlled trial. BMJ 2002; 325: 524-527.##13.	Grunbaum JA, Kann L, Kinchen SA, Williams B, Ross JG, Lowry R, et al. Youth risk behavior surveillance national alternative high school youth risk behavior survey, United States, 1998. J Sch Health 2000; 70(1): 5-17.##14.	Grunbaum JA, Kann L, Kinchen SA, Williams B, Ross JG, Lowry R, et al. Youth risk behavior surveillance-United States, 2001. J Sch Health 2002; 72(8): 313-328.##15.	Ozer EM, Park MJ, Paul T, Brindis CD, Irwin Ce. America’s adolescents: are they healthy? San Francisco, California: National Adolescent Health Information Center; 2003.##16.	Callaghan D. Healthy behaviors, self-efficacy, self-care, and basic conditioning factors in older adults. J Community Health Nurs 2005; 22(3): 169-178.##17.	Chen M-Y, James K, Wang EK. Comparison of health-promoting behavior between Taiwanese and American adolescents: a cross-sectional questionnaire survey. Int J Nurs Stud 2007; 44(1): 59-69.##18.	Rozmus CL, Evans R, Wysochansky M, Mixon D. An analysis of health promotion and risk behaviors of freshman college students in a rural southern setting. J Pediatr Nurs 2005; 20(1): 25-33.##19.	Kreutz G, Ginsborg J, Williamon A. Health-promoting behaviours in conservatoire students. Psychology of Music 2009; 37(1): 47-60.##20.	Huang S-L, Li R-H, Tang F-C. Comparing disparities in the health-promoting lifestyles of Taiwanese workers in various occupations. Ind Health 2010; 48(3): 256-264.##21.	Zhang S-C, Tao F-B, Ueda A, Wei C-N, Fang J. The influence of health-promoting lifestyles on the quality of life of retired workers in a medium-sized city of Northeastern China. Environ Health Prev Med 2013; 18(92): 458-465.##22.	Kim HJ, Kim JH, Park YH. Factors influencing health promoting behavior of the elderly. Journal of Korean Academy of Adult Nursing 2000; 12(4): 573-583.##23.	Carreno J, Vyhmeister G, Grau L, Ivanovic D. A health promotion programme in Adventist and non-Adventist women based on Pender\'s model: A pilot study. Public Health 2006; 120(4): 346-355.##24.	Meissner HI, Yabroff KR, Dodd KW, Leader AE, Ballard-Barbash R, Berrigan D. Are patterns of health behavior associated with cancer screening? Am J Health Promot 2009; 23(3): 168-175.##25.	World Health Organization. Health Promotion in the 21st century: an era of partnerships to achieve health for all 1998 [cited 2013 19 Sep]. Available from: http://www.who.int/ inf-pr-1998/en/pr98-47.html. Accessed September 19, 2013.##26.	Resnick B, Inguito P, Orwig D, Yahiro JY, Hawkes W, Werner M, et al. Treatment fidelity in behavior change research: A case example. Nurs Res 2005; 54(2): 139-143.##27.	Baheiraei A, Mirghafourvand M, Mohammadi E, Nedjat S, Charandabi SM, Rajabi F, et al. Health-promoting behaviors and social support of women of reproductive age, and strategies for advancing their health: Protocol for a mixed methods study. BMC Public Health 2011; 11(1): 191-195.##28.	Morowatisharifabad MA, Ghofranipour F, Heidarnia A, Ruchi GB, Ehrampoush MH. Self-efficacy and health promotion behaviors of older adults in Iran. Soc Behav Pers 2006; 34(7): 759-768.##29.	Motlagh Z, Mazloomy-Mahmoodabad S, Momayyezi M. Study of health-promotion behaviors among university of medical science students. Zahedan J Res Med Sci 2011; 13(4): 29-34.##30.	Dubois EJ. Assessment of health-promoting factors in college students\' lifestyles [doctorate thesis]: Auburn University; 2006.##31.	Geckil E, Yildiz S. Adolescent health behaviors and problems. Adolescence 2006; 3: 26-34.##32.	Baheiraei A, Mirghafourvand M, Charandabi SM-A, Mohammadi E, Nedjat S. Health-promoting behaviors and social support in Iranian women of reproductive age: a sequential explanatory mixed methods study. Int J Public Health 2013: 1-9.##33.	World health organization. BMI-for-age (5-19 years) 2007 [cited 2013 9 Apr]. Available from: http://www.who.int/growthref/who 2007_bmi_for_age/en. Accessed April 9, 2011.##34.	Barati BS. The simple and multiple relationships between self-effectiveness, self-discovery and self-esteem with academic performance of students in the third years of the new system in Ahvaz [MSc thesis]: Shahid Chamran University of Ahvaz; 1997.##35.	Chen MY, Wang EK, Yang RJ, Liou YM. Adolescent health promotion scale: development and psychometric testing. Public Health Nurs 2003; 20(2): 104-110.##36.	Gillis A. The adolescent lifestyle questionnaire: development and psychometric testing. Can J Nurs Res 1997; 29(1): 29-46.##37.	Hendricks C, Murdaugh C, Pender N. The adolescent lifestyle profile: Development and psychometric characteristics. J Natl Black Nurses Assoc 2006; 17: 1-5.##38.	Taymoori P, Moeini B, Lubans D, Bharami M. Development and psychometric testing ##of the Adolescent Healthy Lifestyle Questionnaire. J Edu Health Promot 2012; 1(20): 1-7.##39.	Hulme PA, Walker SN, Effle KJ, Jorgensen L, McGowan MG, Nelson JD, et al. Health-promoting lifestyle behaviors of Spanish-speaking Hispanic adults. J Transcult Nurs 2003; 14(3): 244-254.##40.	Wei C-N, Harada K, Ueda K, Fukumoto K, Minamoto K, Ueda A. Assessment of health-promoting lifestyle profile in Japanese university students. Environ Health Prev Med 2012; 17(3): 222-227.##41.	Baheiraei A, Mirghafourvand M, Mohammadi E, Mohammad-Alizadeh Charandabi S. Facilitators and inhibitors of health-promoting behaviours: the experience of Iranian women of reproductive age. Int J Prev Med 2013; 4(8): 929-939.##42.	Kushnir T, Rabinowitz S, Melamed S, Weisberg E, Ribak J. Health responsibility and workplace health promotion among women: early detection of cancer. Health Care Women Int 1995; 16(4): 329-340.##43.	Choe M, Yi M, Choi J-A, Shin G. Health knowledge, health promoting behavior and factors influencing health promoting behavior of north Korean defectors in south Korea. J Korean Acad Nurs 2012; 42(5): 622-631.##44.	Martinelli AM. An explanatory model of variables influencing health promotion behaviors in smoking and nonsmoking college students. Public Health Nurs 1999; 16(4): 263-269.##45.	Mohamadian H, Ghannaee M, Kortdzanganeh J, Meihan L. Reliability and construct validity of the Iranian version of health-promoting lifestyle profile in a female adolescent population. Int J Prev Med 2013; 4(1): 42-49.##46.	Gillis AJ. Determinants of a health-promoting lifestyle: an integrative review. J Adv Nurs 1993; 18(3): 345-353.##47.	Díez SMU, Pérez-Fortis A. Socio-demographic predictors of health behaviors in Mexican college students. Health Promot Int 2010; 25(1): 85-93.##48.	Chang LC. Health literacy, self-reported status and health promoting behaviours for adolescents in Taiwan. J Clin Nurs 2011; 20(1-2): 190-196.##49.	Katrien De Cocker, Charlene Ottevaere, Michael Sjostrom, Luis A Moreno, Julia Warnberg, Jara Valtuena, et al. Self-reported physical activity in European adolescents: results from the HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) study. Public Health Nutr 2010; 14(2): 246-254.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>بررسی میزان آگاهی دندان پزشکان در ارتباط با سرطان دهان در ساری- ایران در سال 1391</TitleF>
		<TitleE>Evaluation of Dentists Knowledge about Oral Cancer in Sari-Iran in 2013</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف : سرطان دهان یکی از شایع ترین سرطان ها در جهان و یکی از ده عامل مرگ و میر در میان سرطان ها
می باشد. اغلب سرطان های دهانی، دیر هنگام تشخیص داده می شوند و در نتیجه مشکل مهمی برای سلامت عمومی مردم
دنیا محسوب می شود. از آن جا که دندان پزشکان نقش مهمی در شناسایی زود هنگام سرطان های دهان ایفا می کنند، لذا باید
آگاهی کافی در زمینه تشخیص زود هنگام بیماران داشت ه باشند . هدف از این مطالعه، ارزیابی میزان آگاهی دندان پزشکان
شهر ساری از سرطان دهان بود.
مواد و روش ها: این مطالعه از نوع توصیفی- تحلیلی و به روش مقطعی بر روی 150 نفر از دندان پزشکان در سطح شهر
ساری، در سال 1391 انجام شد . پرسش نامه ای طراحی گردید که بخشی ا ز س ؤالات آن در رابطه با اطلاعات افراد مورد مطالعه
و بخشی دیگر شامل س ؤال در ارتباط سرطان دهان بود . با مراجعه حضوری به محل کار دندان پزشکان پرسش نامه ها در اختیار
آنان قرار داده شد و از آنان خواسته شد طی زمان معین به پرسش ها پاسخ دهند و سپس پرسش نامه ها جمع آوری و تصحیح
و ضریب همبستگی پیرسون آنالیز شدند. t-test و آزمون های SPSS گردید. اطلاعات به دست آمده توسط نرم افزار 16
39 سال بود . /94±7/ یافته ها: از 150 نفر دندان پزشک مورد مطالعه 98 نفر مرد و 52 نفر زن و میانگین سنی آن ها، 24
6 و در زنان /91±2/ 7 از 13 بود . میانگین آگاهی در مردان 37 /27±2/ میانگین نمره آگاهی در جمعیت مورد مطالعه 49
91 درصد افراد مورد مطالعه شای ع ترین سرطان (p=0/ 7/78±2/60 بود که از لحاظ آماری این اختلاف معن ی دار بود ( 03
دهان را می شناختند.
استنتاج: بررسی نتایج این مطالعه نشان داد که سطح آگاهی دندا ن پزشکان شهر ساری در ارتباط با سرطان دهان کافی
نمی باشد. لذا با توجه به اهمیت موضوع، اتخاذ راه کارهایی برای افزایش میزان آگاهی دندان پزشکان از سرطان دهان مورد
نیاز است.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Oral cancer is one of the most prevalent cancers and the 10 most
causes of death in the world. Most oral cancers are diagnosed at late stages. Thus, it is an important public
health problem in the world. Since dentists play a critical role of oral cancers, they should be
knowledgeable and skillful in oral cancer diagnosis. The aim of this study was to evaluate the knowledge
of general dentists about oral cancer in Sari.
Material and methods: This descriptive analytical cross-sectional study was done on 150
dentists who had private offices in Sari in 2013. A questionnaire including the information and 13
questions regarding oral cancer was prepared. The questionnaires were delivered to dentists at their
offices and then gathered. The data were analyzed via SPSS software student's t-test, Pearson correlation
coefficients.
Results: There were 98 male and 52 female dentists with the mean age of 39.94±7.24 years (P=0.09).
The mean score of total dentists' knowledge was 7.27±2.49 out of 13. The mean score of knowledge was
6.91±2.37 and 7.78±2.6, for males and females, respectively. There was significant difference between
them (P=0.03). Ninety-One percent of dentists knew the most common types of oral cancer.
Conclusion: The results of this study indicate that knowledge of dentists in Sari about oral
cancer was not sufficient. Because of the importance of the issue, the application of strategies to increase
the knowledge of dentists regarding oral cancer is necessary.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>164</FPAGE>
			<TPAGE>171</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/5
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/16
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/5
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/16
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>آتنا</Name>
				<MidName></MidName>
				<Family>شیوا</Family>
				<NameE>Atena</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Shiva</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>atenashiva@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>سیدجابر</Name>
				<MidName></MidName>
				<Family>موسوی</Family>
				<NameE>Seyed Jabaer</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mousavi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Knowledge</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>oral cancer</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>dentist</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>آگاهی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سرطان دهان</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>دندان پزشک</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Neville BW, Damm D, Allen CM, ouquot JE. Oral and Maxillofacial Pathology. 3th ed. St. Louis: Saunders Co; 2009. p. 409-21.##2.	Maybury C, Horowitz A, Goodman H. Outcomes of oral cancer early detection and prevention statewide model in Maryland. J Public Health Dent 2012; 72(1): 34-38.##3.	Musavi M. Guideline: National Cancer Registry. 1st ed. Tehran: Center for disease control with Chakame Ava group Co; 2006. p. 8.##4.	Greenberg MS, Glick M, Ship JA. Burket\'s Oral medicine. 11th ed. Hamilton: Bc Decker Inc; 2008. p. 150-88.##5.	Vijay Kumar KV, Suresan V. Knowledge, attitude and screening practices of general dentists concerning oral cancer in Bangalore city. Indian J Cancer 2012; 49(1): 33-38.##6.	Motallebnejad M, Hedayati M. General dentist\'s knowledge about oral cancers in Babol, in 2005. J Mash Dent Sch 2006; 30 (3&#38;4): 309-318.##7.	Lopez-Jornet P, Camacho-Alonso F, Molina-Minano F. Knowledge and attitudes about oral cancer among dentists in Spain. Journal of Evaluation in Clinical Practice 2010; ##16( 1    ): 129-133.##8.	Applebaum E, Ruhlen TN, Kronenberg FR, Hages C, Peters ES. Oral cancer knowledge, attitudes and practices: a survey of ##dentists and primary care physicians in Massachasettes. J Dent Assoc 2009; 140(4): 461-467.##9.	Arigawardana A, Ekanagake L. Screening for oralcancer/per cancer: knowledge and opinions of dentistsemployed in the public sector dental services of SriLanka. Asian Pac J Cancer Prev 2008; 9(4):615-8.##10.	Seoane J, Warnakulasuriya S, Varela-Centelles P, Esparza G, Dios PD. Oral cancer: Experiences and diagnostic abilities elicited by dentists in North-western Spain. Oral Dis 2006; 12(5): 487-92.##11.	Saghafi Sh, ZareMohammadi R, Salehinejad J, Falaki F. Evaluation of general dentists knowledge about oralcancer in Mashhad-Iran in 2008. J Mash Dent Sch 2009; 33(2): 107-114.##12.	Nicotera G, Gnisci F, Bianco A, Angelillo IF. Dental hygienists and oral cancer prevention: knowledge, attitudes and behaviors in Italy. Oral Oncol 2004; 40(6): 638-44.##13.	Zarei MR, Asadpour F. Assessing dentist\'s knowledge and awareness in the diagnosis of oral cancer in Kerman. JDent Sch 2002; 4(19): 364-57.##14.	Syme SE, Drury TF, Horowitz AM. Maryland dental hygienists\' knowledge and opinions of oral cancer risk factors and diagnostic procedures. Oral Dis 2001; 7(3): 177-184.##15.	Pitiphat W, Diehl SR, Laskaris G, Cartsos V, Douglass CW, Zavras AI. Factors associated with delay in the diagnosis of oral cancer. J Dent Res 2002; 81(3): 192-197.##16.	Gellrich NC, Suareez-Cunqueiro MM, Bremerich A, Schramm A. Characteristics of oral cancer in a centralEuropean population: defining the dentist\'s role. J Am Dent Assoc 2003; 134(3     ): 307-314.##17.	Aghbali A, Vosoughhoseyni S, Mahmoodifar F, Sayedmostafa M. Evaluation of general dentists knowledge, attitudes and practices about oralcancer in Urmia-Iran in 2010. J 0f Urmia 2010; 34(5): 367-373.##18.	Yellowitz JA, Horowitz AM, Drury TF, Goodman HS. Survey of U.S. dentists\' knowledge and opinions about oral pharyngeal cancer. J Am Dent Assoc 2000; 131(5): 653-661.##19.	Leao JC, Goes P, Sobrinho CB, Porter S. Knowledge and clinical expertise regarding oral cancer among Brazilian dentists. Int J Oral Maxillofac Surg 2005; 34(4): 436-439.##20.	Gajendra S, Cruz GD, Kumar JV. Oral cancer prevention and early detection: knowledge, practices, and opinions of oral health care providers in New York state. J Cancer Educ 2006; 21(3): 157-162.##21.	Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin 2002; 52(4): 195-215.##22.	Canto MT, Horowitz AM, Drury TF, Goodman HS. Maryland family physicians\' knowledge, opinions and practices about oral cancer. Oral Oncol 2002; 38(5): 416-424.##23.	Shah J, Janson NW, Batsakis JG. Oral cancer. 1st ed. United Kingdom: Thieme Medical Pub; 2003. p. 65.##24.	Clovis JB, Horowitz AM, Poel DH. Oral and pharyngeal cancer: Practices and opinions of dentists in British Columbia and Nova Scotia J Can Dent Assoc 2002; 68(7): 421-425.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>سنجش کیفیت زندگی مرتبط با سلامت در زنان مناطق روستایی کرمانشاه و برخی عوامل مرتبط با آن</TitleF>
		<TitleE>The Survey of Health-Related Quality of Life in Kermanshah Rural Women and Some Related Factors</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: امروزه با توسعه جوامع و بهبود سطح زندگی، موضوع «کیفیت زندگی» اهمیت قابل ملاحظه‌ای یافته است. هدف این مطالعه، بررسی کیفیت زندگی مرتبط با سلامت در زنان روستایی کرمانشاه و برخی عوامل مرتبط با آن است.
مواد و روش‌ها: جامعه آماری این تحقیق مقطعی، زنان 20 تا 50 ساله مناطق روستایی شهرستان کرمانشاه بودند. تعداد 394 نفر از طریق نمونه‌گیری خوشه‌ای چند مرحله‌ی از 20 روستا انتخاب و پرسشنامه کیفیت زندگی سازمان جهانی بهداشت در اختیار آنان قرار گرفت. جهت آنالیز داده‌ها از نرم‌افزار SPSS و آزمون‌های آنالیز واریانس، t مستقل و رگرسیون خطی چند متغیره استفاده شد.
یافته‌ها: میانگین سنی پاسخ‌گویان، 98/8±94/32 سال بود. میانگین نمره کیفیت زندگی در ابعاد سلامت جسمانی، روانی، اجتماعی و محیطی به ترتیب برابر (55/61، 22/53، 58/60 و 94/47) بود. بر اساس نتایج رگرسیون خطی چندمتغیره، عوامل تأثیرگذار در حیطه‌های سلامت جسمانی شامل (وجود یا عدم بیماری، سن، سطح توسعه روستا، وضعیت تأهل) (236/0R2=)، سلامت روانی شامل (وجود یا عدم بیماری، وضعیت تأهل، تحصیلات، سطح توسعه روستا) (185/0R2=)، سلامت اجتماعی شامل (وجود یا عدم بیماری، سطح توسعه روستا) (105/0R2=) و سلامت محیطی شامل (وجود یا عدم بیماری، سطح توسعه روستا، تحصیلات، وضعیت تأهل) (170/0R2=) بود.
استنتاج: در این مطالعه کیفیت زندگی زنان روستایی در سطح متوسطی ارزیابی شد. با توجه به این‌که مطالعه حاضر اولین پژوهشی است که به بررسی کیفیت زندگی مرتبط با سلامت در زنان روستایی در ایران پرداخته است، نتایج آن ضمن ارائه اطلاعات مفید در این گروه، می‌تواند جهت طراحی مطالعات آتی مورد استفاده قرار گیرد.
Ghasemi</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Nowadays, quality of life (QOL) has become an important issue because of the development of societies and the improvement of living standards. The aim of this study was to survey the Health-related QOL in Kermanshah rural women and some related factors.
Material and methods: Our target community was selected among 20-50 years old women from 20 villages of Kermanshah county by multistage cluster sampling (n: 394), and our tool was WHOQOL-BREF questionnaire. The data were analyzed by SPSS software and ANOVA, Independent t-test and Linear Regression test.
Results: The mean age of respondents was 32.94±8.98 years. The mean of QOL in Physical, Psychological, Social and Environmental domains was (61.55, 53.22, 60.58, 47.94), respectively. Based on linear regression test, the most effective factors on the four domains of women's QOL were as follows: Physical Health domain (illness status, age, developmental level of the village (DLV), marriage status) (R2=0.236), Psychological Health (illness status, marriage status, educational level, DLV) (R2=0.185), Social Health (illness status, DLV) (R2=0.105) and Environmental Health (illness status, DLV, educational level, marriage status) (R2=0.170).
Conclusion: Based on our data, the level of quality of life was moderate. This study is the first research about Health-related QOL in rural women of Iran therefore, its findings can provide useful information in this group and be used for designing later studies.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>173</FPAGE>
			<TPAGE>181</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/25
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/5
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/25
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/5
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>سید رامین</Name>
				<MidName></MidName>
				<Family>قاسمی</Family>
				<NameE>Seyed Ramin</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghasemi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>نادر</Name>
				<MidName></MidName>
				<Family>رجبی گیلان</Family>
				<NameE>Nader</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Rjabi Gilan</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>rajabi_nader@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>سهیلا</Name>
				<MidName></MidName>
				<Family>رشادت</Family>
				<NameE>Sohyla</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Reshadat</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Quality of Life</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Health</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Rural women</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>کیفیت زندگی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سلامت</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>زنان روستایی</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Thumboo J, Fong KY, Machin D, Chan SP, Soh CH, Leong KH, et al. Quality of life in an urban Asian population: the impact of ethnicity and socio-economic status. Social ##Science &#38; Medicine 2003; 56(8): 1761-1772.##2.	Zhao J, Li Y, Wu Y, Zhou J, Ba L, Gu X, et al. Impact of different contraceptive methods on quality of life in rural women of the Jiangsu province in China. Contraception 2009;80(2): 180-186.##3.	Abdul-Hakim R, Ismail R, Abdul-Razak N. The Relationship between Social Capital and Quality of Life among Rural Households in Terengganu, Malaysia. OIDA International Journal of Sustainable Development 2010; 1(05): 99-106.##4.	Theofilou P. Quality of Life: Definition and Measurement. Europe’s Journal of Psychology 2013; 9(1): 150-162.##5.	Majedi SMLA. The relationship between contextual variables, social capital and satisfaction from quality of life: case study of Fars province villages. The Journal of Roosta va Towse\'e 2007; 9(4): 91-136.##6.	Nooghani MAMA, Safa SH, Kermani M. Quality of life of citizens and it\'s relationship with social capital in Mashhad city. Ferdowsi University Journal of Social Scences 2008; 5(1): 111-140.##7.	Muldoon MF, Barger SD, Flory JD, Manuck SB. What are quality of life measurements measuring? Debate. British Medical Journal 1998(316): 7130-7142.##8.	WHO. WHOQOL-BREF: Introduction, Administration, Scoring and Generic Version of the Assessment, Field Trial Version. In: HEALTH POM, editor. Geneva: World Health Organization; 1996.##9.	Sabbah I, Drouby N, Sabbah S, Retel-Rude N, Mercier M. Quality of life in rural and urban populations in Lebanon using SF-36 health survey. Health and Quality of Life Outcomes 2003; 1(1): 30.##10.	Skevington SM, Lotfy M, O\'Connell KA. The World Health Organization\'s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research 2004; 13(2): 299-310.##11.	Shams-alizade N, Mohsenpour B, Ghaderi E, Rezaei F, Delavari AR. Qualityof lifein 15-64 yearsold people in Kurdistanprovince, westernpart of Iran. The Quarterly Journal ##of Fundamentals of Mental Health 2010; 12(45): 448-456.##12.	Farhadi A, Foroughan M, Mohammadi F. The Quality of Life among Rural Elderlies; A Cross-sectional Study Salmand- Iranian Journal of Ageing 2011; 6(20): 38-46.##13.	Asada Y, Ohkusa Y. Analysis of health-related quality of life (HRQL), its distribution, and its distribution by income in Japan, 1989 and 1998. Social Science &#38; Medicine 2006; 59(7): 1423-1433.##14.	Abbaszadeh F, Baghery A, Mehran N. Quality of Life among Pregnant Women. The Journal of Faculty of Nursing &#38; Midwifery 2009; 15(1): 41-48.##15.	Abedzadeh M, Taebi M, Saberi F, Sadat Z. Quality of life and related factors in Menopausal women in Kashan city. Iranian South Medical Journal 2009; 12(1): 81-88.##16.	Fasihi-Harandi T, Anoosheh M, Ghofranipour F, Montazeri A, Ahmadi F, Mohammadi E, et al. Quality of life in women with breast cancer: a qualitative study. Payesh, Journal of The Iranian Institute For Health Sciences Research 2012; 11(1): 73-81.##17.	Iran Statistical Center. The Findings of Iran\'s Census of Peoples and Housing 2011. Tehran: Iran Statistical Center; 2012.##18.	Moshiri SR, Mahdavi M, Oliaei MS. The role of literacy and women work force in rural household income, case study: Divandareh rural women, Kurdistan, Iran. Joghrafia-va-##Tow se\'eh 2009; (14): 69-82.##19.	Veisi H, Badsar M. Effective factor on women social role in rural actions: case study of Kurdistan Province. Roosta-va-Towse\'eh 2005; 8(4): 19-42.##20.	Jahanlou AS, Alishan Karami N. WHO quality of life-BREF 26 questionnaire: Reliability and validity of the Persian version and compare it with Iranian diabetics quality of life questionnaire in diabetic patients. Primary Care Diabetes 2011; 5(2): 103-107.##21.	Nedjat S, Montazeri A, Mohammad K, Majdzadeh S. The World Health Organization quality of Life (WHOQOL-BREF) questionnaire: Translation and validation study of the Iranian version. Journal of School of Public Health and Institute of Public Health Research 2007; 4(4): 1-12.##22.	Nedjat S, Montazeri A, Holakouie K, Mohammad K, Majdzadeh R. Quality of ##Life of Tehran\'s Population by WHOQOL-BREF questionnaire in 2005. Hakim 2007; 10(3): 1-8.##23.	Abdollahpour I, Salimi Y, Nedjat S, Jorjoran-Shoushtari Z. Quality of life and effective factors on it among governmental staf in Boukan city. The Journal of Urmia University of Medical Sciences 2011; 22(1): 40-47.##24.	Navidian A, Robabi H, Pishkar Mofrad z. Quality of Life of Patients with Pulmonary Tuberculosis During Treatment Course. J Mazand Univ Med Sci 2012; 22(93): 112-122.##25.	Arslantas D, Unsal A, Metintas S, Koc F, Arslantas A. Life quality and daily life activities of elderly people in rural areas, Eskis¸ ehir (Turkey). Archives of Gerontology and Geriatrics 2009; (48): 127-131.##26.	Panayota G, Ioannis Z, Eleni A, Kalliopi K, Areti S, Andreas A, et al. Determinants of quality of life in Greek middle-age women: A population survey. Maturitas 2012; 71(2): 154-161.##27.	Schultz A, Winstead-fry P. Predictors of Quality of Life in Rural Patient with Cancer. Cancer Nursing 2001; 24(1): 12-19.##28.	Rajabi Gilan N. Study on the factors concerning to women empowerment in Kermanshah County. Tabriz: Tabriz; 2007.##29.	Zagozdzon P, Kolarzyk E, Marcinkowski JT. Quality of life and rural place of residence in Polish women-population based study. Annals of agricultural and environmental medicine: AAEM. 2011; 18(2): 429-432.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>بیان پروتئین نوترکیب IpaD-STxB و بررسی ایمنی زایی آن در موش سوری</TitleF>
		<TitleE>Expression of Recombinant Proteins IpaD-STxB and Immunogenicity STxB in the Mice</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: باکتری شیگلا، شایع ترین عامل اسهال بوده و تاکنون واکسن موثری علیه آن یافت نشده است. پروتئین IpaD و انتروتوکسین شیگلا یاB subunit of Shiga toxin (STxB)  نقش مهمی در تهاجم، بیماری‌زایی و ایجاد عفونت توسط شیگلا دارد. برای بررسی ایمنی‌زایی هر یک از پروتئین‌های ممزوج IpaD و STxB می‌توان از دو مدل حیوانی موش و خوکچه هندی استفاده نمود و نقش هر یک از پروتئین‌های نوترکیب IpaD-STxB را در تهیه واکسن مناسب مشخص نمود.
مواد و روش‌ها: مطالعه حاضر از نوع مطالعه تجربی می باشد که در آن اطلاعات مربوط به توالی ژنی ipaD وstxB از بانک ژنی استخراج و به صورت صناعی تهیه شد. این ژن به درون باکتری coli BL21 DE3 E. منتقل و پروتئین مورد نظر توسط باکتری تولید شد. میزان بیان پروتئین نوترکیب مورد ارزیابی و با استفاده از تکنیک لکه‌گذاری وسترن، تأیید شد. پروتئین نوترکیب با استفاده از ستون کروماتوگرافی، تخلیص و در چهار نوبت متوالی به موش سوری تزریق شد. از تزریق دوم (یادآور اول) به بعد، یک هفته پس از انجام تزریق، خون‌گیری انجام و مورد آزمایش الایزا قرار گرفت.
یافته‌ها: نتایج حاکی از افزایش محسوس تیتر آنتی بادی علیه پروتئین IpaD-STxB در موش بود. ایمنی‌زایی آن با استفاده از سم فعال O157:H7 E. coli مورد ارزیابی قرار گرفت. نتایج نشان داد که موش‌های ایمن شده توانستند 5/7 برابر LD50 شیگا توکسین E. coli O157:H7 را تحمل نمایند.
استنتاج: پروتئین حاصل از ترکیب ژن‌های ipaD وstxB می‌تواند موش سوری را نسبت به شیگا توکسین مصون نماید. در نتیجه، پروتئین STxB در مدل حیوانی موش سوری موجب ایمنی زایی شده و پروتئین نوترکیب تولید شده می‌تواند کاندیدای مناسبی جهت تولید واکسن نوترکیب علیه انواع شیگلا باشد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: The most common cause of diarrhea is Shigella and no vaccine has been found so far. IpaD and STxB proteins (B subunit of Shiga toxin) play an important role in invasion, infection and pathogenesis caused by Shigella. To evaluate the immunogenicity of each of the proteins IpaD and STxB can using of two animal models mice and guinea pigs and could be determined role of each recombinant protein IpaD-STxB for appropriate vaccine.
Materials and methods: In this experimental study, the gene sequences of stxB &#38; ipaD were obtained from gene bank and was purchased the synthetic gene. This gene transferred to E. coli BL21DE3 and produced the protein by the bacterium. The level of recombinant protein expression was evaluated and confirmed by techniques of Western bloting. Recombinant proteins were purificated using column chromatography, and were injected into mice four times consecutively. After the second injection (first booster), a week after each injection, were collected blood samples and was performed ELISA.
Results: The results showed that was raised antibody titers against IpaD-STxB protein in the mice. The immunogenicity was evaluated using active toxin E. coli: O157:H7. The challenge results showed that immunized mice could endure 7.5 times the LD50 Shiga toxin E. coli O157: H7.
Conclusion: The protein obtained of the fusion ipaD and stxB genes could protect mice against Shiga toxin. Consequently, STxB proteins were induced immunogenicity in an animal model mice and recombinant protein obtained can be a suitable candidate for the production of recombinant vaccine against Shigella types.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>183</FPAGE>
			<TPAGE>193</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/5
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/16
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/5
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/16
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>حسین</Name>
				<MidName></MidName>
				<Family>هنری</Family>
				<NameE>Hossein</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Honari</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>honari.hosein@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>ایمان</Name>
				<MidName></MidName>
				<Family>املشی</Family>
				<NameE>Iman</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Amlashi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>محمد ابراهیم</Name>
				<MidName></MidName>
				<Family>مینایی</Family>
				<NameE>Mohammad Ebrahim</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Minaei</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Shigella dysenteriae type 1</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Shiga toxin B-subunit (STxB)</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>IpaD protein</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>E. coli O157: H7</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>شیگلا دیسانتری تیپ 1</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>زیر واحد B سم شیگا (STxB)</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>پروتئین IpaD</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>E. coli O157:H7</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Ranjbar R, Soltan dallal MM, Pourshafie MR, Aslani MM, Majdzadeh R. Serogroup Distribution of Shigella in Tehran. Iranian Journal Public Health 2004; 33(3): 32-35. ##2.	Clemens J, Kotloff K, Kay B. Generic protocol to estimate the burden of shigella diarrhoea and dysenteric mortal. WHO. Geneva: Tex Book; 1999. p. 146-151.##3.	Swapan KN. Shigellosis. The Journal of Microbiology 2005; 43(2): 133-143.##4.	Safaei S, Honari H, Mousavy J, Esmaeli A, Ghofrani M. Isolation, cloning and Fusion of N-terminal Region of ipa DShigella dysenteriea and Ricin toxin B Subunit. Genetics in the 3rd Millennium 2013; 10(4): 2880-2889.##5.	Engedal N, Skotland T, Torgersen ML, Sandvig K. Shiga toxin and its use in targeted cancer therapy and imaging. Microbial Biotechnol 2011; 4(1): 32-46.##6.	De Magistris MT. Mucosal delivery of vaccine antigens and its advantages in pediatrics. Adv Drug Deliv Rev 2006; 58(1): 52-67.##7.	Lunelli M, Lokareddy RK, Zychlinsky ##A, and Kolbe M. IpaB–IpgC interaction defines binding motif for typeIII secretion translocator. Proc Natl Acad Sci USA 2009; 106(24): 1-6.##8.	Honari H, Minaei ME, Dehghani AR. Analyzing the various Fusion for ctxB, ipaD and stxB genes of Shigella dysenteriae and Vibrio cholera by Bioinformatics tools. Genetics in the 3rd Millennium 2013; 11(2): 3070-3077.##9.	Hromockyj AE, Maurelli AT. Identification of Shigella invasion genes by isolation of temperature-regulated inv: lacZ operon fusions. Infect Immun 1989; 57(10): 2963-2970.##10.	Sambrook J, Rusell D. Molecular cloning: A laboratory Manual. 3th ed. New York: Cold Spring Harbor Laboratory Press; 2001. ##11.	Bollag Daniel M, Edelstein S. Protein methods. 3th ed. New York: Wiley-Liss; 1992. ##12.	Madanchi H, Honari H, Hesaraki H, Sayadnanesh A. Cloning and expression of stxB gene from shigella dysenteria typeI in E. coli Rosseta DE3. Genetics in the 3rd Millennium 2012; 10(1): 2641-2647. ##13.	Gupta P, Singh MK, Singh Y, Gautam V, Kumar S, Kumar O, et al. Recombinant shiga toxin B subunit elicits protection against shiga toxin via mixed Th type immune response in mice. Vaccine 2011; 29(45): 8094-8100.##14.	Honari H, Amlashi I, Minaei ME, Safaei S. Immunogenicity in guinea pigs by IpaD-STxB recombinant protein. Arak Medical University Journal (AMUJ). 2013; 16(73): 83-93##15.	Chia MY, Hsiao SH, Chan HT, Do YY, Huang PL, Chang HW, et al. The immunogenicity of DNA constructs co-expressing GP5 and ##M proteins of porcine reproductive and respiratory syndrome virus conjugated by GPGP linker in pigs. Vet Microbiol 2010; 146(3-4): 189-199.##16.	Kurohane K, Kobayashi C, Imai Y. Facilitated production of secretory IgA against Shiga toxin B subunits by intranasal application of antigen-coated polystyrene microspheres. Microbiol Immunol 2005;49(2):149-54.##17.	Zhu C, Yu J, Yang Z, Davis K, Rios H, Wang B, et al. Protection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit B. Clin Vaccine Immunol 2008; 15(2): 359-366.##18.	Pina DG, Johannes L. Cholera and Shiga toxin B-subunit thermodynamic and Structural considerations for function and biomedical applications. Toxicon 2005; 45(4): 389-393.##19.	Esmaeili A, Honari H, Hamedian M, Safaei S, Ghofrani M. Targeted cloning of GFP as a tracker and its fusion mediated by PRARR flexible linkers to CTB-STB chimerical vaccine genes. Genetics in the 3rd Millennium 2012; 10(1): 2657-2665.##20.	Ranjbar R, Haghi-Ashtiani MT, Jonaidi Jafari N, Abedini M. The prevalence and antimicrobial susceptibility of bacterial uropathogens isolated from pediatric patients. Iranian J Publ Health 2009; 38(2): 134-138.##21.	Stensrud KF, Adam PR, La Mar CD, Olive AJ, Lushington GH, Sudharsan R, et al. Deoxycholate Interacts with IpaD of Shigella flexneri in inducing the Recruitment of IpaB to the Type III Secretion Apparatus Needle Tip. The Journal of Biological Chemistry 2008; 283(27): 18646–18654.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>حذف فلوراید از محلول های آبی با استفاده از بیومس اصلاح شده عدسک آبی: بررسی ایزوترم و سینتیک‌های جذب</TitleF>
		<TitleE>Removal of Fluoride from Aqueous Solution by Using of Adsorption onto Modified Lemna Minor: Adsorption Isotherm and Kinetics Study</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: فلوراید در آب آشامیدنی بسته به غلظت می‌تواند بسیار مضر یا مفید باشد و مقادیر زیاد آن باعث بروز اثرات نامطلوب بهداشتی از جمله فلوروزیس دندانی و اسکلتی، ضایعات غدد درون ریز، غدد تیروئید وکبد می‌شود. در این مطالعه کارایی عدسک آبی در حذف فلوراید مورد بررسی قرار گرفته است.
مواد و روش‌ها: این تحقیق یک نوع مطالعه تجربی- آزمایشگاهی بود. ابتدا گیاه عدسک آبی جمع‌آوری شده و در فور در دمای 105 درجه سانتی‌گراد در مدت 24 ساعت خشک و با الک 18 تا 30 اینچ دانه‌بندی گردید. مقادیر pH، دوز جاذب، زمان تماس و غلظت‌های مختلف فلوراید مورد بررسی قرار گرفت و غلظت باقی مانده با استفاده با اسپکتروفتومتر در طول موج 570 نانومتر آنالیز شد. داده‌های جذب توسط ایزوترم‌های جذب و سنتیک‌ها شرح داده شدند.
یافته‌ها: نتایج نشان داد که با افزایش pH میزان حذف کاهش می‌یابد و pH بهینه برای جذب فلوراید 5 بود. افزایش زمان تماس و دوز جاذب منجر به افزایش کارایی حذف فلوراید می‌شود. داده‌‍‌های ایزوترم جذب سطحی نشان می‌دهد که جذب فلوراید از ایزوترم لانگمیر نوع 2 بهتر پیروی می‌کند. سینتیک جذب فلوراید بر روی عدسک اصلاح شده از مدل شبه درجه دوم تبعیت می‌کند.
استنتاج: نتایج حاصل نشان داد که گیاه عدسک آبی می‌تواند به‌عنوان جاذب مؤثر و ارزان قیمت در حذف فلوراید از محلول‌های آبی مورد استفاده قرار گیرد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose:  Fluoride in drinking water can be either beneficial or detrimental to health depending on its concentration. Its high concentrations leads to dental and skeletal fluorosis and lesions of the endocrine glands, thyroid and liver. This paper describes the removal of fluoride from water using lemna minor.
Material and methods: This research was a lab study. The lemna minor plants were collected and dried in the oven at 105  in 24 h and sieved in 18-30 mesh. The optimum values of pH, contact time and adsorbent dosage were determined and the different concentrations of fluoride were experimented in lab scale conditions for modified lemna minor. The fluoride concentration was measured in wavelength of 518 nm by spectrophotometer. Also, the found data of this research were fitted with Variety Isotherm and kinetic models.
Results: The results showed that by increasing pH solution, removal efficiency decreased and optimum pH was 5. Increasing of contact time and adsorbent dose can lead to the increase of the removal efficiency.Adsorption isotherm data show that the fluoride sorption followed the Langmuir No 2. Fluoride sorption is better agreed with pseudo- second order of Kinetics model which was well described by pseudo- second order model.
Conclusion: The result of the present work shows that lemna minor can be used as an effective and cheap adsorbent for fluoride removal.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>195</FPAGE>
			<TPAGE>204</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/5
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/16
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/5
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/16
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>محمدعلی</Name>
				<MidName></MidName>
				<Family>ززولی</Family>
				<NameE>Mohammad Ali</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Zazouli</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>داود</Name>
				<MidName></MidName>
				<Family>بلارک</Family>
				<NameE>Davood</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Belarak</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Dbalarak2@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>فاطمه</Name>
				<MidName></MidName>
				<Family>کریم نژاد</Family>
				<NameE>Fateme</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Karimnezhad</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>فریده</Name>
				<MidName></MidName>
				<Family>خسروی</Family>
				<NameE>Farideh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khosravi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Fluoride</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Lemna minor</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Adsorption kinetic</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Adsorption isotherm</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>فلوراید</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>عدسک آبی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>ایزوترم جذب</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سینتیک جذب</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Jorfi S, Kalantary RR, Bandpi AM, Jaafarzadeh N, Esrafili A, Alaei L. Fluoride Removal fromWater By Adsorption using Bagasse, Modified Bagasse and Chitosan. Iran J Health &#38; Environ 2011; 4(1): 35-48.##2.	STripathy S, Bersillon JL, Gopal K. Removal of fluoride from drinking water by adsorption onto alum-impregnated activated alumina. Separation and Purification Technology 2006; 50: 310-317.##3.	Fan X, Parker D, Smith M. Adsorption kinetics of fluoride on low cost materials. Water Research 2003; 37(20): 4929-4937.##4.	Ku Y, Chiou H-M. The adsorption of fluoride ion from aqueous solution by activated alumina. Water, Air, and Soil Pollution 2002; 133(1-4): 349-361.##5.	Srimurali M, Pragathi A, Karthikeyan J. A study on removal of fluorides from drinking water by adsorption onto low-cost materials. Environmental Pollution 1998; 99(2): 285-289.##6.	Tor A. Removal of fluoride from an aqueous solution by using montmorillonite. Desalination 2006; 201(1): 267-276.##7.	Tchomgui-Kamga E, Ngameni E, Darchen A. Evaluation of removal efficiency of fluoride from aqueous solution using new charcoals that contain calcium compounds. Journal of Colloid and Interface Science 2010; 346(2): 494-499.##8.	Thakre D, Jagtap S, Bansiwal A, Labhsetwar N, Rayalu S. Synthesis of La-incorporated chitosan beads for fluoride removal from water. Journal of Fluorine Chemistry 2010; 131(3): 373-377.##9.	Miretzky P, Cirelli AF. Fluoride removal from water by chitosan derivatives and composites: A review. Journal of Fluorine Chemistry 2011; 132(4): 231-240.##10.	Chen N, Zhang Z, Feng C, Sugiura N, Li M, Chen R. Fluoride removal from water by granular ceramic adsorption. Journal of Colloid and Interface Science 2010; 348(2): 579-584.##11.	Asgari G, Roshani B, Ghanizadeh G. The investigation of kinetic and isotherm of fluoride adsorption onto functionalize pumice stone. Journal of Hazardous Materials 2012; 217-218: 123-132.##12.	Kumar E, Bhatnagar A, Ji M, Jung W, Lee S-H, Kim S-J, et al. Defluoridation from aqueous solutions by granular ferric hydroxide (GFH). Water Research 2009; 43(2): 490-498.##13.	Wu X, Zhang Y, Dou X, Yang M. Fluoride removal performance of a novel Fe–Al–Ce trimetal oxide adsorbent. Chemosphere 2007; 69(11): 1758-1764.##14.	Kemer B, Ozdes D, Gundogdu A, Bulut VN, Duran C, Soylak M. Removal of fluoride ions from aqueous solution by waste mud. Journal of Hazardous Materials 2009; 168: 888-894.##15.	Cengeloglu Y, Kır E, Ersoz M. Removal of fluoride from aqueous solution by using red mud. Separation and Purification Technology 2002; 28: 81-86.##16.	Meenakshi S, Sundaram CS, Sukumar ##R. Enhanced fluoride sorption by mechanochemically activated kaolinites. Journal of Hazardous Materials 2008; 153(1): 164-172.##17.	Bhatnagar A, Kumar E, Sillanpää M. Fluoride removal from water by adsorption—a review. Chemical Engineering Journal 2011; 171(3): 811-840.##18.	Horvat T, VidakoviC-Cifrek Z, Orescanin V, Tkalec M, Pevalek-Kozlina B. Toxicity assessment of heavy metal mixtures by Lemna minor L. Science of the Total Environment 2007; 384: 229-238.##19.	Zazouli MA, Balarak D, Mahdavi Y. Pyrocatechol Removal From Aqueous Solutions by Using Azolla Filiculoides. Health Scope 2013; 2(1): 25-30.##20.	Diyanati RA, Yousefi Z, Cherati JY, Balarak D. Adsorption of phenol by modified azolla from Aqueous Solution. J Mazand Univ Med Sci 2013; 22(2): 13-21.##21.	Zazouli MA, Balarak D, Mahdavi Y, Ebrahimi M. Adsorption rate of 198 reactive red dye from aqueous solutions by using activated red mud. Iranian Journal of Health Sciences 2013; 1(1): 29-40.##22.	Diyanati RA, Yazdani J, Belarak D. EEffect of sorbitol on phenol removal rate by lemna minor. J Mazand Univ Med Sci 2013; 22(2): 58-64.##23.	Zazouli MA, Yazdani J, Balarak D, Ebrahimi M, Mahdavi Y. Removal Acid Blue 113 from Aqueous Solution by Canola. J Mazand Univ Med Sci 2013; 23(Suppl 2): 71-78.##24.	Mahvi AH, Boldaji MR, Dobaradaran S. Evaluating the Performance of Iron Nano-particle Resin in Removing Fluoride from Water. Water and Wastewater 2009;21(76 )       : 33-38.##25.	Malakootian M, Yousefi N, Haghighifard NJ. Kinetics modeling and isotherms for adsorption of phosphate from aqueous solution by modified clinoptilolite. Water and Wastewater 2010;22 ( 80): 21-30.##26.	Hameed BH. Evaluation of papaya seeds as a novel non-conventional low-cost adsorbent for removal of methylene blue. Journal of Hazardous Materials 2009; 162(2-3): 939-944.##27.	Zazouli MA, Balarak D. Effect of Azolla filiculoides on removal of reactive red 198 in ##aqueous solution. Journal of Advance in Environmental Health Research 2013; 1(1): 44-50.##28.	Zazouli MA, Balarak D. Application of azolla filiculoides biomass for 2-Chlorophenol and 4-Chrorophenol Removal from aqueous solutions. Iranian Journal of Health Sciences 2013; 1(2): 43-55.##29.	Bulut Y, Baysal Z. Removal of Pb(II) from wastewater using wheat bran. Journal of Environmental Management 2006; 78: 107-113.##30.	Deng L, Su Y, Su H, Wang X, Zhua X. Sorption and desorption of lead (II) from wastewater by green algae Cladophora fascicularis. Journal of Hazardous Materials 2007; 143: 220-225.##31.	Zazouli MA, Balarak D, Mahdavi Y, Barafrashtehpour M, Ebrahimi M. Adsorption of Bisphenol from Industrial Wastewater by Modified Red Mud. Journal of Health &#38; Development 2013; 2(1): 1-11.##32.	Pajooheshfar SP. Survey Removal of phenol from contaminated water using activated carbon and carbon skin almonds and walnuts. Environmental Science and Technology 2009; 10(4): 219-233.##33.	Shokohi R, Jafari Z. removal dye Acid Blue 113 from aqueous environment by adsorption on Activated red mud. Medical Kordestan 2011; 16: 55-65.##34.	Wajima T, Umeta Y, Narita S, Sugawara K. Adsorption behavior of fluoride ions using ##a titanium hydroxide-derived adsorbent. Desalination 2006; 249: 323-330.##35.	Kamble SP, Jagtap S, Labhsetwar NK, Thakare D, Godfrey S, Devotta S, et al. Defluoridation of drinking water using chitin, chitosan and lanthanummodified chitosan. Chemical Engineering Journal 2007; 129: 173-180.##36.	Tang T, Guan X, Wang J, Gao N, McPhail M, Chusuei C. Fluoride adsorption onto granular ferric hydroxide: Effects of ionic strength, pH, surface loading, and major co-existing anions. Journal of Hazardous Materials 2009; 171: 774-779.##37.	Asgari G, Sidmohammadi A, Ebrahimi A, Gholami Z, Hoseinzadeh E. Study on phenol removing by using modified zolite (Clinoptilolite) with FeCl3 from aqueous solutions. Health System. 2010; 6: 848-857. ## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>مقایسه مشکلات تنظیم هیجانی در افراد با رفتارهای جنسی پرخطر و عادی</TitleF>
		<TitleE>Emotion Dysregulation in Individuals with Risky Sexual Behaviors and Normal People</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف :در سال های اخیر مشکلات تنظیم هیجانی ب ه عنوان یکی از عوامل م ؤثر و تعیین کننده در گرایش افراد
به ویژه جوانان و نوجوانان به رفتارهای پرخطر معرفی شده اند و از آن جایی که رفتارهای جنسی پرخطر در زمره رفتارهایی
هستند که می توانند سبب آسی ب های جدی به فرد و جامعه شوند، مطالعه متغیرهای تعیین کننده و مرتبط با آن ها حائز
اهمیت است . بنابراین، هدف مطالعه حاضر بررسی مشکلات تنظیم هیجانی در افراد دارای رفتارهای پرخطر جنسی در
مقایسه با افراد عادی می باشد.
مواد و روش ها: روش این پژوهش توصیفی از نوع علی مقایس ه ای بود. برای دستیابی به هدف از بین افراد مراجع هکننده به
مرکز مبارزه با بیماری های رفتاری شهر ارومیه طی سال های 1384 تا 1390 نمونه ای 80 نفری انتخاب شد . جهت مقایسه ،
گروهی از افرادی که از نظر سن، جنس و تحصیلات با گروه نخست همتا شده بودند ، انتخاب گردیدند . روی هر دو گروه
گروه های وابسته استفاده شد. t آزمون دشواری های تنظیم هیجانی گرتز و رومر اجرا گردید. جهت تحلیل داده ها از آزمون
یافته ها:: بین نمره کل و تمام م ؤلفه های مشکلات تنظیم هیجانی در دو گروه مطالعه تفاوت معنی دار وجود داشت و
.(p&#60;0/ و 05 p&#60;0/ میانگین گروه دارای رفتار پرخطر جنسی به صورت معنی داری بیش تر از گروه همتا بود ( 01
استنتاج: با توجه به وجود دشواری های تنظیم هیجان در گروه دارای رفتارهای پرخطر جنسی در قیاس با گ روه همتا
پیشنهاد می شود برنامه های آموزش مدیریت و تنظیم هیجانی در زمره برنامه های پیشگیری اجتماعی قرار گرفته و درما ن های
مبتنی بر کاهش دشواری های خودتنظیمی هیجانی به عنوان یک گزینه در مراکز درمانی مورد توجه قرار گیرد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: In recent years, emotion dysregulation has been introduced as one
of the most effective factors in tendency of people, especially young people, for risky behaviors. Risky
sexual behaviors could result in serious social and individual damages, therefore, study of determinant
variables are considered important. The present study aimed at investigating emotional dysregulation in
people with risky sexual behaviors in comparison with ordinary people.
Material and methods: This descriptive comparative study was performed in eighty people
with behavioral disorders attending Urmia City counseling centers between 2005-2011. Another group
was also selected which was matched with the first group in terms of age, sex and educational
background. Difficulties in Emotion Regulation Scale (DERS Gratz &#38; Roemer, 2004) were applied for
both groups. Dependent group’s T- test was used in this study.
Results: The results indicated a significant difference between total score and all components of
emotional problems in both groups and the mean of total score in group with sexual risky behavior was
significantly higher than that of the control group (P&#60;0.01, P&#60;0.05, respectively).
Conclusion: This study showed various problems in emotional regulation in the group with risky
sexual behaviors hence, more training on emotional regulation and management are recommended.
Furthermore, treatments based on reducing emotional self-regulatory problems should be considered as an
alternative in treatment centers.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>206</FPAGE>
			<TPAGE>214</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/9
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/20
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/9
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/20
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>فرزانه</Name>
				<MidName></MidName>
				<Family>میکائیلی منیع</Family>
				<NameE></NameE>
				<MidNameE></MidNameE>
				<FamilyE></FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>atrtaghizade@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Emotion dysregulation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>risky sexual behavior</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تنظیم هیجانی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>مشکلات تنظیم هیجانی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>رفتارهای جنسی پرخطر</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Aldao A, Nolen-Hoeksema S, Schweizer ##S. Emotion-regulation strategies across psychopathology: A meta-analytic review. CLIN PSYCHOL REV 2010; 30(2): 217-237.##2.	Eftekhari A, Zoellner LA, Vigil SA. Patterns of emotion regulation and psychopathology. Anxiety, Stress, &#38; Coping 2009; 22(5): 571-586.##3.	Rothermund K, Voss A, Wentura D. Counter-regulation in affective attentional bias: Abasicmechanism thatwarrants flexibility in motivation and emotion. Emotion 2008; ##8( 1): 34-46.##4.	Hamilton NA, Karoly P, Gallagher M, Stevens N, Karlson C, McCurdy D. The Assessment of Emotion Regulation in Cognitive Context: The Emotion Amplification and Reduction Scales. Cogn Ther Res 2009; 33(7): 255-263.##5.	Graziano PA, Reavis Rd, Keane SP, Calkins Sd. The role of emotion regulation in children\'s early academic success. J SCHOOL PSYCHOL 2007; 45(1 ): 3-19.##6.	Hilt L, Hanson J, Pollak SD. Emotion Dysregulation. In B. Brown and M. Prinstein (Eds.), Encyclopedia of Adolescence, vol. 3, Elsevier, 2011; p. 160-169.##7.	Cole PM, Michel MK, O’Donnell Teti L. The development of emotion regulation ##and dysregulation: A clinical perspective. Monographs of the Society for Research in Child Development 1994; 59: 73-100.##8.	Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale. J PSYCHOPATHOL BEHAV ASSESS 2004; 26( 1): 41-54.##9.	Newhill CE, Bell MM, Eack SM, Mulvey EP. Confirmatory Factor Analysis of the Emotion Dysregulation Measure. JSSWR 2010; 1(3): 159-168.##10.	Mennin DS, Farach FJ. Emotion and evolving treatments for adult psychopathology. CLIN PSYCHOL-SCIPR. 2007; 14( 4 ): 329-352.##11.	Liverant GI, Brown TA, Barlow DH, Roemer L. Emotion regulation in unipolar depression: The effects of acceptance and suppression of subjective emotional experience on the intensity and duration of sadness and negative affect. BEHAV RES THER 2008; 46(11 ): 1201-1209.##12.	Trosper SE, Buzzella BA, Bennett SM, Ehrenreich JT. Emotion Regulation in Youth with Emotional Disorders: Implications for a Unified Treatment Approach. Clin Child Fam Psychol Rev 2009; 12( 3 ): 234-254.##13.	Harrison A, Tchanturia K, Treasure J. Attentional Bias, Emotion Recognition, and Emotion Regulation in Anorexia: State or Trait? Biol Psychiatry 2010; 68( 8 ): 755-761.##14.	Roemer L, Lee JK, Salters-Pedneault K, Erisman SM, Orsillo SM, Mennin DM. Mindfulness and Emotion Regulation Difficulties in Generalized Anxiety Disorder: Preliminary Evidence for Independent and Overlapping Contributions. Behavior Therapy 2009; 40( 2 ): 142-154.##15.	Huebner A, Howell L. Examining the relationship between adolescent sexual risk-taking and perceptions of monitoring, communication, and parenting styles. J ADOLESCENT HEALTH 2003; 33(7): 71-78.##16.	Madise N, Zulu E, Ciera J. Is Poverty a Driver for Risky Sexual Behaviour? Evidence from National Surveys of Adolescents in four African Countries. Afr J Reprod Health 2007; 11(3): 83-98.##17.	Strathdee SA, Hogg RS, Martindale SL, Cornelisse PG, Craib KJ, Montaner JS, O\'Shaughnessy MV, Schechter MT. Determinants of sexual risk-taking among young HIV-negative gay and bisexual men. J Acquir Immune Defic Syndr 1998; ##19(1): 61-66.##18.	Beck A, McNally I, Petrak I. Psychosocial predictors of HIV/STI risk behaviours in a sample of homosexual men. Sex Transm Infect 2003; 79( 2 ): 142-146.##19.	Cooper ML. Alcohol use and risky sexual behavior among college students and youth. J STUD ALCOHOL 2002; 14(Suppl): 101-117.##20.	Hendershot C, Stoner S, George W, Norris J. Alcohol use, expectancies, and sexual sensation seeking as correlates of HIV risk behavior in heterosexual young adults. PSYCHOL ADDICT BEHAV 2007; 21(3): 365-372.##21.	Meade C, Graff F, Griffin M, Weiss R. HIV risk behavior among patients with co-occurring bipolar and substance use disorders: Associations with mania and drug abuse. DRUG ALCOHOL DEPEN 2008; 92(1-3): 296-300.##22.	Donenberg GR, Emerson E, Bryant FB, Wilson H, Weber-Shifrin E. Understanding AIDS-risk behavior among adolescents in psychiatric care: Links to psychopathology and peer relationships. J Am Acad Child Adolesc Psychiatry 2001; 40(6): 642-653.##23.	Caminis A, Henrich C, Ruchkin V, Schwab-Stone M, Martin A. Psychosocial predictors of sexual initiation and high-risk sexual behaviors in early adolescence. CAPMH 2007; 1(14): 1-14.##24.	Cooper LM, Wood PK, Orcutt HK, Albino A. Personality and the predisposition to engage in risky or problem behaviors during adolescence. J PERS SOC PSYCHOL 2003; 84( 2 ): 390-410.##25.	Byrnes JP. The development of self-regulated decision making. In: The development of judgment and decision making in children and adolescents. Jacobs JE, Klaczynski PA, (eds). Mahwah, NJ: Lawrence Erlbaum Associates; 2005; p. 5-38.##26.	Steinberg L. Cognitive and affective development in adolescence. TRENDS COGN SCI 2005; 9( 2 ): 69-74.##27.	Auerbach RP, Abelaa JRZ, Ho M-HR. Responding to symptoms of depression and anxiety: Emotion regulation, neuroticism, and engagement in risky behaviors. BEHAV RES THER 2007; 45( 9 ): 2182-2191.##28.	Mc Laughlin KA, Hatzenbuehler ML, Mennin DS, Nolen-Hoeksema S. Emotion dysregulation and adolescent psychopathology: A prospective study. BEHAV RES THER 2011; 49(19): 544-554.##29.	Mikolajczak1 M, Petrides KV, Hurry J. Adolescents choosing self-harm as an emotion regulation strategy: The protective role of trait emotional intelligence. BRIT J CLIN PSYCHOL 2009; 48( 2 ): 181-193.##30.	Fox HC, Axelrod SR, Paliwal P, Sleeper J, Sinha R. Difficulties in emotion regulation and impulse control during cocaine abstinence. DRUG ALCOHOL DEPEN 2007; 89(2-3): 298-301.##31.	Fox HC, Hong KA, Sinha R. Difficulties in emotion regulation and impulse control in recently abstinent alcoholics compared with social drinkers. Addictive Behaviors 2008; 33(2 ): 388-394.##32.	Ridanovic Z. AIDS and Islam. Medicinski Archiv 1997; 51: 45-46.##33.	Azizi A, Mirzaei A, Shams J. Correlation between Distress Tolerance and Emotional Regulation with Students Smoking Dependence. Hakim Research Journal 2010; 13(1): 11-18 (Persian.)##34.	Anestis MD, Bagge CL, Tull MT, Joiner TE. Clarifying the role of emotion dysregulation in the interpersonal-psychological theory of suicidal behavior in an undergraduate sample. J PSYCHIAT RES 2011; 45(5): 603-611.##35.	Deckman T, DeWall NC. Negative urgency and risky sexual behaviors: A clarification of the relationship between impulsivity and risky sexual behavior. PERS INDIV DIFFER 2011; 51(5): 674-678.##36.	Kahn JA, Kaplowitz RA, Goodman E, Emans SJ. The association between impulsiveness and risky sexual behaviors in adolescent and young adult women. J ADOLESCENT HEALTH 2002; 30(4): 229-232.##37.	Walsh K, DiLillo D, Scalora M. The cumulative impact of sexual revictimization on emotion regulation difficulties: An examination of female inmates. Violence Against Women 2011; 17( 8): 1103-1118.##38.	Walsh K, DiLillo D. Messman-Moore TL. Lifetime sexual victimization and poor risk perception: Does emotion dysregulation account for the links? J INTERPERS VIOLENCE 2012; 27(15): 3054-3071.##39.	Messman-Moorea TL, Walsh KL, DiLillo D. Emotion dysregulation and risky sexual behavior in revictimization. Child Abuse &#38; Neglect 2010; 34( 12): 967-976.##40.	Tull MT, Weiss NH, Adams CE, Gratz KL. The contribution of emotion regulation difficulties to risky sexual behavior within a sample of patients in residential substance abuse treatment. Addictive Behaviors 2012; 37(10): 1084-1092.##41.	Feldman BL, Gross JJ, Christensen TC, Benvenuto M. Knowing what you\'re feeling and knowing what to do about it: Mapping the relation between emotion differenttiation and emotion regulation. Cognition and Emotion 2001; 15( 6): 713-724.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>اثر آدیپونکتین بر بیان ژن استئونکتین در رده سلولی عضله صاف رگ</TitleF>
		<TitleE>Adiponectin Effects on Osteonectin Gene Expression in Vascular Smooth Muscle Cell Line</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف : آترواسکلروز یکی از دلایل عمده مرگ و میر در بزرگ سالان در اکثر جوامع است، بیش تر مطالعات
بر نقش محافظتی آدیپونکتین و خواص ضد التهابی آن متمرکز بوده و نقش آن برکلسیفیه شدن عروق کم تر مورد توجه
بوده است . بنابراین مطالعاتی که به مشخص کردن مکانیسم و علل کلسیفیه شدن کمک کند ، می توانند ارزشمند باشند .
هدف این مطالعه بررسی اثر هورمون آدیپونکتین بر بیان ژن استئونکتین که یکی از پروتئین های م ؤثر در کلسیفیه شدن
عروق است، می باشد.
مواد و روش ها: در این مطالعه تجربی، سلول های عضلانی صاف عروق از انستیتو پاستورایران تهیه و در محیط
5 μg/ml حاوی بتاگلیسروفسفات به عنوان محرک کلسیفیه شدن ، کشت شدند . سلول ها با غلظت F12K کشت
آدیپونکتین تیمار گردید و در زمان های 24 و 48 ساعته ، بیان ژن استئونکتین در این سلول ها در مقابل کنترل با استفاده از
مورد بررسی قرار گرفت. Real time PCR تکنیک
یافته ها: :آدیپونکتین بیان ژن استئونکتین را در سلول های عضلات صاف رگ ها در زمان های 24 و 48 سا عته نسبت
3 بار افزایش می دهد. / 2 و 6 / به کنترل به ترتیب 17
استنتاج: آدیپونکتین با افزایش بیان ژن استئونکتین می تواند به عنوان یک عامل خطر در تشدید کلسیفیکاسیون در
آترواسکلروز عمل کند.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Atherosclerosis is a major cause of death in adults in most countries.
Many studies have focused on the protective role and anti-inflammatory properties of adiponectin but its
role in calcification has been less studied. Studies that could determine the causes and mechanisms of
calcification could be of great value. The aim of this study was to investigate the effects of adiponectin on
osteonectin gene expression, a protein involved in vascular calcification.
Materials and methods: In this experimental study, vascular smooth muscle cells were obtained
from Pasteur Institute of Iran and were cultured in F12K medium containing β-glycerophosphate as
calcifying stimuli. The cells were treated with 5μg/ml adiponectin. At 24 and 48 hours osteonectin gene
expression in these cells was studied against control cells using real time PCR.
Results: We observed that adiponectin increased osteonectin gene expression against control
cells 2.17 and 3.6 fold in vascular smooth muscle cells at 24 and 48 hours, respectively.
Conclusion: Increasing the expression of osteonectin gene lead to increases in calcification,
therefore, adiponectin could be considered as a risk factor for atherosclerosis.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>216</FPAGE>
			<TPAGE>222</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/18
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/29
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/18
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/29
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>سارا</Name>
				<MidName></MidName>
				<Family>نیکنام</Family>
				<NameE>Sara</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Niknam</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>کیهان</Name>
				<MidName></MidName>
				<Family>قطره سامانی</Family>
				<NameE>Keihan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghatreh Samani</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>kgsamani@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>سید اسد الله</Name>
				<MidName></MidName>
				<Family>امینی</Family>
				<NameE>Seyed Asadollah</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Amini</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>عفت</Name>
				<MidName></MidName>
				<Family>فرخی</Family>
				<NameE>Effat</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Farokhi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Atherosclerosis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>vascularsmooth muscle cells</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>adiponectin</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>osteonectin.</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>آترواسکلروز</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سلول های صاف دیواره رگ ها</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>آدیپونکتین</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>استئونکتین</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Ding M, Xie Y, Wagner RJ, Jin Y, Carrao AC, Liu LS, et al. Adiponectin induces vascular smooth muscle cell differentiation via repression of mammalian target of rapamycin complex 1 and FoxO4. Arteriosclerosis, Thrombosis, and Vascular Biology 2011; 31(6): 1403-1410.##2.	Morrison Ph. Melloni\'s Illustrated Medical Dictionary. 2nd ed. New York: Scientific American, Inc; 2006.##3.	Topol EJ, Califf RM. Textbook of cardiovascular medicine: Lippincott Williams &#38; Wilkins; 2007.##4.	Bentzon JF, Falk E. Pathology of stable and acute coronary syndrome. In: Acute Coronary Syndromes; A companion to Braunwald’s Heart Disease. Threroux P. 1st ed. Saunders; 2003. p. 67-79.##5.	Hansson GK. Inflammation, atherosclerosis and coronary artery disease. New England ##Journal of Medicine 2005; 352: 1685-1695.##6.	Janzen J, Vuong P. Arterial calcifications: morphological aspects and their pathological implications. Zeitschrift für Kardiologie 2001; 90(3): III6-III11.##7.	Li JJ, Zhu CG, Yu B, Liu YX, Yu MY. The role of inflammation in coronary artery calcification. Ageing Research Reviews 2007; 6(4): 263-270.##8.	Demer LL, Tintut Y. Vascular calcification pathobiology of a multifaceted disease. Circulation 2008; 117(22): 2938-2948.##9.	Shioi A, Mori K, Jono S, Wakikawa T, Hiura Y, Koyama H, et al. Mechanism of atherosclerotic calcification. Zeitschrift für Kardiologie 2000; 89(2): S075-S079.##10.	Boström K, Demer LL. Regulatory mechanisms in vascular calcification. Crit Rev Eukaryot Gene Expr 2000; 10(2): 151.##11.	Boström K, Watson K, Horn S, Wortham C, Herman I, Demer L. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993; 91(4): 1800.##12.	Steitz SA, Speer MY, Curinga G, Yang H-Y, Haynes P, Aebersold R, et al. Smooth muscle cell phenotypic transition associated with calcification upregulation of cbfa1 and downregulation of smooth muscle lineage markers. Circulation Research 2001; 89(12): 1147-1154.##13.	Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arteriosclerosis, Thrombosis, and Vascular Biology 2001; 21(12): 1998-2003.##14.	Wallin R, Wajih N, Greenwood GT, Sane DC. Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy. Medicinal Research ##Reviews 2001; 21(4): 274-301.##15.	Ragino YI, Kashtanova E, Chernjavski A, Volkov A, Polonskaya YV, Tsimbal SY, et al. Blood Level of Osteonectin in Stenosing Atherosclerosis and Calcinosis of Coronary Arteries. Bulletin of Experimental Biology and Medicine 2011; 151(3): 370-373.##16.	Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiposeMost Abundant Gene Transcript 1). Biochem Biophys Res Commun 1996; 221(2): 286-289.##17.	Ekmekci H, Ekmekci OB. The role of adiponectin in atherosclerosis and thrombosis. Clinical and applied thrombosis/ hemostasis. 2006; 12(2): 163-168.##18.	Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 2000; 102(11): 1296-1301.##19.	Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000; 96(5): 1723-1732.##20.	Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules adipocyte-derived plasma protein adiponectin. Circulation 1999; 100(25): 2473-2476.##21.	Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103(8): 1057-1063.##22.	Yamauchi TKJ, Waki T. The fat derived hormone adiponectin reserves insulin resistance associated with both lipoatrophy and obesity. 2000.##23.	Shimada K, Miyazaki T, Daida H. Adiponectin and atherosclerotic disease. Clinica Chimica Aacta 2004; 344(1): 1-12.##24.	Tsubakio-Yamamoto K, Matsuura F, Koseki M, Oku H, Sandoval JC, Inagaki M, et al. Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages. Biochemical and Biophysical Research Communications 2008; 375(3): 390-394.##25.	Kizer JR, Barzilay JI, Kuller LH, Gottdiener JS. Adiponectin and risk of coronary heart disease in older men and women. Journal of Clinical Endocrinology &#38; Metabolism 2008; 93(9): 3357-3364.##26.	Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. Journal of Biological Chemistry 2004; 279(2): 1304-1309.##27.	Wannamethee SG, Welsh P, Whincup PH, Sawar N, Thomas MC, Gudnarsson V, et al. High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? Eur J Cardiovasc Prev Rehabil 2011; 18(1): 65-71.##28.	Luo XH, Luo XH, Zhao LL, Yuan LQ, Wang M, Xie H, et al. Development of arterial calcification in adiponectin-deficient mice: adiponectin regulates arterial calcification. J Bone Miner Res 2009; 24(8): 1461-1468.##29.	Luo XH, Guo LJ, Yuan LQ, Xie H, Zhou HD, Wu XP, et al. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Experimental Cell Research 2005; 309(1): 99-109.##30.	Luo XH, Zhao LL, Yuan LQ, Wang M, Xie H, Liao EY. Development of Arterial Calcification in Adiponectin Deficient Mice: Adiponectin Regulates Arterial Calcification. Journal of Bone and Mineral Research 2009; 24(8): 1461-1468.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>رابطه روان رنجورخویی، برون گرایی، عاطفه مثبت و عاطفه منفی با اختلال های روانی</TitleF>
		<TitleE>Relationship of Neuroticism, Extraversion, and Positive and Negative Affect with Mental Disorders</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: تاکنون در مورد رابطه شخصیت و سلامت روان پژوهش‌هایی انجام شده است، اما این موضوع نیازمند پژوهش‌ها و توجه بیش‌تری است، از این رو پژوهش حاضر با هدف تعیین رابطه روان‌رنجورخویی، برون گرایی، عاطفه مثبت و عاطفه منفی با اختلال‌های روانی انجام گرفت.
مواد و روش‌ها: پژوهش حاضر از نوع همبستگی- توصیفی بود. جامعه آماری پژوهش شامل کلیه دانشجویان دانشگاه پیام نور هرسین بود که به شیوه نمونه‌گیری تصادفی ساده، 350 نفر انتخاب شدند. برای گردآوری داده‌ها از پرسشنامه‌های ویژگی‌های شخصیتی آیزنک، نشانگان اختلال‌های روانی (SCL-90) و مقیاس عاطفه منفی و مثبت استفاده شد. برای تحلیل داده‌ها از شاخص های آماری ضریب همبستگی پیرسون، همبستگی بنیادی و تحلیل رگرسیون استفاده شد.
یافته‌ها: : نتایج  نشان داد که بین روان‌رنجورخویی و عاطفه منفی با اختلال‌های روانی رابطه مثبت بین برون‌گرایی و عاطفه مثبت با اختلال های روانی رابطه منفی وجود دارد. هم‌چنین نتایج نشان داد که برون گرایی در مقایسه با متغیرهای مورد بررسی سهم کم‌تری در رابطه با اختلال‌های روانی دارد و در پیش‌بینی نمره کل نقش معنی‌داری ندارد.
استنتاج: براساس نتایج پژوهش می‌توان نتیجه گرفت بین ویژگی‌های شخصیتی روان رنجور خویی و برون‌گرایی و عاطفه منفی و مثبت با اختلال‌های روانی رابطه وجود دارد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Some researches has been done on the relationship between personality and mental health, however, this subject requires further study and consideration. This research was carried out so as to investigate the relationship of neuroticism, extraversion, positive affect and negative affect with mental disorders.
Materials and methods: The present study is a descriptive of correlation type. The research population included all the students at Payame Noor University of Harsin, Iran. Among those 350 were selected using simple random method. For data collection questionnaires of SCL-90, Eysenck personality and positive and negative affect scales (PANAS-X) were applied. Statistical indices such as correlation and regression were used.
Results: The results showed that mental disorders are positively correlated with neuroticism and negative affect but a negative correlation was found between extraversion and positive affect. It was also found that extraversion has a weak effect in mental disorders compared to other considered factors. Therefore, it does not have a significant role in the prediction of total score.
Conclusion: This study indicated a relationship between personality traits of neuroticism, extraversion, and positive and negative affect with mental disorders.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>224</FPAGE>
			<TPAGE>233</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/182014/03/3
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/12/12
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/182014/03/3
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/12/12
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>علی</Name>
				<MidName></MidName>
				<Family>زکی یی</Family>
				<NameE>Ali</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Zakiee</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>سمیرا</Name>
				<MidName></MidName>
				<Family>رستمی</Family>
				<NameE>Samira</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Rostami</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>سعید</Name>
				<MidName></MidName>
				<Family>کماسی</Family>
				<NameE>Saeed</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Kamasi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Neuroticism</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>extraversion</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>positive affect</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>negative affect</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>mental disorders</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>روان رنجورخویی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>برون گرایی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>عاطفه مثبت</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>عاطفه منفی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>اختلال‌های روانی</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	American psychiatric association. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. Washington, DC: Author; 2007.##2.	Ahmadvand M, Sepehrmanesh Z, Ghoreishi F, Asarian F, Mosavi G, Saei R, et al. Prevalence of mental disorders in the general population in Kashan city. Iranian Journal of Epidemiology Specialty 2010; 6(2): 16-24.##3.	Eysenck HJ. The definition of personality disorders and the criteria appropriate for their description. Journal of Personality Disorders 1987; 1: 211-219.##4.	Tajar J. Psychology of personality assessment methods. Ghom: Bahman Ara; 2006.##5.	Darabi H. Psychology of personality. Tehran: Abiz; 2009.##6.	Mansoor M. Juvenile and Addiction. J Psych 1998; 1(3): 203-207.##7.	Eysenk HJ. Dimensions of Personality. New Brun swick, NJ: Transaction; 1998.##8.	Eksi H. Personality and coping: Multidimensional research on situational and dispositional coping. Educational Sciences Theory &#38; Practice 1998; 4(1): 100-104.##9.	Hayes N, Joseph S. Big 5 correlate of threemeasures of subjective well-being. Personality &#38; Individual 2003; 2(9): 25-31.##10.	Aghayosefi A, Behroozian S, Saadipoor ##E. Relationship between personality characteristics and emotionaland mental health treatment for people with Phenylketonuria. Research on Exceptional Children 2008; 8(4): 370-381.##11.	Khodaei A, Shokri O. The role ofpersonality traits andcoping stylesin student mental health. Cognitivescience 2008; 1: 28-38.##12.	Farhoodian, A. Forgivenessand mental health variables. Cognitivescience 2008; 1(6): 76-77.##13.	Krueger RF, Mc Gue M, Iacono WG. ##The higher-order structure of common ##DSM mental disorders: internalization, externalization and their connections to personality. Personality and Individual Differences 2001; 30(9): 1245-1259.##14.	Clark LA, Watson D, Mineka S. Temperament, personality, and the mood and anxiety disorders. Journal of Abnormal Psychology 1994; 103(1): 103-116.##15.	Akiskal HS, Hirschfeld R, Yerevanina B. The relationship of personality to affective disorders. Archives of General Psychiatry 1983; 40: 801-810.##16.	Watson D, Clark LA. The PANAS-X manual for the positive and negative affect schedule- expanded form. Imc 1994; 103(1): 103-116.##17.	Crawford JR, Henry JD. The positive and negative affect schedule (PANAS): Construct validity, measurement properties and normative data in a large non-clinical sample. British Journal of Clinical Psychology 2004; 43(1): 245-265.##18.	Rashidi F, Ghodsi A, Shafihabadi A. The role of irrational beliefs on mental health of secondary school students in Tehran. New Journal of Educational Sciences 2009; 5(2): 65-49.##19.	Bagheri N. The Relationship between irrational beliefs and mental health of teachers in primary schools and city Branch in year 80-81. Master\'s thesis, School of Psychology University Teacher Education. 2001.##20.	Mandal SP, Arya WK, Pandey R. Mental Health and Mindfulness: Mediational Role of Positive and Negative Affect. SIS J Proj Psy &#38; Ment Health 2012; 19(6): 150-159.##21.	Shekibaei T. Distinct Effects of training on psychological problems of divorced women in Tehran. Journal of Psychology and Educational Sciences 2009; 7(2): 115-131.##22.	Anisi J, Akbari F, Majdian M, Atashkar M, Ghorbani Z. Standardization of mental disorders Symptoms Checklist 90 Revised (SCL-90-R) in Army Staffs. Journal of Military Psychology 2011; 2(5): 29-37.##23.	Pochon JB, Levy R, Fossati P, Lehericy S, Poline JB, Pillon B, et al. The neural system that bridgeges reward and cognition in humans: A fMRI study. Proceedings of the National Academy of Sciences 2002; 99(8): 5669-5674.##24.	Mohamadi N. Factor structure and mode hybrid forms of positive and negative- scale. Journal of Behavioral Sciences 2011; 5(1): 21-26.##25.	Askari S. Zakiei A, Alikhan M. Personality characteristics and locus of control in relation to readiness for addiction among male university students. Psychological Science 2011; 10(40): 485-498.##26.	Gryv S, Stordal E, Romild UK, Hellzen O. The Relationship among Neuroticism, Extraversion, and Depression in The HUNT Study: In Relation to Age and Gender. Mental Health Nursing 2012; 33(11): 777-785.##27.	Larsen RJ, Ketelaa T. Extraversion, neuroticism and susceptibility to positive and negative mood induction procedures. Department of Psychology, University of Michigan, Ann Arbor, MI 48109, U.S.A. Printed in Great Britain. All rights reserved. Person. in&#38;d. D# 1989; 10(12): 1221-1228.##28.	Diehl M, Hay EL, Berg KM. The Ratio between Positive and Negative Affect and Flourishing Mental Health across Adulthood. Aging Ment Health 2011; 15(7): 882-893.##29.	Timothy AB, Bruce FC, Barlow DH. Structural Relationships Among Dimensions of the DSM-IV Anxiety and Mood Disorders and Dimensions of Negative Affect, Positive Affect, and Autonomic Arousal. Journal of Abnormal Psychology 1998, 107(2): 179-192.##30.	Hu J, Gruber KJ. Positive and negative affect and health functioning indicators in older adults with chronic illnesses. Mental Health Nursing 2008; 29(8): 895-911.##31.	Verduyn P, Brans K. The relationship between extraversion, neuroticism and aspects of trait affect. Personality and Individual Differences 2012; 52: 664–669.##32.	Cloninger CR, Zohar AH. Personality and the perception of health and happiness. Journal of Affective Disorders 2011; 128: 24-32.##33.	Cloninger CR. Personality and Psychopathology (American Psychopathological Association Series). Washington, D.C.: American Psychiatric Press; 1999.##34.	Cloninger CR. Feeling Good: the Science of Well-Being. New York: Oxford University Press; 2004.##35.	Cloninger CR. The science of well-being: an integrated approach to mental health and its disorders. World Psychiatry 2006; 5: 71-76.##36.	Diener E, Biswas-Diener R. Happiness: Unlocking the Secrets of Psychological Wealth. Malden, MA: Blackwell Publishing; 2008.##37.	Herero VG, Extremera N. Daily life activities as mediators of the relationship between personality variables and subjective well-being among older adults. Personality and Individual Differences 2010; 49(2): 124-129.##38.	Josefsson K, Cloninger CR, Hintsanen M, Jokela M, Pulkki-R. back, L., &#38; Keltikangas- Jrvinen, L. Associations of personality profiles with various aspects of wellbeing: A population-based study. Journal of Affective Disorders 2011; 133: 265-273.##39.	Joseph S, Wood A. Assessment of positive functioning in clinical psychology: Theoretical and practical issues. Clinical Psychology Review 2010; 30(2): 830-838.##40.	Wood AM, Tarrier N. Positive Clinical Psychology: A new vision and strategy for integrated research and practice. Clinical Psychology Review 2010; 30(8): 819-829.##41.	Aboaja A, Duggan C, Park B. An exploratory analysis of the NEO-FFI and DSM personality disorders using multivariate canonical correlation. Personality and Mental Health 2011; 5(3): 1-11.##42.	Chan R, Joseph S. Dimensions of personality, domains of aspiration, and subjective well-being. Personality and Individual Differences, 2000; 28(4): 347-354.##43.	Gross JJ, Sutton SK, Ketelaar T. Relations Between Affect and Personality: Support for the Affect-Level and Affective-Reactivity Views. Personality &#38; Social Psychology 1998; 24(3): 279.##44.	Little LM, Simmons BL, Nelson DL. Health Among Leaders: Positive and Negative Affect, Engagement and Burnout, Forgiveness and Revenge. Journal of Management Studies 2007; 44(2): 0022-2380.##45.	Dzuka J, Dalbert C. Mental health and personality of Slovak unemployed adolescents: About the beliefs in a just world\'s impact. Journal of Applied Social Psychology 2002; 4(7): 732-757.##46.	Zakiei A. The relationship between Alexithymia, Ellis Irrational Beliefs, positive and negative affection on psychiatric disorders in Kermanshah Razi University students. Master\'s thesis, Psychology Group, University of Razi Kermansh. 2012.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>بررسی شیوع هپاتیت دارویی و عوامل مرتبط با آن در بیماران مبتلا به سل مراجعه کننده به بیمارستان رازی در طی سال های 1385 تا 1390</TitleF>
		<TitleE>Prevalence of Drug-Induced Hepatitis and its Risk Factors in the Treatment of Tuberculosis in TB Infected Patients Attending Razi Hospital, 2006-2011</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف : مسمومیت کبدی و افزایش بدون علامت مقدار آنزیم های کبدی یکی از عوارض جدی رژیم
درمانی ضد سل بوده که در برخی از موارد منجر به بروز هپاتیت می شود . لذا این مطالعه با هدف تعیین شیوع هپاتیت
دارویی و عوامل مرتبط با آن در بیماران مبتلا به سل مراجعه کننده به بیمارستان رازی انجام شده است.
85 با تشخیص قطعی - مواد و روش ها: این مطالعه به روش مقطعی روی پرونده تمامی بیماران ی که طی سال های 90
سل در بخش عفونی بیمارستان رازی قائم شهر بستری شده اند انجام شد . متغیرهای مورد بررسی شامل سن، جنس، نوع
بیماری سل، مصرف داروهای همراه، سط ح پایه آنزیم های کبدی، تغییرات آنزیمی حین درمان، عفونت ه م زمان (مانند
هپاتیت های ویروسی – ایدز ) بود. مبنای تشخیص هپاتیت دارویی افزایش حداقل پنج برابری آمینوترانسفرازها بود . اطلاعات
و آزمون دقیق فیشر مورد تجزیه و chi square با استفاده از آزمو ن های SPSS به دست آمده توسط نرم افزار آماری 17
0 به عنوان سطح معنی داری در نظر گرفته شد. / کم تر از 05 P تحلیل قرار گرفت و
8/ 91 درصد و سل خارج ریوی 3 / 56 درصد مذکر بودند . فراوانی سل ریوی 7 / یافته ها: از 230 بیمار تحت مطالعه 5
23 درصد از بیماران بیماری / 92 درصد از بیماران مب تلا به سل، از نوع استاندارد بود. 5 / درصد بوده است . نوع درمان در 5
9 درصد بوده و ارتباط معنی داری بین جنسیت ، نوع سل و نوع / زمینه ای داشتند . میزان شیوع هپاتیت دارویی در این مطالعه 5
درمان با هپاتیت دارویی وجود نداشت ولی بین گروه سنی و هپاتیت دارویی ارتباط معن یداری گزارش گردید.
استنتاج: نتایج مطالعه حاضر نشان داد که سن بالا یکی از عوامل خطر در ایجاد هپاتیت دارویی به دنبال درمان ضد
سل بوده است. به همین دلیل لازم است این دسته از بیماران تحت بررسی منظم بالینی و آزمایشگاهی قرار گیرند.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Hepatotoxicity and elevated serum aminotransferase is a severe side
effect of anti-Tuberculosis therapy and some cases could even develop hepatitis. This study aimed at
determining the prevalence of drug induced hepatitis and predisposing factor after anti-Tuberculosis
therapy in Razi hospital.
Materials and methods: In this cross-sectional study we used the medical records of all
confirmed cases of tuberculosis admitted at the infectious disease ward of Ghaemshahr Razi hospital
between 2006-2011. Variables included age, sex, type of TB, other medications, basal levels of liver
enzymes, enzyme changes during treatment, and co-infection (such as hepatitis B - HIV). The diagnosis
of drug induced hepatitis was done with at least five-fold increase of aminotransferase levels. Data was
analyzed using SPSS17, chi square tests and Fisher's exact test.
Results: Of 230 patients, 56.5% were male. The frequency of pulmonary TB and extra
pulmonary TB was 91.7% and 8.3%, respectively. Standard treatment was used in 92.5% of patients with
tuberculosis. 23.5% of patients had an underlying disease. Prevalence of drug-induced hepatitis in this
study was 9.5%. There was no significant correlation between gender, type of tuberculosis and type of
drug treatment with drug-induced hepatitis, but there was a significant relationship between age and druginduced
hepatitis.
Conclusion: The results showed that old age was the only significant risk factor for druginduced
hepatitis in the treatment of tuberculosis, hence, elderly patients must be placed under regular
clinical and laboratory evaluation.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>235</FPAGE>
			<TPAGE>239</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/182014/03/32014/02/16
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/27
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/182014/03/32014/02/16
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/27
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>مژگان</Name>
				<MidName></MidName>
				<Family>تیمورزاده بابلی</Family>
				<NameE>Mozhgan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Teymoorzadeh Baboli</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>الهام</Name>
				<MidName></MidName>
				<Family>یوسفی عبدالملکی</Family>
				<NameE>Elham</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Yousefi Abdolmaleki</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>محبوبه</Name>
				<MidName></MidName>
				<Family>شیرزاد</Family>
				<NameE>Mahbobeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Shirzad</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>محمد</Name>
				<MidName></MidName>
				<Family>عابدی سماکوش</Family>
				<NameE>Mohammad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Abedi Samakoosh</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>رویا</Name>
				<MidName></MidName>
				<Family>قاسمیان</Family>
				<NameE>Roya</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghasemian</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Drug-induced hepatitis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Tuberculosis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Anti-Tuberculosis therapy</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>هپاتیت دارویی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سل</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>درمان ضد سل</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Longo D, Fauci A, Kasper D, Hauser S, Jameson J, Loscalzo J. Harrison\'s Principles of Internal Medicine. 18th ed. New York: McGraw-Hill Education; 2011. p. 1006-1036.##2.	Shakya R, Subba B, CDC Recommendation against the Use of Rifampine and Pyrazinamide for Treatment of  Latene Tubercolosis infection. Morb Mortal Wkly Rep 2003; 52(31): 735-739.##3.	Kopanoff DE, Snider de Jr, Caras GJ. Isoniazide related hepatitis: a U.S Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978; 117(6): 991-1001.##4.	Nolan CM, Goldberg SV, Buskin SE. Hepatotoxicity Assiciated with Isoniazid Preventive Therapy. JAMA 1999; 281(11): 1014-1018.##5.	Lobue PA, Moser KS. Use of Isoniazid for Latent Tuberculosis infection in a public health clinic. AMJ Respir Crit Care Med 2003; 168(4): 443-447.##6.	Chan CH, Or KK, Cheung W, Woo J. Adverse drug reactions and outcome of elderly patients on antituberculosis chemotherapy with and without rifampicin. J Med 1995; 26(1-2): 43-52.##7.	Fernandez-Villar A, Sopena B, Vazquez R, Ulloa F, Fluiters E, Mosteiro M, et al. Isoniazid hepatotoxicity among drug users: the role of hepatitis C. Clin Infect Dis 2003; 36(3): 293-298.##8.	Patel PA, Voigt MD. Prevalence and interaction of hepatitis B and latent Tuberculosis in Vietnamese immigrants of The USA. Am G Gastroentrol 2006; 97(5): 1198-1203.##9.	Mitchison D, Davies G. The chemotherapy of tuberculosis: past, present and future. Int J Tuberc Lung Dis 2012; 16(6): 724-732.##10.	Mohammad Zadeh M, Behnaz F. Incidence of drugs associated with Hepatitis and risk factors in TB patients treated at Yazd health centers. J Shahid Sadoughi Univ Med Sci 1998; 6(2): 19-15 (Persian).##11.	Afsharian M, Meigouni SS, Janbakhsh A, Mansouri F, Vaziri S, Sayyad B, et al. Prevalence of Probable Drug-Induced Hepatitis following the Treatment of Tuberculosis in Kermanshah Sina Hospital (1996–2004). Behbood 2007; 11(3): 331-338 (Persian).##12.	Xia YY, Zhan SY. Systematic review of anti-tuberculosis drug induced adverse reactions in China. Zhonghua Jie He He Hu Xi Za Zhi 2007; 30(6): 419-423.##13.	Babalık A, Arda H, Bakırcı N, Ağca S, Oruç K, Kızıltaş S, et al. Management of and risk factors related to hepatotoxicity during tuberculosis treatment. Tuberk Toraks 2012; 60(2): 136-144.##14.	Marzuki OA, Fauzi AR, Ayoub S, Kamarul Imran M. Prevalence and risk factors of anti-tuberculosis drug-induced hepatitis in Malaysia. Singapore Med J 2008; 49(9): 688-693.##15.	Shigeto E. Survey of anti-tuberculosis drug-induced severe liver injury in Japan. Kekkaku 2007; 82(5): 467-473.##16.	International Union against Tuberculosis. Efficacy of various duration of Isoniazide preventive therapy for tuberculosis: five years of follow up in the IUAT trial. Bull World Health Organ 1982; 60(4): 555-565.##17.	Shakya R, Subba B, Shrestha B. Incidence of hepatotoxicity due to antitubercular medicine and assessment of risk factors. Ann Pharmacotherapy 2004; 38(6): 1074-1079.##18.	Dossing M, Wilcke JT, Askgaard DS, Nybo. Liver injury during antituberculosis treatment: an 11 year study. Tuber Lung Dis 1996; 77(4): 335-340.##19.	Schaberg T, Rebhan K, Lode H. Risk factors for side effects of Isoniazide, Rifampin and Pyrazinamide in patients hospitalized for pulmonary tuberculosis. Eur Respi J 1996; 9(10): 2026-2030.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>ارتباط سلامت روان با پیشرفت تحصیلی و متغیرهای دموگرافیک دانشجویان علوم پزشکی</TitleF>
		<TitleE>Relationship between Mental Health, Demographic Variables and Academic Achievement of Medical Sciences Students</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: اهمیت مطالعه سلامت روان در دانشگاه‌ها از این جهت که ارتباط مستقیمی با پیشرفت تحصیلی دانشجویان دارد ارزشمند است. هدف کلی پژوهش حاضر بررسی تأثیر سلامت روانی و متغیرهای دموگرافیک بر پیشرفت تحصیلی دانشجویان دانشگاه علوم پزشکی مازندران در سال 1391 بوده است.
مواد و روش‌ها: مطالعه حاضر از نوع توصیفی- مقایسه‌ای و مقطعی است. آزمودنی‌های پژوهش شامل 350 دانشجو در دانشکده‌های دانشگاه علوم پزشکی مازندران بودند که از طریق نمونه‌گیری طبقه بندی شده تصادفی انتخاب شدند. جهت گردآوری داده‌ها از پرسشنامه سلامت عمومی گلدبرگ (GHQ-28) استفاده شد.
یافته‌ها: 334 دانشجو به پرسشنامه‌ها پاسخ دادند که 153 نفر (8/45 درصد) مرد و 181 نفر (2/54 درصد) زن بودند. 8/45 درصد از دانشجویان دارای سلامت روانی خوب و 2/54 درصد مشکوک به اختلال در سلامت روانی بودند. بین متغیرهای سن، جنس، دانشکده، رتبه تولد، وضعیت والدین و نیمسال ورودی به دانشگاه با سلامت روانی دانشجویان تفاوت معنی‌داری دیده نشد (05/0p&#62;)، اما بین متغیر وضعیت ازدواج (034/0=p) و بین متغیرهای متوسط درآمد ماهیانه (001/0p&#62;) و نیز معدل تحصیلی (001/0p&#62;) با سلامت روانی رابطه معنی‌داری به دست آمد. هم‌چنین اکثر دانشجویان درجاتی از اختلالات مربوط به چهار بعد سوالات پرسشنامه را نشان دادند، که بیش‌ترین اختلال مربوط به بعد اختلال کارکرد اجتماعی بود.
استنتاج: با توجه به نتایج پژوهش حاضر از جمله همبستگی متقابل بین سلامت روانی و عملکردتحصیلی، افزایش مشکلات روانی و میزان موارد مشکوک به اختلال روانی در دانشجویان، توجه جدی به این موضوع جهت حل مشکلات بهداشت روانی دانشجویان و فعال‌سازی مراکز مشاوره دانشجویی امری ضروری است. لذا کمک مشاورین و اساتید و متخصصین، انجام برنامه‌ریزی جامع، و مداخله در امر ارتقاء سلامت روان جهت پیشگیری و درمان اختلالات روان‌شناختی برای پیشرفت تحصیلی دانشجویان مؤثر خواهد بود.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: The importance of studying mental health at universities is precious, because of expressed linkage to the students' educational progress. The main goal of the current research has been the study of effects of mental health on educational progress among students of Mazandaran University of Medical Sciences, in the year 2012.
Materials and methods: This research is a descriptive-comparative cross-sectional study. The subjects included 334 students, 153 males and 181 females of Mazandaran University of Medical Sciences which were selected through stratified random sampling. In order to gather the research data, the Goldberg's General Health Questionnaire (GHQ-28) was used.
Results: %45.8 of students had good mental health status, while %54.2 of them was suspected to have mental health disorders. Between age, gender, faculty, birth order, parental status, university entrance semester, and mental health of students, there were not significant differences (P≥ 0.05), but the variable "marital status" (P=0.034), the variable "average monthly earnings" (P≤0.001), and average grade points of students (P≤0.001) were related to their mental health. Another finding of the research showed that most of students had some degree of disorders linked to the four dimensions of questionnaires' queries, most disorders were social function.
Conclusion: Considering the results of this study, including the mutual correlation between mental health and academic performance, the high rate of mental problems and suspect cases of  mental disorders among the students, the serious attention to this issue is of high importance to  resolve the mental health problems of students and activating Students Consultancy Centers. Hence, the assistance of consultants, professors and specialists, comprehensive planning, and interventions towards the promotion of mental health to prevent and treat psychological disorders, will be effective for students' educational progress.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>241</FPAGE>
			<TPAGE>246</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/182014/03/32014/02/162014/02/5
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/16
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/182014/03/32014/02/162014/02/5
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/16
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>پیمان</Name>
				<MidName></MidName>
				<Family>پرویزراد</Family>
				<NameE>Peyman</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Parvizrad</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>جمشید</Name>
				<MidName></MidName>
				<Family>یزدانی چراتی</Family>
				<NameE>Jamshid</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Yazdani Charati</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>محمد رضا</Name>
				<MidName></MidName>
				<Family>صادقی</Family>
				<NameE>Mohammad Reza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sadeghi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>اکبر</Name>
				<MidName></MidName>
				<Family>محمدی</Family>
				<NameE>Akbar</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mohammadi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>هادی</Name>
				<MidName></MidName>
				<Family>حسینی</Family>
				<NameE>Hadi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hosseini</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>hadi hosaini69@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Mental Health</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Academic Achievement</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Students</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سلامت روانی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>پیشرفت تحصیلی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>دانشجویان</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Haddadi Koohsar AA, Roshan R, Asghar Nejad Farid AA. A Comparative Study of the Relationship Emotional Intelligence with Mental Health and Academic Achievement in Shahed and Non-Shahed Students in University of Tehran. J Psych Educ 2007; 37(1): 73-97 (Persian).##2.	Caplan RD, Cobb S, French JRP, John RP, Van Harrison R, Pinneau JSR. Job Demands and Worker Health. University of Michigan, Institute for Social Research, Ann Arbor 1980.##3.	Pakiezeh A. A Comparative Study of Students\' Mental Health Effects of Aactivation of the Concept of Spirituality on the Mental Health, Papers Collection of 4th Seminar of University Student\'s Mental Health, Shiraz University, Shiraz 2008: 76-79. Available from http://www.ensani.ir/fa/conte nt/124135/default.aspx. Accessed January 15, 2013 (Persian).##4.	Omokhodion FO. Psychosocial Problems of Pre-clinical Students in the University of Ibadan Medical School. Afr J Med Sci 2003; 32(2): 135-138.##5.	Behrouzian F, Neamatpour S. Stressors Coping Strategies and Their Relation with General Health ofFirst Year Students of Ahvaz University of Medical Sciences in 2005. Jundishapur Sci Med J 2007; 6(3): 276-284 (Persian)##6.	Noorbala AA, Bagheri Yazdi SA, Mohammad K. The Validation of General Health Questionnaire- 28 as a Psychiatric Screening Tool. Hakim Res J 2009; 11(4): 47-53 (Persian).##7.	Aghavi SMR. Validity and Reliability of the General Health Questionnaire (GHQ-28) in college students of Shiraz university. J Psychol 2002; 5(4(20)): 381-398 (Persian).##8.	Ahmadi Z, Sahbaei F, Mohammadzade SH, Mahmoodi M. Surveying Health Status in Nursing Students and Non-nursing Students of Islamic Azad University-Branch of Shahroodand Comparison Them with Others. Islam Azad Univ Med Sci J 2007; 17(2): 107-111 (Persian).##9.	Zeighami M, Pour Bahaadini Zarandi N. The Relationship between Academic Achievement and Students’ General Health and Coping Styles: A Study on Nursing, Midwifery and Health Students of Islamic Azad University-Kerman Branch. J Strides Dev Med Educ (SDME) 2011; 8(1): 41-48 (Persian).##10.	Tyssen R, Vaglum P, Grønvold NT, Ekeberg O. Factors in Medical School that Predict Postgraduate Mental Health Problems in Need of Treatment A Nationwide and Longitudinal Study. Med Educ 2001; 35(2): 110-120.##11.	Mehran M. Comparison of Anxiety in Medical Students with Students in Clinical Psychology, Master\'s Thesis, Islam Azad Univ. Roodehen Branch. 1997. 97-109 (Persian).##12.	Davidson L. Anxiety Disorders in College Students. J Psychol 1993; 14: 126-139.##13.	Karami S, Piraste A. The Survey of Mental Health Status in Zanjan Medical Sciences University Students. Sci J Zanjan Med Sci Uni 2002; 35: 66-73 (Persian).##14.	Tavakolizadeh J, Khodadadi Z. Assessment of Mental Health Among Freshmen Entering the First Semester inGonabad University of Medical Sciences in 2009-2010. Ofogh-e-Danesh 2010; 16(2): 45-51 (Persian).##15.	Shariati M, Kaffashi A, Ghaleh Bandy MF, Fateh A, Ebadi M. Mental health in Medical Students of the Iran University of Medical Sciences (IUMS). Payesh 2002; 1(3): 29-37 (Persian).##16.	Adham D, Salem-Safi P, Amiri M, Dadkhah B, Mohammadi M, Mozaffari N, et al. The Survey of Mental Health Status in Ardabil Medical Sciences College Students in 2007-2008. J Ardabil Med sci H Serv 2008; 8(3): 229-234 (Persian).##17.	Farokhbakhsh S, Gholamrezayee S, Nickpei A. Mental Health Survey of Students\' Academic. The Journal of Mental Health 2007; 8(33 &#38; 34): 61-66 (Persian).##18.	Abdollahi AA, Asayesh H, Jafari SY, Rezaiean M. Golestan Medical University Students\' Mental Health: When They Enter to University and One Year After. J Gorgan Bouyeh Fac Nurs Midwif 2011; 8(19): 52-58.##19.	Hosseini SH, Sadeghi A, Rajabzadeh R, RezaZadeh J, Nabavi SH, Ranayy M, et al. Mental Health in North Khorasan University of Medical Sciences And Related Factors in 2010. J N Khor Univ of Med Sci 2011; 2(3): 23-28 (Persian).##20.	Solaimanizadeh L, Solaimanizadeh F, Javadi M, Abasszadeh A. Association Between Mental Health and Educational Stressful Factors Among Students of Razi Nursing and Midwifery School in Kerman. Ir J Med Educ 2011; 11(3): 200-209 (Persian).##21.	Ansari H, Bahrami L, Akbarzade L, Bakhasani NM. Assessment of General Health and Some Related Factors among Students of Zahedan University of Medical Sciences in 2007, J Tabib-E-Shargh 2008; 9(4): 295-304 (Persian).##22.	Delaram M, Salehian T, Froozandeh N, Alidoosti M. Comparison of General Health in Droupout and Non-droupout Students of Shahrekord University of Medical Sciences. J Ilam Univ Med Sci 2012; 20(2): 1-8 (Persian).## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>بررسی غلظت ترکیبات شبه استروژنی 4- نونیل فنل، اوکتیل فنل و بیس فنل آ در رسوبات سطحی سواحل بخش جنوب غربی دریای خزر (کیاشهر- آستارا )</TitleF>
		<TitleE>Concentrationof 4- Nonylphenol, Octylphenol and Bisphenol A, Estrogen Doubt Compounds in Sediments of Southwest Coastal of Caspian Sea (Keyashahr-Astara)</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: امروزه آلودگی محیط زیست به خصوص آلودگی اکوسیستم‌های آبی جوامع انسانی و سایر موجودات زنده را درگیر مشکلات جدی نموده است. ترکیبات مختل کننده غدد درون ریز یا ترکیبات شبه استروژنی به علت ایجاد اثرات منفی در انسان و حیوانات (ماهیان و دوزیستان) امروزه بسیار شایان توجه‌اند. این مطالعه به منظور تعیین غلظت ترکیبات 4- نونیل فنل، اوکتیل فنل و بیس‌فنل آ در رسوبات سطحی 4 منطقه ساحلی (کیاشهر، انزلی، کپورچال و آستارا) در دریای خزر انجام پذیرفت.
مواد و روش‌ها: به منظور بررسی غلظت ترکیبات شبه استروژنی، نمونه‌های رسوب سطحی از عمق 10 متر 4 منطقه ساحلی در محدوده مورد مطالعه (کیاشهر، انزلی، کپورچال و آستارا) برداشت گردید. پس از آماده سازی نمونه ها (خشک کردن، استخراج و کروماتوگرافی ستونی) غلظت این ترکیبات توسط دستگاه گاز کروماتوگرافی با طیف سنج جرمی تعیین شد.
یافته‌ها: بر اساس نتایج غلظت ترکیبات 4- نونیل فنل، اوکتیل فنل و بیس‌فنل‌آ در رسوبات سطحی مناطق مورد مطالعه به ترتیب در محدوده 48/174- 41/16، 90/41- 63/5 و 66/30-3/0 نانوگرم به ازای هر گرم وزن خشک تعیین گردید. ایستگاه واقع در منطقه انزلی از هر سه ترکیب مقادیر قابل توجهی نشان دادند که نشان می‌دهد منابع وارد کننده این ترکیبات در منطقه وجود دارد و ایستگاه‌های واقع در منطقه کپورچال و آستارا مقادیر بسیار پایینی نشان دادند. مقایسه غلظت‌های بدست آمده با استاندارد کیفیت رسوب نشان داد که در برخی ایستگاه‌ها این ترکیبات پتانسیل ایجاد اثرات منفی بر موجودات منطقه را دارا می‌باشند.
استنتاج: با توجه به این که این ترکیبات در غلظت‌های کم نیز باعث ایجاد اثرات منفی شده و هم‌چنین قادرند در طول زنجیره غذایی منتقل شوند لذا نگرانی در ارتباط با حضور این آلاینده‌ها در آب‌های ساحلی خزر وجود دارد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Today, environmental pollution, especially pollution of aquatic ecosystems, humans and other organisms are faced with serious problems. Endocrine disrupting chemicals are one group of chemical compounds that are important because of their significant adverse effects in humans and animals. Therefore, this study aimed to determine the concentration of 4-Nonylphenol, Bisphenol A and Octylphenol compounds in surface sediments of 4 areas in the coastal of Caspian Sea.
Materials and methods: Surface sediments samples taken from stations were studied and after preparation (Drying, Extraction, Clean up) the samples were injected into the Gas Chromatography-mass Spectrometry
Results: The concentration ranges of 4-Nonylphenol, Octylphenol and Bisphenol A compounds in surface sediment samples were as follows (in ng/gdw): 16.41-174.48, 5.63-41.90 and 0.3-30.66 respectively. The station that is located in the Anzali region showed significant amounts of all three compounds, Because the sources of  these compounds there and the stations that are located in Kaporchal and Astara regions showed extremely low concentration. Compare concentrations were abtained from coasals of Caspian Sea with sediment quality standard showed that these compounds have potential to cause negative effects on the organisms in some stations
Conclusion: There are concerns about the presence of Estrogen Doubt Compounds in the aquatic ecosystems due to the adverse effects of them in biological communities health even at low concentrations.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>248</FPAGE>
			<TPAGE>256</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/182014/03/32014/02/162014/02/52014/02/5
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/16
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/182014/03/32014/02/162014/02/52014/02/5
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/16
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>سمیه</Name>
				<MidName></MidName>
				<Family>رشیدی یزدکی</Family>
				<NameE>Somayeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Rashidi Yazdaki</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>علیرضا</Name>
				<MidName></MidName>
				<Family>ریاحی بختیاری</Family>
				<NameE>Alireza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Riahi Baktiari</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>riahi@modares.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Estrogen Doubt Compounds</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Sediments</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Wastewaters</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Caspian Sea</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>ترکیبات شبه استروژنی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>رسوبات</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>فاضلاب</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>دریای خزر</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Pojana G, Gomiero A, Jonkers N, Marcomini A. Natural and synthetic endocrine disrupting compounds (EDCs) in water, sediment and biota of a coastal lagoon. Environ Interl 2007; 33(7): 929-936.##2.	Campbell CG, Borglin SE, Green FB, Grayson A, Wozei E, Stringfellow WT. Biologically directed environmental monitoring, fate, and transport of estrogenic endocrine disrupting compounds in water: A review. Chemo 2006; 65(8): 1265-1280.##3.	Manzano M, Perales J, Sales D, Quiroga J. Effect of concentration on the biodegradation of a nonylphenol polyethoxylate in river water. Bull of Environ Conta and Toxi 1998; 61(4): 489-496.##4.	Soto AM, Justicia H, Wray JW, Sonnenschein C. p-Nonyl-phenol: an estrogenic xenobiotic released from&#34; modified&#34; polystyrene. Environ Hea Pers 1991; 92: 167-173.##5.	White R, Jobling S, Hoare S, Sumpter ##J, Parker M. Environmentally persistent alkylphenolic compounds are estrogenic. Endoc 1994; 135(1): 175-182.##6.	Zgoła-Grześkowiak A, Grześkowiak T. Determination of alkylphenols and their short-chained ethoxylates in Polish river waters. Intel J of Environ Analy Chem 2011; 91(6): 576-584.##7.	Lee YJ, Ryu H-Y, Kim H-K, Min CS, Lee JH, Kim E, et al. Maternal and fetal exposure to bisphenol A in Korea. Repro Toxi 2008; 25(4): 413-419.##8.	Ben-Jonathan N, Steinmetz R. Xenoestrogens: the emerging story of bisphenol A. Tre in Endoc &#38; Meta 1998; 9(3): 124-128.##9.	Vazquez-Duhalt R, Marquez-Rocha F, Ponce E, Licea A, Viana M. Nonylphenol, an integrated vision of a pollutant. App Eco and Environ Res 2005; 4(1): 1-25.##10.	Ying GG, Kookana RS. Degradation of five selected endocrine-disrupting chemicals in seawater and marine sediment. Environ Sci &#38; Tech 2003; 37(7): 1256-1260.##11.	Jafari A, Abasabad R, Salehzadeh A. Endocrine disrupting contaminants in water resources and sewage in Hamadan City of Iran. Ir J of Environ Hea Sci &#38; Engin 2009; 6(2): 89-96.##12.	Mortazavi S, Riyahi Bakhtiari A, Sari AE, Bahramifar N, Rahbarizade F. Phenolic endocrine disrupting chemicals (EDCs) in Anzali Wetland, Iran: Elevated concentrations of 4-nonylphenol, octhylphenol and bisphenol A. Mar Pollut Bull 2012; 64(5): 1067-1073.##13.	Bakhtiari AR, Zakaria MP, Yaziz MI, Lajis MNH, Bi X, Rahim MCA. Vertical distribution and source identification of polycyclic aromatic hydrocarbons in anoxic sediment cores of Chini Lake, Malaysia: Perylene as indicator of land plant-derived hydrocarbons. App Geochem 2009; 24(9): 1777-1787.##14.	Isobe T, Nishiyama H, Nakashima A, Takada H. Distribution and behavior of nonylphenol, octylphenol, and nonylphenol monoethoxylate in Tokyo metropolitan area: their association with aquatic particles and sedimentary distributions. Environ Sci &#38; Tech 2001; 35(6): 1041-1049.##15.	Yang G-P, Ding H-Y, Cao X-Y, Ding Q-Y. Sorption behavior of nonylphenol on marine sediments: Effect of temperature, medium, sediment organic carbon and surfactant. Mari Pollut Bull 2011; 62(11): 2362-2369.##16.	Mammadov R, Khushravan H, Kaveyanpour MH. Hydrological Atlas of Caspian Sea. ##1st ed. Tehran: Publishing of Knowledge Secrets; 2012.##17.	Rico-Rico Á, Temara A, Behrends T, Hermens JL. Effect of sediment properties on the sorption of C&#60; sub&#62; 12&#60;/sub&#62;-2-LAS in marine and estuarine sediments. Environl Pollut 2009; 157(2): 377-383.##18.	David A, Fenet H, Gomez E. Alkylphenols in marine environments: Distribution monitoring strategies and detection considerations. Mar Pollut Bull 2009; 58(7): 953-960.##19.	Koh C-H, Khim JS, Villeneuve DL, Kannan K, Giesy JP. Characterization of trace organic contaminants in marine sediment from Yeongil Bay, Korea: 1. Instrumental analyses. Environ Pollut 2006; 142(1): 39-47.##20.	Bakke T, Källqvist T, Ruus A, Breedveld GD, Hylland K. Development of sediment quality criteria in Norway. J of Soi and Sedi 2010; 10(2): 172-178.##21.	Khim J, Lee K, Kannan K, Villeneuve D, Giesy J, Koh C. Trace organic contaminants in sediment and water from Ulsan Bay and its vicinity, Korea. Arch Environ Contam Toxicol 2001; 40(2): 141-150.##22.	Heemken O, Reincke H, Stachel B, Theobald N. The occurrence of xenoestrogens in the Elbe river and the North Sea. Chemo 2001; 45(3): 245-259.##23.	Petrovic M, Fernández-Alba AR, Borrull F, Marce RM, González ME, Barceló D. GBarceló D.Occurrence and distribution of nonionic surfactants, their degradation products, and linear alkylbenzene sulfonates in coastal waters and sediments in Spain. Environ Toxicol Chem 2002; 21(1): 37-46.##24.	Cheng CY, Liu LL, Ding WH. Occurrence and seasonal variation of alkylphenols in marine organisms from the coast of Taiwan. Chemo 2006; 65(11): 2152-2159.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>تغییرات زمانی و مکانی غلظت نیترات و نیتریت منابع آب آشامیدنی شهرستان کهگیلویه با استفاده از سیستم اطلاعات جغرافیایی(GIS)</TitleF>
		<TitleE>Temporal and Spatial Variation of Nitrate and Nitrite Concentration in Drinking Water Resource in Kohgiluyeh County Using Geographic Information System</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف : نیترات یکی از آلوده کننده های منابع آب زیرزمینی است که عمدتاً در ارتباط با مناطق کشاورزی و
محدوده های دفع فاضلاب می باشد . هدف از این بررسی ، تعیین تغییرات مکانی و زمانی نیترات و نیتریت منابع آب
می باشد. (Geographic Information system) GIS آشامیدنی شهرستان کهگیلویه با استفاده از
مواد و روش ها: مطالعه حاضر از نوع توصیفی مقطعی در سال 1391 بود که بر روی 18 منبع آب شرب و تعداد 108
نمونه در شهرهای مختلف شهرستان که گیلویه صورت گرفت و نتایج آنالیز 5 ساله آرشیو شده ، توسط شرکت آب و
نسخه 16 و آزمون همبستگی پیرسون مورد تجزیه و تحلیل قرار گرفت. SPSS ، نسخه 3 و 9 GIS فاضلاب با نر مافزار
18 و در تابستان و زمستان سال 1389 به ترتیب برابر با /5±1/ یافته ها: میانگین غلظت نیترات در سال 1385 برابر با 5
20 میلی گرم در لیتر بود که همبستگی مستقیمی بین سال و افزایش غلظت نیترات و جود داشت /83±2/ 20± و 2 4/6
غلظت نیتریت در بیش تر سال ها ثابت بوده است . تغییرات مکانی نشان دهنده کیفیت بدتر در قسمت .(R =0/92 ،p= 0/01)
شمال غربی بود. بهترین روش درون یابی برای نیترات و نیتریت کریجینگ معمولی بوده است.
استنتاج: طبق نتایج میزان نیترات روند افزایشی داشته و در بعضی قسمت ها در حال افزایش یافتن بیش از استاندارد
می باشد. دلایل آن زمین شناسی منطقه و کشاورزی می باشد که جهت جلوگیری از این روند، حریم گذاری چاه ها، استفاده
از رودخانه جهت تأمین آب کشاورزی، ساخت تصفیه خانه فاضلاب و غیره باید صورت گیرد</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Nitrate is one of the pollutants of groundwater resources which is
easily found in agricultural and wastewater disposal areas. The aim of this study was to determine the
spatial and temporal variations of nitrate and nitrite in drinking water resources of Kohgiluyeh -a city in
Iran- using Geographic Information System (GIS).
Materials and methods: This cross-sectional study was carried out in 2011 in which 18
sources of drinking water (108 samples) and results of five-year-archived analysis in Water and sewage
Co of Kohgiloyeh were studied applying GIS software ver. 9.3, SPSS ver. 16, and Pearson correlation
test.
Results: The results showed that the mean of nitrate concentration in 2007 was 18.5 ± 1.5 and in
the summer and fall of 2011 was 20 ± 4.6 and 20.83 ± 2.2 ppm, respectively which indicates a direct
correlation between years and the increase in nitrate concentration (R= 0.92, P= 0.01). However, the
nitrite concentration was found steady in most years. The spatial variations represent worse quality of
northwest. Ordinary kriging is the best interpolation method for nitrate and nitrite.
Conclusion: According to the results, the concentration of nitrite and nitrate has increased during
the past years and in some parts are even rising more than the standard levels. The reasons could be
regional geology and agricultural and to prevent such problems protecting the wells, using river water for
agriculture, and construction of wastewater treatment plants could be of great benefit.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>258</FPAGE>
			<TPAGE>263</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/182014/03/32014/02/162014/02/52014/02/52014/02/18
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/29
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/182014/03/32014/02/162014/02/52014/02/52014/02/18
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/29
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>محمدعلی</Name>
				<MidName></MidName>
				<Family>ززولی</Family>
				<NameE>MohammadAli</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Zazouli</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>منصور</Name>
				<MidName></MidName>
				<Family>برافراشته پور</Family>
				<NameE>Mansour</NameE>
				<MidNameE></MidNameE>
				<FamilyE>BarafrashtehPour</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>bmansoor50@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>زهرا</Name>
				<MidName></MidName>
				<Family>برافراشته پور</Family>
				<NameE>Zahra</NameE>
				<MidNameE></MidNameE>
				<FamilyE>BarafrashtehPour</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>وحید</Name>
				<MidName></MidName>
				<Family>قلندری</Family>
				<NameE>Vahid</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghalandari</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Nitrate</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>nitrite</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>GIS</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>dehdasht</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>temporal and spatial variation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>نیترات</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>نیتریت</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>GIS</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>دهدشت</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تغییرات زمانی و مکانی</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Mohseni-Bandpi A, Elliott DE, Zazouli MA. Biological nitrate removal processes from drinking water supply-a review. JEHSE 2013; 11(1): 35.##2.	Martin EJ, Martin ET. Technologies for Small Water and Wastewater Systems. Environmental Engineering Series. Van Nostrand Reinhold. New York: John Wiley &#38; Sons, Inc; 1991.##3.	WHO. Guidlines for drinking Water Quality. 2nd ed. Geneva. 1996.##4.	Salvato J. Environmental Engineering and Sanitation. 4rd ed. New York: JOHN Wiley and Sons. Inc; 1992.##5.	Peavy SH, Rowe DR, Tchobanoglous G. Environmental Engineering. 1st ed. New York: Mc Graw-Hill; 1985. ##6.	Ardavan B, Farhad H. Effect of geological formations on water quality, the aquifer of Dehdasht. Geography 2009; 3(11): 93-112.##7.	Yousefi Z, BarafrashtehPour M, Taghavi M, MashayekhSalehi A, Sedaghat F. Survey on Temporal and spatial variation of nitrate and nitrite in drinking water of Gachsaran by using Geographic Information System (GIS). J Mazand Univ Med Sci 2013; 22(2): 158-162 (Persian).##8.	Nejatyjhromi Z, Chitsazan M, Mirzai Y. the Geostatestical investigation of nitrate distribution of Agheli plain aquifer in GIS. Geomatics National Conference on 2011. 311-319.##9.	APHA. AWWA. WPCF. Standard Methods for the Examination of Water and Wastewater. 19th ed. Washington, DC: American Public Health Association, USA; 1995.##10.	Pasban A, Amani J, Chatr Simab M. Evaluation of nitate concentration in drinking water wells Bojnoord In 2007, 12th national Conference on Environmental Health, 2007, Shahid Beheshti university of medical science. (Persian)##11.	Zazouli MA, Alam Gholilou M. Survey of chemical quality (Nitrate, Flouride, Hardness, Electrical Conductivity) of driking water in Khoy city. J Mazandaran Univ Med Sci 2013; 23(Suppl-2): 80-84 (Persian).##12.	Ehsani H, Javid A, Hasani A, Shariat M, Rahmani A. Evaluation of nitrate variation and Total dissolved solids trend in drinking water using GIS Hamedan plain ground, 10th national Conference on Environmental Health, 2007.##13.	Azizi F. Spatial assessment of groundwater quality and aquifer vulnerability Emamzadeh Jafar Gachsaran by using of DRASTIC model and quality index of GWQI, Water Resources Engineering, Fifth Year, 2012: 11-14.##14.	Ostovari Y, Beigi Harchegani H, Davoodian A. Spatial variation in nitrate of groundwater in Lordegan Plains. Irrigation and Water Management 2012; 2(1): 67-55.##15.	Babiker IS, Mohamed MAA, Hiyama T. Assessing groundwater quality using GIS. Water Resources Management 2007; 21(4): 699-715.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>بررسی غلظت فلوئور در منابع آب شرب مناطق روستایی</TitleF>
		<TitleE>Fluorine Concentration in Drinking-Water Resources in Rural Areas</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: فلوئور یکی از عناصر مهم در ترکیب دندان ها و استخوان ها به شمار می رود. این عنصر می تواند از راه
های مختلف وارد بدن گردد ولی عمده ترین راه جذب آن از طریق آب آشامیدنی است . مطالعه حاضر با هدف بررسی
میزان فلوئور در منابع آب آشامیدنی مناطق روستایی استان مازندران انجام شد.
مواد و روش ها: این مطالعه از نوع توصیفی گذشته نگر می باشد که در سال 1390 بر روی آب شرب مناطق روستای ی
15 شهر استان مازندران انجام گرفت. در طی 4 فصل جمعاً 642 نمونه بررسی شد. در هر فصل به طور متوسط از 160 منبع یا
مخزن زمینی یا هوایی نمونه برداری شد که حداکثر تعداد نمونه فصلی، 183 نمونه و حداقل ، 144 نمونه بوده اس ت. کلیه
نمونه ها به آزمایشگاه های مختلف تحت پوشش شرکت آب و فاضلاب انتقال یافت و مطابق روش ذکر شده در مرجع
استاندارد، آنالیز شد.
5 درصد در حد استاندارد بوده است . / 94 درصد کم تر از حد استاندارد و 77 / یافته ها: از مجموع 642 نمونه آب، 23
میانگین میزان فلوئور در بین مناطق روستایی استان، اختلاف معنی داری داشتند. بالاترین میزان میانگین فلوئور در منابع آب
0 میلی گرم در لیتر مشاهده / 0 و کم ترین آن در فصل تابستان به میزان 06 / شرب مناطق روستایی در فصل بهار به میزان 61
0/31 بود. mg/l گردید. میانگین میزان فلوئور آب شرب در مناطق روستایی استان
استنتاج: میزان فلوئور در اکثر منابع آب مناطق روستایی استان مازندران ک متر از میزان حداقل توصیه شده است که
ضرورت دارد تلاش جدی جهت حل این مشکل به عمل آید.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Fluoride is one of the most important elements in the composition
of teeth and bones. Itcan enter the body through different ways. The main means of absorption is drinking
water. This study was done to determine the amount of fluorine in drinking-water resources of rural areas
in Mazandaran province.
Material and methods: This retrospective descriptive study was carried out in rural drinking
waterresources in 15 cities of Mazandaran province, Iran, 2011. A total of 642 samples was analyzed in
four seasons. In each season, about 160 water samples were taken from ground or elevated reservoirs. The
maximum and minimum numbers of seasonal water samples were 183 and 144, respectively. All samples
were transferred to various laboratories affiliated withWater and SewageCompany and were analyzed
according to standardreferences.
Results: Out of 642 samples, 94.23% was less than the standard level and 5.77% was in standard
level. The meanof fluorine concentration inruralareas of Mazandaran province was significantly different.
The highestamount of fluorine in drinking water at rural areas was 0.6 mg/l in spring and the lowest level
was observed in summer (0.06 mg/l). The mean concentration offluorine in drinking water of the rural
areas of Mazandaran province was 0.31 mg/l.
Conclusion: The amount of fluorine in all water resources of rural areas in Mazandaran province
is lower than the recommended minimum value, so it is an urgent necessity to plan for solving this
problem.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>265</FPAGE>
			<TPAGE>269</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/182014/03/32014/02/162014/02/52014/02/52014/02/182014/06/8
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1393/3/18
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/182014/03/32014/02/162014/02/52014/02/52014/02/182014/06/8
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1393/3/18
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>ذبیح الله</Name>
				<MidName></MidName>
				<Family>یوسفی</Family>
				<NameE>Zabihollah</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Yousefi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>عطریه</Name>
				<MidName></MidName>
				<Family>تقی زاده</Family>
				<NameE>Atrieh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Taghizadeh</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>atrtaghizade@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Fluorine</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>drinking water</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>rural areas Mazandaran</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>فلوئور</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>آب شرب</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>روستاهای مازندران</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Maleki A, Alavi N, Safari M, Rezaee R. Determination of Fluoride in Sanandaj Drinking Water Resources. Jundishapur Journal of Health Sciences 2012; 4(1): 17-24 (Persian).##2.	Sayf N. Drinking water in Nahavand town and health effect [MS Dissertation]. Iran. Tehran. Department of Health, Tehran University of Medical Science. 1991 (Persian).##3.	Firouzmanesh M. Fluorine and Iodide in Sanandaj water drinking [MS Dissertation]. Iran. Tehran. Department of Health, Tehran University of Medical Science. 1990. (Persian).##4.	Mahvi AH. Health aspect and Beauty-known water quality from AWWA. Tehran: Balgostar Publication; 1996. p.50. (Persian)##5.	Shahryari T, Azizi M, Sharifzadeh GhR, Hajiani M, Zeraatkar V, Aliabadi R. Evaluation of fluorine concentration in drinking-water sources in South Khorasan,  Journal of Birjand University of Medical 2010, 17(1): 33-41 (Persian).##6.	Riahi F, Radgoodarzi M, Application of Titanium Compounds to Reduce Fluoride Ion in Water Resources With High Fluoride Ion Contents. Water and Wastewater; 2005; 16(2 (54)): 82-87.##7.	WHO Guidelines for Drinking-Water Quality. Second Addendum to Third Edition. Volume 1 Recommendations. Available from: http://www.who.int/watersanitation health/dwq/secondaddendum20081119.pdf. ##8.	Sandy C, Richard G. Environmental Health Engineering in the Tropics: An Introductory Text, 2nd ed Translated by: Eysalo M, Mahvi AH. Tehran: Jahad Daneshgahy. 1992. p. 88. (Persian).##9.	Ramazani GH, Shahmirzadi S, Volai N, Sadat S. Evaluation fluoride in drinking water Sari Spring 2009. Journal of Researchin Dental 2009; 6(3(21)): 76-72.##10.	Samarghandi M, Sadri G. Determination of fluoride content in drinking water of Hamedan and Bahar cities since 1998-1999. J Hamedan Univ Med Sci 2001; 8: 42-7 (Persian).##11.	Rezaei M, Majidi Gharetapeh A. Evaluation fluoride in drinking water in some areas inhabited cities of Neka, joybar, Savadkuh in year 2008. Journal of Dentistry 2010 7(2): 54-58 (Persian).##12.	Seraj B, Shahrabi M, Falahzade M, Falahzade F, Akhondi N, Roohi N. Effect of high fluoride concentration in drinking water on children’s intelligence. J Dent Med Tehran Univ Med Sci 2006; 19: 80-86 (Persian).##13.	Fallahian F. Fluorosis. J Dent Med Tehran Univ Med Sci 2003; 16(35): 73-78 (Persian).##14.	Iran Institute of Standards and Industrial Research. Water characteristics: Standard Number 1053, 2000. (Persian).##15.	Institute of Standards and Industrial Research of Iran: Drinking Water-Physical and Chemical Specifications; ISIRI Number 1053, 5th revision; 2010. Available at:www. isiri.org.##16.	Sadeghi H, Rohollahi S. Study of Ardabil Drinking Water Physicochemical Parameters. Journal of Ardabil University of Medical Sciences &#38; Health Services 2007; 7(1): 52-56 (Persian).##17.	Rajaei Q, Mehdinejad MH, Hesari Motlagh S. A Survey of chemical quality of rural drinking water of Birjand and Qaen Plains, Iran. Health Care Research 2012; 7: 737-745 (Persian).## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>ارزیابی سطح آگاهی مراجعین به مراکز بهداشتی درمانی استان مازندران درباره بیماری وبا</TitleF>
		<TitleE>Knowledge of People Attending Health Centers in Mazandaran Province on Cholera</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>سابقه و هدف: همه ساله در کشور ما گزارش هایی از بیماری وبا گزارش می‌شود.آگاهی بخشی از جمعیت عمومی در مورد وبا در راس فعالیت‌های پیشگیرانه از این بیماری است. با توجه به توریستی بودن استان مازندران، هدف از این مطالعه ارزیابی سطح آگاهی جمعیت عمومی استان مازندران درباره بیماری وبا است
مواد و روش‌ها: در این مطالعه توصیفی- مقطعی، از میان جمعیت عمومی ساکن در استان مازندران که جهت دریافت خدمات بهداشتی درمانی در اردیبهشت 1392 به مراکز روستایی یا شهری مراجعه نمودند، 425 نفر به طور تصادفی انتخاب شدند که به پرسشنامه‌ای حاوی 10 سوال در مورد جنبه‌های مختلف بیماری وبا در حضور مطالعه‌گر پاسخ دادند. سپس اطلاعات توسط نرم افزار  SPSS16 با استفاده از آمار توصیفی و آزمون Chi-Square مورد تجزیه و تحلیل قرار گرفت.
یافته‌ها: 222 (2/52 درصد) نفر زن و 203 (8/47 درصد) نفر مرد بودند. میانگین سنی جمعیت مورد بررسی 5/11±34 سال بود. سطح آگاهی افراد به ترتیب 5/27 درصد ضعیف (3≥نمره)، 2/33 درصد متوسط (نمره 4و5)، 8/34 درصد خوب (نمره 6 و 7) و 5/4 درصد خیلی خوب (نمره≥8) بود. اختلاف معنی‌داری بین نمره‌های کسب شده در دو جنس وجود نداشت ولی در گروه‌های دو سر طیف مورد مطالعه (کم‌تر از 20 و بالاتر از 60 سال) به‌وضوح وضعیت ضعیف‌تری از لحاظ سطح آگاهی مردم وجود دارد.
استنتاج: سطح آگاهی جمعیت در وضعیت مطلوبی قرار ندارد و اجرای برنامه‌های آموزشی خصوصاً برای گروه‌های هدف با میزان آگاهی پایین باید مورد توجه قرار گیرد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background and purpose: Annually outbreak of cholera is reported in our country. Awareness of the general population about cholera is the cornerstone of disease prevention. The aim of this study was to assess the awareness of general population in Mazandaran province about cholera.
Materials and methods: This cross-sectional study was carried out in April 2013. The study population included 425 people of general population attending health centers in Mazandaran province who were randomly selected. They completed a questionnaire containing 10 questions about cholera in the presence of researcher. SPSS ver. 16 was used to analyze the data.
Results: The participants were 222 (52.2%) female and 203 (47.8%) male with the mean age of 34±11.50 years. The awareness level were, 27.5% poor (score≤3), 33.2% moderate (score4 and 5), 34.8% good (score 6 and 7) and 4.5% very good (score≥8). We observed low levels of awareness among those aged under 20 and over 60 years old. However, no significant difference was seen in two genders.
Conclusion: This study revealed a low level of awareness among general population on cholera. Therefore, educational programs are recommended to enhance the knowledge of people on cholera.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>271</FPAGE>
			<TPAGE>275</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/182014/03/32014/02/162014/02/52014/02/52014/02/182014/06/82014/02/10
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/21
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/182014/03/32014/02/162014/02/52014/02/52014/02/182014/06/82014/02/10
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/21
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>علی رضا</Name>
				<MidName></MidName>
				<Family>داودی بدابی</Family>
				<NameE>Alireza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Davoudi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>نرگس</Name>
				<MidName></MidName>
				<Family>نجفی</Family>
				<NameE>Narges</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Najafi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>لطف اله</Name>
				<MidName></MidName>
				<Family>داودی</Family>
				<NameE>Lotfollah</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Davoodi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>lotfdavoodi@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>فاطمه</Name>
				<MidName></MidName>
				<Family>آهنگرکانی</Family>
				<NameE>Fatemeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ahangarkani</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>حسن</Name>
				<MidName></MidName>
				<Family>اصغری</Family>
				<NameE>Hasan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Asghari</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>سارا</Name>
				<MidName></MidName>
				<Family>جاودانی یکتا</Family>
				<NameE>Sara</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Javdani Yekta</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Awareness</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Health centers</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>cholera</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Mazandaran</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سطح آگاهی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>مراکز بهداشتی درمانی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>وبا</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>مازندران</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Carlos Seas, Eduardo Gotuzzo. Vibrio cholera. Chapter 214. In: Principles and practice of infectious disease. Mandell GL, Bennett JE, Dolin R, (eds). 7th ed. Elsevier: USA; 2010. p. 2777-2785.##2.	World Health Organization (2011 August) Global Health Observatory (GHO): Number of reportedcholera cases. Available from: http://www.Who.int/gho/epidemic_diseases/ cholera/ cases text/en/index.html. Accessed##August 14, 2012.##3.	Waldor MK, Keusch GT. Vibrio cholera Chapter 57. In: Harrison’s infectious disease. Braunwald A, Eugene M, (eds). 17th ed. ##New York: MC Graw-Hill; 2011. p. 540-546.##4.	Tabatabaei M, Zahraei M, Ahmadnia H, Ghotbi M, Rahmi F. Principles of disease prevention. Chapter 17. 1st ed. Tehran: Rooh Ghalam; 2006. p. 131-137. (Persian).##5.	Davoudi A, Babamahmoudi F, Najafi N, Alikhani A, Ghasemian R, Alian S, et al. Awareness of General Practitioners in Mazandaran province on Diagnosis, Treatment and Prevention of Cholera. J Mazandaran Univ Med Sci 2013; 23(101): 113-118 (Persian).##6.	Jamshidi M. The level of GPs of Bandar abbas around TB and DOTS way. Hormozgan Medicine of Collage 2003; 32(2): 32-34 (Persian). ##7.	Hadi N, Shiraly R. Medial Interns’ knowledge about Hypertension in Shiraz University of Medical Sciences. Iran J Med Educ 2005; 5(2): 165-170 (Persian).##8.	Dehghani R, Davari B, Akbari H, Salimi S, Khodaveisi S. Evaluation of the girl junior student of Ghom about cholera. Magiran Com 2011; 74(14): 24-28.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>یک مورد خال ملانوسیتیک با جز کانونی سلول آتی پیک اپی تلوئید</TitleF>
		<TitleE>Melanocytic nevus with An Atypical epitheloid cell component</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>خال‌ها جزء تومورهای خوش خیم پیگمانته پوست به شمار می‌رود در حالی که، ملانوم بدخیم جزء سرطان‌های بسیار تهاجمی پوست است. با توجه به شباهت بسیار زیاد بعضی از انواع خال‌های خوش خیم به ویژه نوع دارای جزء کانونی سلول آتیپیک اپی‌تلوئید با ملانوم بدخیم و تفاوت زیاد در سیر بیماری و درمان، افتراق آن‌ها از نظر بالینی و پاتولوژی بسیار مهم است. بیمار حاضر خانم 24 ساله‌ای است که جهت برداشتن یک ضایعه پیگمانته ناحیه لب جهت برداشتن به متخصص پوست مراجعه نموده و با تشخیص یک نوع نادر، به نام خال ملانوسیتیک با جز کانونی سلول آتی پیک اپی تلوئید،که یکی از موارد افتراقی مشکل از ملانوم بدخیم می‌باشد، معرفی می‌شود.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Nevi are a pigmented benign tumor in the skin but the malignant melanoma is a aggressive malignant neoplasm in the skin. 
A melanocytic nevus with an atypical epitheloid cell component is a benign neoplasm in skin that can be difficult to distinguish from melanoma.
In this study we reported a case of melanocytic nevus with an atypical epitheloid cell component on the upper lip in 24 years old girl.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>277</FPAGE>
			<TPAGE>281</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/182014/03/32014/02/162014/02/52014/02/52014/02/182014/06/82014/02/102014/03/8
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/12/17
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/182014/03/32014/02/162014/02/52014/02/52014/02/182014/06/82014/02/102014/03/8
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/12/17
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>لاله</Name>
				<MidName></MidName>
				<Family>واحدی لاریجانی</Family>
				<NameE>Lale</NameE>
				<MidNameE></MidNameE>
				<FamilyE>VahediLarijani</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>مریم</Name>
				<MidName></MidName>
				<Family>قاسمی</Family>
				<NameE>Maryam</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghasemi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>زهره</Name>
				<MidName></MidName>
				<Family>حاج حیدری</Family>
				<NameE>Zohre</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hajheydari</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Melanocytic nevus</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>An Atypical epitheloid  component</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>melanoma</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>خال ملانوستیک</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>اپی تلوئید آتی پیک</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>ملانوم بدخیم</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Elder DE, Elenitsas R, Johnson BL, Murphy GF. Lever\'s Histopathology of the Skin. Philadelphia, PA: Lippincott Williams &#38; Wilkins; 2009. p. 699-701.##2.	Pouryazdanparast P, Haghighat Z, Beilfuss BA, Guitart J, Gerami P. Melanocytic nevi with an atypical epithelioid cell component: clinical, histopathologic, and fluorescence in situ hybridization findings. Am J Surg Pathol 2011; 35(9): 1405-1412.##3.	High WA, Alanen KW, Golitz LE. Is melanocytic nevus with focal atypical epithelioid components (clonal nevus) a superficial variant of deep penetrating nevus? J Am Acad Dermatol 2006; 55(3): 460-466.##4.	Scolyer RA, Zhuang L, Palmer AA, Thompson JF, McCarthy SW. Combined naevus: a benign lesion frequently misdiagnosed both clinically and pathologically as melanoma. Pathology 2004; 36(5): 419-427.##5.	Ball NJ, Golitz LE. Melanocytic nevi with focal atypical epithelioid cell components: a review of seventy-three cases. J Am Acad Dermatol 1994; 30(5 Pt 1): 724-729.##6.	Chorny JA, Barr RJ, Kyshtoobayeva A, Jakowatz J, Reed RJ. Ki-67 and p53 expression in minimal deviation melanomas as compared with other nevomelanocytic lesions. Mod Pathol 2003; 16(6): 525-529.##7.	Satoh S, Hashimoto-Tamaoki T, Furuyama J, Mihara K, Namba M, Kitano Y. High frequency of tetraploidy detected in malignant melanoma of Japanese patients by fluorescence in situ hybridization. Int J Oncol 2000; 17(4): 707-715.## #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>مروری بر روش های مختلف تشخیصی بیماری بابزیوز</TitleF>
		<TitleE>An Overview on Different Diagnostic Methods for Babesiosis</TitleE>
		<TitleLang_ID>1</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>بابزیوز یکی از مهم ترین بیماری های عفونی انگلی در صنعت دام پروری اکثر نقاط دنیا است. علی رغم مطالعاتی که با
استفاده از روش های تشخی صی گوناگون روی این بیماری انجام شده است وضعیت کنونی استفاده از روش های تشخیصی
با ویژگی و حساسیت بالا ب ه طور دقیق روشن نیست . لذا هدف از این مطالعه بررسی مقالات منتشر شده در ایران و جهان و
مرور روش های تشخیصی بابزیوز است. مطالعه حا ضر از نوع مروری غیر نظام من د است. جامعه مورد مطالعه از پایگاه های
و غیره گردآوری Google scholar, Pub med, Web of Science, Scopus, Springer, SID اطلاعاتی علمی قابل دسترس نظیر
شد. بررسی مطالعات انجام شده در ایران و جهان نشان داد در نقاط مختلف جهان از روش های تشخیصی متفاوت جهت
شناسایی جنس و گونه های بابزیا استفاده شده است . هرچند در ایران و برخی از نقاط جهان با وجود روش های نوین
تشخیصی، هنوز روش های سنتی مانند اسمیر خون محیطی با حساسیت تشخیصی پایین استفاده م ی شوند اما روند استفاده از
این قبیل روش ها در سال های اخیر سیرنزولی داشته است واس تفاده از رو ش های مولکولی و سرولوژی رو به افزایش است .
اغلب محققین جهت افزایش دقت و قدرت تشخیص از دو روش اختصاصی (مولکولی و سرولوژی) بیش تر بهره گرفته اند.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Babesiosis is one of the most important parasitic infectious diseases in livestock industry
throughout the world. Studies with various diagnosis methods have been done on this disease,
nevertheless the current status of using the diagnosis methods with high specificity and sensitivity is not
well defined. Hence, this narrative review investigated the published articles on the status of Babesiosis
and its diagnostic methods in Iran and the world. The data were collected from available scientific
databases including Google scholar, Pub med, Web of science, Scopus, Springer, and Scientific
Information Database (SID). We found many studies with different diagnostic methods for detection of
genus and species of Babesia spp. In recent years, using specific diagnostic methods has increased,
although traditional methods (peripheral blood smear) with low sensitivity are still applied in some parts
of the world and also in Iran. Our investigations show that researchers frequently use molecular and
serological methods to increase the accuracy of diagnosis.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>283</FPAGE>
			<TPAGE>295</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/182014/03/32014/02/162014/02/52014/02/52014/02/182014/06/82014/02/102014/03/82014/02/16
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1392/11/27
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/02/162014/03/12014/03/112014/02/42014/02/42014/03/82014/02/82014/02/182014/01/282014/02/42014/02/52014/02/102014/01/282014/05/172014/02/42014/01/282014/03/82014/02/52014/01/252014/02/52014/02/52014/02/92014/02/182014/03/32014/02/162014/02/52014/02/52014/02/182014/06/82014/02/102014/03/82014/02/16
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1392/11/27
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>سیدموسی متولی</Name>
				<MidName></MidName>
				<Family>حقی</Family>
				<NameE>Seyed Moosa</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Motevalli Haghi1</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>مهدی</Name>
				<MidName></MidName>
				<Family>فخار</Family>
				<NameE>Mahdi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Fakhar</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>mahdif53@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>مهدی</Name>
				<MidName></MidName>
				<Family>شریف</Family>
				<NameE>Mehdi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sharif</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>مسعود</Name>
				<MidName></MidName>
				<Family>کیقبادی</Family>
				<NameE>Masoud</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Keyghobadi</FamilyE>
				<Organizations>
				<Organization>علوم پزشکی مازندران</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Babesiosis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>diagnosis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>peripheral blood smear</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>molecular method</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>serological method</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>بابزیوز</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تشخیص</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>روش مولکولی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>روش سرولوژی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>اسمیرخون محیطی</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Gharavi MJ. Clinical Parasitology. 3th ed. Tehran: Teimorzahed; 2003.##2.	Tavassoli M. Veterinary Protozoology. 1st ed. Uromieh: University Publisher Center; 2006. p. 186-211.##3.	Fischer M. Manual of Tropical Veterinary Parasitology. CAB International, London. 2008; 2: 16-20.##4.	Kreier JP, Baker JR. Parasitic Protozoa. 1st ed. Winchester: Allen and Unwin, Inc; 1987.##5.	Kalani H, Fakhar M, Pagheh A. An overview on present situation of babesiosis and theileriosis and their distribution of ticks in Iran. Iranian J Med Microbiol 2010; 5(7): ##59-71.##6.	Conrad PA, Kjemtrup AM, Carreno RA, Thoford J, Wainwright K, Eberhard M, et al. Description of Babesia duncani n.sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms. Int J Parasitol 2006; 36(7): 779-789.##7.	Schnittger L, Rodriguez AE, Florin-Christensen M, Morrison DA. Babesia: A world emerging. Infect Genetic Evolu 2012; 12(8): 1788-1809.##8.	Uilenberg G. Babesia-A historical overview. Vet Parasitol 2006; 138(1-2): 3-10.##9.	Noaman V, Jahangirnejad AA, Nabinejad A. A study on prevalence and identification of Babesia spp. in immigrant sheep and goats and nomadic people of Isfahan Province. Pajouhesh Sazandegi 2004; 67: 35-41.##10.	Rafiyi A. Veterinary protozoology and comparative. Tehran: Publications of the Scientific Research Council Secretariat. Ministry of Sciences and Higher Education 1978.##11.	Sadeghi Dehkordi Z, Zakeri S, Nabian S, Bahonar A, Ghasemi F, Noorollahi F, Rahbari S. Molecular and biomorphometrical identification of ovine Babesiosis in Iran. Iranian J Parasitol 2010; 5(4): 21-30.##12.	Fakhar M, Hajihasani A, Maroufi SH, Alizadeh H, Shirzad H, Piri F, Pagheh A. An epidemiological survey on bovine and ovine babesiosis in Kurdistan Province, western Iran. Trop Anim Health Prod 2012; 44(2): 319-322.##13.	Motavalli Haghi SM, Fakhar M, Sharif M, Paghe AS, Sharbatkhori M, Tavakoli R, et al. Molecular identification of ovine Babesia spp. in north of Iran. Res Mol Med 2013; 1(1): 36-40.##14.	ِDelpy RLP. Agents en Iran dans le sang des animaux domestiques. Bull Path Exot 1936; 29: 157-161.##15.	Hashemi-Fesharaki R, Uilenberg G. Babesia crassa n.sp. (Sporozoa, Babesiidae) of domestic sheep in Iran. Vet Quarterly 1981; 3(1): 1-8.##16.	Hashemi-Fesharaki R. Tick-born disease of sheep and goats and their related vectors in Iran. Parasitologia 1997; 39: 115-117.##17.	Razmi GhR, Nouroozi E, Transovarial Transmission of Babesia ovis by Rhipicephalus sanguineus and Hyalomma marginatum. Iranian J Parasitol 2010; 5(3): 35-39.##18.	Razmi GR, Najarnejad V, Rashtibaf M. Determination the frequency of Ixodid ticks on the sheep in Khorasan Razavi province, Iran. Arch Razi Institute 2011; 66(2): 129-132.##19.	Mazlum Z. Tick species of Iran, its distribution, host and seasonal activity. J Vet Fac Uni Tehran 2007; 62(1): 1-28.##20.	Razmi G, Pourhosseini M, Yaghfouri S, Rashidi A, Seidabadi M. Molecular detection of Theileria spp. and Babesia spp. in sheep and ixodid ticks from the northeast of Iran. J Parasitol 2013; 99(1): 77-81.##21.	Razmi GR, Naghibi A, Aslani MR, Dastjerdi K, Hossieni H. An epidemiological study on Babesia infection in small ruminants in Mashhad suburb, Khorasan Province, Iran. Small Rumin Res 2003; 50(1): 39-44.##22.	Shayan P, Hooshmand E, Rahbari S, Nabian S. Determination of Rhipicephalus spp. as vectors for Babesia ovis in Iran.Parasitol Res 2003; 101(4): 1029-1033.##23.	Razmi GR, Naghibi A, Aslani MR, Fathivand M, Dastjerdi K. An epidemiological study on ovine babesiosis in the Mashhad suburb area, province of Khorasan, Iran. Vet Parasitol 2002; 108(2): 109-115.##24.	Ziapour SP, Esfandiari B, Youssefi MR. Study of the prevalence of Babesiosis in domesticated animals with suspectedsigns in Mazandaran Province, north of Iran, during 2008 .J Animal Vet Adv 2011; 10(6): 712-714.##25.	Hosseni HS. Parasitic infections of domesticated animals. Tehran: Tehran University Press; 2003.##26.	Azizi H, Pourjafar M, Ayati Sajzeyi H. Prevalence of Sheep Babesiosis during Spring and Summer 2003 in Lenjan- Isfahan. J Sch Vet Med 2005; 9(11): 67-75.##27.	Tavassoli M, Haji-Ghahremani SH. Identification of Babesia speices and tick infestation in sheep in Ardabil. J faculty Vet Med Univ Tehran 1993; 59(1): 10-12.##28.	Tavasoli M, Rahbari S. Seroepidemiological survey of Babesia ovis in sheep at different geographical regions of Iran. J faculty Vet Med Univ Tehran 1998; 53: 55-59.##29.	Hashemzadeh farhang H, Nabavi L, Seyfiabad shapouri MR, Rahbari S, Azizi F. Development of an ELISA technique for the detection of Babesia ovis and serological survey of the parasite in Khouzestan province, southern Iran. Iranian J Vet Res 2006; 7(2): 53-58.##30.	Tavassoli M, Tabatabaei M, Mohammadi M, Esmaeilnejad B, Mohamadpour H. PCR-based detection of Babesia spp. infection in collected ticks from cattle in West and North-West of Iran. J Arthropod Borne Dis 2013; 7(2): 132-138.##31.	Shayan P, Rahbari S. Simultaneous differentiation between Theileria spp. and Babesia spp. On stained blood smear using PCR. Parasitol Res 2005; 97(4): 281-286.##32.	Razmi GR, Khodaverdi M. Diagnosis of Theileria annulata in cattle with subclinical or clinical symptoms by polymerase chain reaction (PCR). 15th Iranian Veterinary Congress 2008; Tehran, Iran.##33.	Heidarpour Bami M, Khazraiinia P, Haddadzadeh HR, Kazemi B. Identification of Theileria species in sheep in the eastern half of Iran using nested PCR-RFLP and microscopic techniques. Iranian J Vet Res 2010; 11(3): 262-266.##34.	Noaman V. A molecular study on Theileria and Babesia in cattle from Isfahan province, Central Iran, J Parasit Dis 2013. (Published Online).##35.	Razmi G, Pourhosseini M, Yaghfouri S, Rashidi A, Seidabadi M. Molecular detection of Theileria spp. and Babesia spp. in sheep and ixodid ticks from the northeast of Iran. J Parasitol 2013; 99(1): 77-81.##36.	Almeria S, Castella J, Ferrer D, Ortuño A, Estrada-Peña A, Gutiérrez JF. Bovine piroplasma in Minorca (Balearic Island, Spine): a comparison of PCRbased and light microscopy detection. Vet Parasitol 2001; 99(3): 249-259.##37.	Ahmed J, Yin H, Schnittger L, Jongejan F. Ticks and tick-borne diseases in Asia with special emphasis on China. Parasitol Res 2002; 88(13 Suppl 1): S51-55.##38.	Altay K, Aydin MF, Dumanli N, Aktas M. Molecular detection of Theileria and Babesia infections in cattle. Vet Parasitol 2008; 158##(4): 295-301.##39.	Caccio SM, Antunovic B, Moretti A, Mangili V, Marinculic A, Baric RR, et al. Molecular characterization of Babesia canis canis and Babesia canis vogeli from naturally infected European dogs. Vet Parasitol 2002; 106(4): 285 - 292.##40.	Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215: 403-410.##41.	Fahrimal Y, Goff WL, Jasmer DP. Detection of Babesia bovis carrier cattle by using polymerase chain reaction amplification of parasite DNA. J Clin Microbiol 1992; 30: 1374-1379.##42.	Theodoropoulos G, Gazouli M, Ikonomopoulos JA, Kantzoura V, Kominakis A. Determination of prevalence and risk factors of infection with Babesia in small ruminants from Greece by polymerase chain reaction amplification. Vet Parasitol 2005; 135(2): 99-104.##43.	Figueroa JV, Chieves LP, Johnson GS, Buening GM. Multiplex polymerase chain reaction based assay for the detection of Babesia bigemina, Babesia bovis and Anaplasma marginale DNA in bovine blood. Vet Parasitol 1993; 50: 69-81.##44.	Sparagano O, Loria GR, Gubbels MJ, De Vos AP, Caracappa S, Ongejan F. Integrated molecular diagnosis of Theileria and Babesia species of cattle in Italy. Ann N Y Acad Sci 2000; 916: 533-539.##45.	Oyamada M, Davoust B, Boni M, Dereure J, Bucheton B, Hammad A, et al. Detection of Babesia canis rossi, B. canis vogeli, and Hepatozoon canis in dogs in a village of Eastern Sudan by using a screening PCR and sequencing methodologies. Clin Diag Lab Immun 2005; 12(11): 1343-1346.##46.	Passos LM, Geiger SM, Ribeiro MF, Pfister K, Zahler-Rinder M. First molecular detection of Babesia vogeli in dogs from Brazil. Vet Parasitol 2005; 127(1): 81-85.##47.	Applewhaite LM, Craig TM, Wagner GG. Serological prevalence of bovine babesiosis in Guyana. Trop. Anim Health Prod 1981; 13: 13-18.##48.	Bose R, Jacobson RH, Gale KR, Waltisbuhl DJ, Wright IG. An improved ELISA for the detection of antibodies against Babesia bovis using either a native or a recombinant B. bovis antigen. Parasitol Res 1990; 76: 648-652.##49.	Hauschild S, Shayan P, Schein E. Characterization and comparison of merozoite antigens of different Babesia canis isolates by serological and immunological investigations. Parasitol Res 1995; 81: 638-642.##50.	Silva MG, Henriques G, Snchez C, Marques PX, Suarez CE. First survey for Babesia bovis and Babesia bigemina infection in cattle from Central and Southern regions of Portugal using serological and DNA detection methods. Vet Parasitol 2009; 166(1-2): 66-72.##51.	Silva MG, Marques PX, Oliva A. Detection of Babesia and Theileria species infection in cattle from Portugal using a reverse line blotting method. Vet Parasitol 2010; 174(3-4): 199-205.##52.	Terkawi MA, Huyen NX, Shinuo C, Inpankaew T, Maklon K, Aboulaila M, et al. Molecular and serological prevalence of Babesia bovis and Babesia bigemina in water buffaloes in the northeast region of Thailand. Vet Parasitol 2011; 178(3-4): 201-207.##53.	Terkawi MA, Thekisoe OM, Katsande C, Latif AA, Mans BJ, Matthee O, et al. Serological survey of Babesia bovis and Babesia bigemina in cattle in South Africa. Vet Parasitol 2011; 182(2-4): 337-342.##54.	Shikano SK, Nakada R, Shimada HT, Ono K. A short term in vitro cultivation of Babesia rodhaini and Babesia microti. J Vet Med Sci 1995; 57: 955-957.##55.	Canning EU, Winger CM. Babesiidae. In vitro methods for parasite cultivation. Taylor AER, Baker JR, (ed). New York: Academic Press; 1987; p. 199-229.##56.	Levy MG, Ristic M. Cultivation and in vitro studies of Babesia. In vitro cultivation of protozoan parasites. Jensen JB, (ed). Boca Raton, Fla: CRC Press; 1983. p. 221-241.##57.	Bautista CR, Kreier JP. The action of macrophages and immune serum on growth of Babesia microti in short-term cultures. Tropenmed Parasitol 1980; 31: 313-324.##58.	Erp EE, Smith RD, Ristic M, Osorno BM. Continuous in vitro cultivation of Babesia bovis. Am J Vet Res 1980; 41: 1141-1142.##59.	Goff WL, Yunker CE. Effects of pH, buffers and medium storage on the growth of Babesia bovis in vitro. Int J Parasitol 1988; 18: 775-778.##60.	Gorenflot A, Brasseur P, Precigout E, L\'Hostis M, Marchand A, Schrevel J. Cytological and immunological responses to Babesia divergens in different hosts: ox, gerbil, man. Parasitol Res 1991; 77: 3-12. ##61.	Zweygarth E, Van Niekerk CJ, de Waal DT. Continuous in vitro cultivation of Babesia caballi in serum-free medium. Parasitol Res 1999; 85: 413-416.##62.	Holman P, Chieves WM, Frerichs D, Olson G, Wagner G. Babesia equi erythrocytic stage continuously cultured in an enriched medium. J Parasitol 1994; 80: 232-236.##63.	Shikano S, Nakada R, Hashiguchi T, Shimada T, Ono K. A short term in vitro cultivation of Babesia rodhaini and Babesia microti. J Vet Med Sci 1995; 57:955-957.##64.	Quick RE, Herwaldt JW, Thomford ME, Garnett ML, Eberhard M, Wilson DH, et al. Babesiosis in Washington State: a new species of Babesia? Ann Int Med 1993; 119: 284-290.##65.	Thomford JW, Conrad SR, Telford IIID, Mathiesen BH, Bowman A, Spielman ML, et al. Cultivation and phylogenetic characterization of a newly recognized human pathogenic protozoan. J Infect Dis 1994; 169: 1050-1056.##66.	Persing DH, Herwaldt C, Glaser RS, Lane JW, Thomford D, Mathiesen PJ, et al. Infection with a Babesia-like organism in northern California. New Engl J Med 1995; 332: 298-303.##67.	Jackson LA, Waldron SJ, Weier HM, Nicoll ##CL, Cooke BM. Babesia bovis: culture of laboratory-adapted parasite lines and clinical isolates in a chemically defined medium. Exp Parasitol  2001; 99(3): 168-74.##68.	Brown CGD. Theileriidae. In vitro methods for parasite cultivation. In Taylor AER, Baker JR, (ed). New York: Academic Press; 1987. p. 230-253.##69.	Thomford JW, Conrad PA, Boyce WM, Holman PJ, Jessup DA. Isolation and in vitro cultivation of Babesia parasites from free-ranging desert bighorn sheep (Ovis canadensis nelsoni) and mule deer (Odocoileus hemionus) in California. J Parasitol 1993; 79: 77-84.##70.	Mosqueda J, Olvera-Ramírez A, Aguilar-Tipacamú G, Cantó GJ. Current Advances in detection and treatment of Babesiosis. Current Med Chemist 2012; 19(10): 1504-1518.##71.	Buling A, Criado-Fornelio A, Asenzo G, Benitez D, Barba-Carretero JC, Florin-Christensen M. A quantitative PCR assay for the detection and quantification of Babesia bovis and B. bigemina. Vet Parasitol 2007; 147(1-2): 16-25.##72.	New standard for veterinary Diagnosis. 2012; Available at: http://www.petnad.com/produc ts_ 3.php? prod=14. Accessed May 2, 2013.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>

</ARTICLES>

</JOURNAL>
</XML>
